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8ABSTRACT 
In everyday life, humans may be exposed to chemicals at different occasions and in 
a number of different ways. Chemicals may be released into the environment during 
production or disposal of products and disperse into air, surface water or 
groundwater, soil, crops and wildlife. Occupational exposure to chemicals may also 
occur during production or use of a product. Furthermore, chemical exposure may 
result from the use of a large variety of consumer products. Finally, a large number of 
chemicals are deliberately used for specific applications (pesticides, biocides, 
veterinary products, food additives), resulting in exposure through food and other 
routes. 
Regarding Pesticides or Plant Protection Products (PPRs), these have been used to 
protect crops from being damaged or destroyed by disease and pests and thus, to 
maintain crop yields since last century.
The majority of pesticides are chemicals. Residues are the measurable amounts of 
these chemicals resulting from the use of pesticides that remain on cereals, fruit and 
vegetables after harvesting. Pesticides residues present on crops used to feed 
animals and in the environment can be found in foods of animal origin such as meat, 
milk and eggs. 
By their nature, pesticides are potentially toxic to other organisms, including humans, 
and need to be used safely and disposed of properly. The EU approach to pesticides 
aims to pesticide use be limiting to the minimum quantity that allows them to carry 
out their job effectively while ensuring food is safe to eat. Thus, the pesticide 
residues in food and feed are being monitored on each Member State (MS) annually. 
These results are included in the annual report by EFSA (European Food Safety 
Authority) which additionally, assesses the exposure of EU – consumers to these 
residues. As EU decision – makers use these data as a basis for future actions such 
as monitoring activities, pesticide authorisations and MRL setting, this has resulted in 
the removal of the EU-market of a large number of pesticides that failed to meet 
current safety standards.
Methods: The present study is focused on examining the safety approach of 
pesticide residues found in various food categories together with their potential 
cumulative effect. This study is based on data from EFSA regarding the dietary 
consumption of consumers in the country of Greece whereas, the diet survey was 
addressed to “lactating diet” on the one hand and “regional Crete” on the other hand. 
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9The population class chosen was “lactating women” and “children”, respectively. The 
values of pesticide residues present in various food categories were extracted from 
many studies involving mostly European markets and less international ones.              
Results: It is discussed the evidence for possible contributions of environmental 
chemicals to Neurotoxicity including Developmental Neurotoxicity (DNT) and Cancer 
risk, as end-points. Therefore, the outcome of Risk Characterisation Ratio (RCR) for 
Chronic and Acute exposure, Margin of Safety (MoS), Cumulative Chronic risk and 
Cumulative Cancer risk has been assessed. 
Conclusions: Acute risk to human health has been induced by the presence of 
some pesticide residues in foods for the sub – population “lactating women”. The 
most important aspect of this study is the identification of cumulative cancer risk to 
both sub – populations “lactating women in Greece” and “children in the regional 
prefecture of Crete” due to the consumption of foods detected with various pesticide 
residues. According to the latest scientific development internationally that gave rise 
to cumulative risk assessment, cumulative effects will only occur when chemicals 
with similar toxicological properties present on food are consumed together. Thus, 
the development of pesticides with better qualitative and quantitative attributes with 
regard to elimination of severe toxicity effects to human health should be progressed 
and also combined with effective pest management training to all stakeholders. 
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1.1.1. TERMS – DEFINITIONS – CLASSES 
According to the website of the Directorate General for Health and Food Safety of the 
European Commission, the term “pesticide” is referred to as “something that 
prevents, destroys, or controls a harmful organism (“pest”) or disease, or 
protects plants or plant products during production, storage and transport”.
The term includes, amongst others: herbicides, fungicides, insecticides, acaricides, 
nematicides, molluscicides, rodenticides, growth regulators, repellents and biocides.1
According to EFSA (European Food Safety Authority) website, the term “pesticides” 
is commonly used as a synonym for plant protection products. Plant protection 
products (PPPs) are pesticides that are mainly used to keep crops healthy and 
prevent them from being destroyed by disease and infestation. They include 
herbicides, fungicides, insecticides, acaricides, plant growth regulators and 
repellents.2 
Plant protection products contain at least one active substance. These substances 
can be chemicals or micro-organisms, including viruses that enable the product to 
perform its action. In the current study, whenever the term “pesticides” is used this 
refers to the plant protection products and the active substances contained in them. 
PPPs are products in the form in which they are supplied to the user, consisting of, or 
containing active substances, safeners or synergists, and intended for one of the 
following uses3:  
 (a) protecting plants or plant products against all harmful organisms or 
preventing the action of such organisms, unless the main purpose of these 
products is considered to be for reasons of hygiene rather than for the 
protection of plants or plant products (e.g. fungicides, insecticides);
 (b) influencing the life processes of plants, such as substances influencing 
their growth, other than as a nutrient (e.g. plant growth regulators, rooting 
hormones);
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 (c) preserving plant products, in so far as such substances or products are 
not subject to special Community provisions on preservatives (e.g. extending 
the life of cut flowers);
 (d) destroying undesired plants or parts of plants, except algae unless the 
products are applied on soil or water to protect plants (e.g. 
herbicides/weedkillers to kill actively growing weeds);
 (e) checking or preventing undesired growth of plants, except algae unless 
the products are applied on soil or water to protect plants (e.g. 
herbicides/weedkillers preventing the growth of weeds).
The pesticides are classified under functional classes, according to the Codex 







 Insect growth regulator
 Insecticide
 Nematocide
 Plant growth regulator
 Scald control agent
 Storage scald preventer
 Synergist
1.1.2. PESTICIDES AND EU – LEGISLATION 
The placing of a pesticide on the EU market is regulated by the “Regulation (EC) 
No 1107/2009 of the European Parliament and of the Council of 21 October 2009 
concerning the placing of plant protection products on the market and repealing 
Council Directives 79/117/EEC and 91/414/EEC”.3 At this point, it is necessary to 
present the following definitions that apply under this Regulation:
“Residues” means one or more substances present in or on plants or plant products, 
edible animal products, drinking water or elsewhere in the environment and resulting 
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from the use of a plant protection product, including their metabolites, breakdown or 
reaction products.
“Substances” means chemical elements and their compounds, as they occur 
naturally or by manufacture, including any impurity inevitably resulting from the 
manufacturing process.
“Substance of concern” means any substance which has an inherent capacity to 
cause an adverse effect on humans, animals or the environment and is present or is 
produced in a plant protection product in sufficient concentration to present risks of 
such an effect. Such substances include, but are not limited to, substances meeting 
the criteria to be classified as hazardous in accordance with Regulation (EC) No 
1272/2008 of the European Parliament and of the Council of 16 December 2008 on 
classification, labelling and packaging of substances and mixtures, and present in the 
plant protection product at a concentration leading the product to be regarded as 
dangerous within the meaning of Article 3 of Directive 1999/45/EC. 
“Plant products” means products of plant origin in an unprocessed state or having 
undergone only simple preparation, such as milling, drying or pressing, but excluding 
plants.
“Harmful organisms” means any species, strain or biotype belonging to the animal 
kingdom or plant kingdom or pathogenic agent injurious to plants or plant products.
“Non-chemical methods” means alternative methods to chemical pesticides for 
plant protection and pest management, based on agronomic techniques such as 
those referred to in point 1 of Annex III to Directive 2009/128/EC, or physical, 
mechanical or biological pest control methods.
“Authorisation of a plant protection product” means an administrative act by 
which the competent authority of a Member State authorises the placing on the 
market of a plant protection product in its territory. 
“Rapporteur Member State (RMS)” means the Member State which undertakes the 
task of evaluating an active substance, safener or synergist.
All matters related to legal limits for pesticide residues in food and feed are covered 
by Regulation (EC) No 396/2005.7 This regulation also contains provisions on official 
controls of pesticides residues in food of plant and animal origin that may arise from 
their use in plant protection.
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The residues of the plant protection products, consequent on application consistent 
with good plant protection practice and having regard to realistic conditions of use, 
shall meet the following requirements: (a) they shall not have any harmful effects on 
human health, including that of vulnerable groups, or animal health, taking into 
account known cumulative and synergistic effects where the scientific methods 
accepted by the Authority to assess such effects are available, or on groundwater; 
(b) they shall not have any unacceptable effect on the environment.3 
For residues which are of toxicological, ecotoxicological, environmental or drinking 
water relevance, there shall be methods in general use for measuring them. 
Analytical standards shall be commonly available.3 
1.1.3. SUSTAINABLE USE OF PESTICIDES
The EU sets rules for the sustainable use of pesticides to reduce the risks and 
impacts of pesticide use on people's health and the environment (Directive 
2009/128/EC).4  
Main Actions for sustainable use of pesticides: 
 National Action Plans – EU countries adopt them setting objectives and 
timetables to reduce risks and impacts of pesticide use.
 Training – Professional pesticide users, distributors and advisors get proper 
training.
EU countries establish competent authorities and certification systems.
 Information and awareness raising – Member States shall take measures 
to inform the general public and put in place systems to gather information on 
acute poisoning incidents and chronic poisoning developments.
 Aerial spraying – Aerial spraying is prohibited. EU countries may allow it 
under strict conditions after warning people.
 Minimising or banning – EU countries minimise or ban the use of pesticides 
in critical areas for environmental and health reasons.
 Inspection of equipment in use – All pesticides application equipment will 
have to be inspected at least once by 2016 to grant a proper efficient use of 
any plant protection product;
 Integrated pest management (IPM) – Promotion of low pesticide-input 
management including non-chemical methods. Professional users will have to 
apply general principles of IPM from 1 January 2014.5  
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1.1.4. APPROVAL OF ACTIVE SUBSTANCES
A plant protection product usually contains more than one component. The active 
component against pests /plant diseases, as mentioned above, is called “active 
substance”. The Commission evaluates every active substance for safety before it 
reaches the market in a product. Substances must be proven safe for people's 
health, including their residues in food and effects on animal health and the 
environment.
Procedure:
1. Application to an EU country called Rapporteur Member State (RMS)
2. RMS verifies if the application is admissible
3. RMS prepares a draft assessment report
4. EFSA issues its conclusions
5. Standing Committee for Food Chain and Animal Health votes on approval or 
non-approval
6. Adoption by the Commission
7. Publication of a Regulation in the EU Official Journal
Under the new EU rules, it takes 2.5 to 3.5 years from the date of admissibility of the 
application to the publication of a Regulation approving a new active substance. This 
time varies greatly as depends on how complex and complete the dossier is.6
Before an active substance can be used within a pesticide in the EU, it must 
be approved by the European Commission. 
Substances undergo an intensive evaluation and peer-review by Member States and 
the European Food Safety Authority before a decision can be made on approval. 
1.1.4.1. LIST OF CANDIDATES FOR SUBSTITUTION 
“The European Commission is required by Regulation (EC) No 1107/2009 to 
establish a list of substances identified as “candidates for substitution”. The list 
identifies active substances with certain properties.
For plant protection products (PPPs) containing these active substances, Member 
States will be required to evaluate if they can be replaced (substituted) by other 
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adequate solutions (chemical and non-chemical). To prepare such a list, the 
Commission requested a consultant to prepare a report on the implementation of the 
criteria set by the Regulation. The report does not contain any official listing, but 
presents different options drawn from possible interpretations of the criteria.
Member States and stakeholders were consulted on the approach taken and on the 
input values taken to determine if an active substance qualifies to be a candidate for 
substitution. The analysis has been conducted by comparing the agreed and peer 
reviewed endpoints, against the relevant seven conditions specified in Annex II, point 
4 of the Regulation. The information is grouped in a comprehensive database that 
will be updated on a regular basis. The current draft list contains 77 candidates for 
substitution.6 
1.1.5. AUTHORISATION OF PESTICIDES 
According to a large body of EU legislation, the release of a plant protection product 
into the market is divided into two major parts that are in close collaboration; the one 
is undertaken by EFSA through evaluation of the active substances based on their 
risk assessment and the other, by the Member States that evaluate and authorise the 
products at national level.2 
EU countries authorise pesticides on their territory and ensure compliance with EU 
rules. Regulation (EC) No 1107/2009 lays down the rules, procedures and 
timeframes for authorisation of PPPs. Prior to placing on the market or using any 
pesticide, it must be authorised in the Member State(s) concerned. 
The application procedure is dependent on a zonal system in EU to enable a 
harmonised and efficient system to operate. The EU is divided into 3 zones; North, 
Central and South. Member States assess applications on behalf of other countries 
in their zone and sometimes on behalf of all zones. Applicants, Member States, the 
European Commission and the European Food Safety Authority (EFSA) can be 
involved in the process of authorisation.8 
There are different types of application that can be submitted depending on the 
intended use of the PPP, the Member State(s) for which the PPP is required and the 
regulatory status of any existing authorisations. The controls of the use and placing 
on the market of PPPs are performed by Member States.8 
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1.1.6. MAXIMUM RESIDUE LEVEL (MRL)
In simple words, the traces a pesticide leaves in treated products is called “residue”.   
Pesticide residues resulting from the use of plant protection products on food or feed 
crops may pose a risk to public health. For this reason, a comprehensive legislative 
framework has been established in the European Union which defines rules for the 
approval of active substances used in plant protection products, the use of plant 
protection products and for pesticide residues in food. 
Maximum residue levels (MRLs) are the upper levels of pesticide residues that are 
legally permissible in or on food or animal feed, based on good agricultural practice 
(GAP) and the lowest consumer exposure necessary to protect vulnerable 
consumers. They are derived after a comprehensive assessment of the properties of 
the active substance and the intended use of the pesticide. These legal limits also 
apply to imported food.2 
Before an MRL is set or amended – for example, because an applicant requests the 
authorisation of a new plant protection product – EFSA assesses the residue 
behaviour of the pesticide and possible consumer health risks from residues in food. 
Provided that EFSA’s risk assessment does not identify any unacceptable risks to 
consumers, EU-harmonised MRLs are set (Database of MRLs in the EU) 9 and the 
plant protection product can be authorised. As well as assessing new MRLs, the 
Pesticides Unit, in close cooperation with Member States, reviews the scientific basis 
of existing MRLs and performs consumer risk assessments to ensure they are 
compliant with current data requirements and are safe for consumers.  The outcome 
of EFSA’s MRL assessments are presented as reasoned opinions.2 
Chronic (long-term) and acute (short-term) dietary consumer exposure to pesticide 
residues are estimated using a calculation model developed by EFSA (PRIMo – 
Pesticide Residue Intake Model) 10. The model is based on national food 
consumption data and unit weights provided by Member States and implements 
internationally agreed risk assessment methodologies.2
All the above process – from approval of active substances to authorisation of PPPs 
– contributes to better protection of agricultural production and at the same time is 
ensuring that PPPs, when properly applied for the purpose intended, are sufficiently 
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effective and have no unacceptable effects on plants and plant products, on the 
environment and there are no harmful effects on humans. Despite this rather strict 
and costly pre-market pesticide approval process, pesticides and their conversion 
products end up in the plants and plant products in undesirable concentrations 
posing toxicological risk to various population categories.
1.1.7. PESTICIDES AND HUMAN HEALTH – NEUROTOXICITY 
Pesticides are one of the most commonly encountered classes of neurotoxic 
substances. They can include insecticides (used to control insects), fungicides (i.e. 
for blight and mildew), rodenticides (for rodents, such as rats, mice and gophers) and 
herbicides (to control weeds) (Hayes, 1991).28 Active ingredients are combined with 
so-called inert substances to make thousands of different pesticide formulations. 
Workers who are overexposed to organophosphate pesticides may display obvious 
signs and symptoms of poisoning, including tremors, weakness, ataxia, visual 
disturbances and short-term memory loss (Ecobichon J. & Joy M., 1982; Abou-Donia 
M.B., 1995).29, 30   
The organophosphate insecticides have neurotoxic properties and account for 
approximately 40% of registered pesticides in the USA. Delayed neurotoxicity can be 
seen as a result of exposure to certain organophosphate pesticides, producing loss 
of motor function and an associated neuropathology (Ecobichon D.J. & Joy R.M., 
1982).29  
Organophosphate and carbamate insecticides are known to interfere with a specific 
enzyme, acetylcholinesterase (AChE) (Davis C.S. & Richardson R.J., 1980; Abou-
Donia M.B., 1995; Metcalf R.L., 1995).30,31,32 Neuropathy has also been reported 
following consumption of non-pesticide organophosphates, such as tri-o-
cresylphosphate (TOCP). 
Other classes of pesticides, including the organochlorines (Cannon et al., 1978; 
Woolley D.E., 1995)33, 34 and pyrethroids (Clark J.M., 1995)35, may produce signs of 
functional neurotoxicity. A number of reports have noted that many cases of human 
poisonings due to the ingestion or absorption of neurotoxic pesticides go unreported. 
This is especially true in developing countries, where up to 45% of pesticide 
poisoning cases occur in young children (WHO, 2000).36 
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Structure-activity relationships (SARs) are widely used to predict toxicological 
properties of chemicals based on chemical structure. The basis for inference from 
SARs can be either comparison with structures known to have biological activity or 
knowledge of structural requirements of a receptor or macromolecular site of action. 
Although information from SARs can significantly aid in the design of studies, there 
have been limitations. In neurotoxicology, as in many other areas, there have been 
relatively few well characterized SARs. However, there are some examples where 
SARs have been demonstrated and have provided guidance for evaluating additional 
compounds such as, organophosphorus compounds predicted to cause 
organophosphate-induced delayed neurotoxicity (Johnson M.K., 1988).17, 26   
To date, SARs have been demonstrated only for some specific forms of 
neurotoxicity; thus, the use of SARs for excluding potential neurotoxicity is not 
generally acceptable. For some homologous groups of chemicals, SARs combined 
with knowledge of chemical or physical properties have provided information on the 
risk of acute neurotoxicity or narcotic effects.17 
Such information is helpful for evaluating potential toxicity when only minimal data 
are available. The SARs of some chemical classes, such as hexanes, 
organophosphates, carbamates and pyrethroids, may help predict neurotoxicity or 
interpret data from neurotoxicological studies. Under certain circumstances (e.g., in 
the case of new chemicals), this procedure is one of the primary methods used to 
evaluate the potential for toxicity when few or no empirical toxicity data are available. 
It should be recognized, however, that effects of chemicals in the same class can 
vary widely. Moser (1995)27, for example, reported that the behavioural effects of 
prototypic cholinesterase-inhibiting pesticides differed qualitatively in a battery of 
behavioural tests.17  
1.2. NEUROTOXICITY 
1.2.1. DEFINITIONS
Neurotoxicity occurs when the exposure to natural or manmade toxic substances 
(neurotoxicants) alters the normal activity of the nervous system. This can eventually 
disrupt or even kill neurons, key cells that transmit and process signals in the brain 
and other parts of the nervous system. Neurotoxicity can result from exposure to 
substances used in chemotherapy, radiation treatment, drug therapies, and organ 
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transplants, as well as exposure to heavy metals such as lead and mercury, certain 
foods and food additives, pesticides, industrial and/or cleaning solvents, cosmetics, 
and some naturally occurring substances. Symptoms may appear immediately after 
exposure or be delayed. They may include limb weakness or numbness; loss of 
memory, vision, and/or intellect; headache; cognitive and behavioral problems; and 
sexual dysfunction. Individuals with certain disorders may be especially vulnerable to 
neurotoxicants.11
1.2.2. THE NERVOUS SYSTEM   
The nervous system receives and sends signals throughout the body to control bodily 
functions. The nervous system consists of the central nervous system (brain and 
spinal cord) and peripheral nervous system (nerve fibers that attach to and lie outside 
the brain and spinal cord). The nervous system has two components, motor (efferent) 
and sensory (afferent), that carry information from and to, respectively, the central 
nervous system. The brain is the organ of thought, emotion, and processing of the 
various senses and communicates with and controls various other systems and 
functions. The nervous system also provides special senses such as sight, hearing, 
taste, feel, and smell. It uses the eyes, ears, tongue, skin, and nose to gather 
information about the body's environment.18
According to the International Programme on Chemical Safety (IPCS) – 
Environmental Health Criteria 60, the importance of studying the Nervous System 
lays down to its complexity. The brain is an extremely complex organ, the function of 
which is to receive and integrate signals and then to respond appropriately, to 
maintain bodily functions. It supports a diversity of complex processes including 
cognition, awareness, memory, and language. Sexual behaviour, locomotion, and the 
use of a vast array of tools ranging from the slingshot to the microcomputer, suggest 
the range of responses available to the human organism. Moreover, the nervous 
system is influenced by the functioning of other organ systems (e.g., hepatic, 
cardiovascular, and endocrine systems). Thus, toxicant-induced alterations in any of 
these organ systems can be reflected in changes in neurobehavioural output. This 
fact alone suggests that nervous system function should be among the first to be 
thoroughly assessed in cases of exposure to known or potentially hazardous agents. 
Major outbreaks of neurotoxicity in human populations of various sizes have 
emphasized the importance of neurotoxicology as an independent discipline.12 
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The science of Neurotoxicology includes studies on the actions of chemical, 
biological, and certain physical agents that produce adverse effects on the nervous 
system and /or behaviour during development and at maturity. Toxic disorders of the 
nervous system of human beings and animals may occur following abuse of such 
substances as ethanol, inhalants, narcotics, therapeutic drugs, products or 
components of living organisms (e.g., bacteria, fungi, plants, animals), chemicals 
designed to affect certain organisms (e.g., pesticides), industrial chemicals, chemical 
warfare agents, additives and natural components of food, raw materials for 
perfumes, and certain other types of chemicals encountered in the environment.12 
Caution must be exercised in labelling a substance neurotoxic. The intended use and 
effect of the compound, the dose, the exposure scenario and whether or not the 
compound acts directly or indirectly on the nervous system must be taken into 
consideration. For example, pharmaceutical agents, vitamins and herbal substances 
may offer safe and beneficial effects at low concentrations, whereas higher doses 
may result in neurotoxicity. Therefore, the neurotoxic potential always needs to be 
considered in terms of the dose relationship.17 
1.2.3. METHODS FOR ASSESSING HUMAN NEUROTOXICITY
1.2.3.1. CLINICAL NEUROLOGICAL EVALUATION
The assessment of potential neurotoxicity in individuals begins with a clinical 
evaluation of an individual patient in order to establish a differential diagnosis of 
neurotoxic disease and to rule out other possible etiologies. The clinical evaluation of 
a suspected case of neurotoxicity includes a detailed medical history and a standard 
clinical neurological examination. Depending on the clinical signs, symptoms or type 
of exposure, these techniques may be supplemented by other assessment 
procedures, including clinical neuropsychological evaluation, neurophysiological tests 
and neuroimaging techniques.17  
1.2.3.2. NEUROPSYCHOLOGICAL AND NEUROBEHAVIOURAL TESTING
1.2.3.2.1. INDIVIDUAL NEUROPSYCHOLOGICAL ASSESSMENT
In addition to the neurological examination, neuropsychological testing is often 
carried out in the clinical evaluation of neurotoxicity, especially in those cases where 
there is an indication of cognitive or affective changes. Similar to the neurological 
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examination, neuropsychological testing also helps in ruling out other etiologies as 
well as establishing the extent of psychological impairment.17 
1.2.3.2.2. COGNITIVE TESTING BATTERIES
One approach to evaluating changes in neurobehavioural functioning in studies of 
exposed populations involves a shortened battery of clinical neuropsychological tests 
that focus on those effects most commonly seen in CNS toxic disorders.17  
1.2.3.2.3. PSYCHIATRIC AND SYMPTOM QUESTIONNAIRES
Changes in affect are some of the most dramatic effects of severe neurotoxic 
exposures. Psychotic symptoms, including delusions, hallucinations and paranoia, 
have been noted in mercury, arsenic and manganese poisoning cases (White R.F. & 
Proctor S.P., 1995)37, and suicidal depression resulting from poisoning with carbon 
disulfide has been well known for over a century (Mikkelsen S., 1995).38 Less severe 
effects (e.g., changes in mood and energy levels) have also been reported in 
exposed populations and, in some cases, may be the earliest indication of neurotoxic 
exposure (IPCS, 1986).12 As a result, questionnaires and symptom ratings are also 
typically included both in the assessment of individual neurotoxicity cases and in 
epidemiological studies of exposed populations.17 
1.2.3.2.4. BEHAVIOURAL NEUROPHYSIOLOGICAL TESTS
Because sensory and motor changes have often been associated with exposure to 
particular chemicals, both the neurological examination and symptom questionnaires 
typically include items designed to obtain information regarding sensory and motor 
disturbances. In recent years, although neurotoxic exposures have been associated 
with effects on different sensory modalities, including hearing, most of the work in the 
area of behavioural neurophysiological testing has concentrated on colour vision, 
contrast sensitivity, vibration sensitivity and olfactory discrimination.17 
1.2.3.3. ELECTROPHYSIOLOGICAL TESTS
Similar to behavioural tests, electrophysiological tests of PNS and CNS function may 
be used to augment the neurological examination. Although these tests are not in 
themselves diagnostic of neurotoxicity, they can be used to help detect and 
characterize dysfunction. Electrophysiological methods are generally used to 
diagnose individual patients but could be applied to the study of exposed 
populations, particularly exposed workers. One advantage of electrophysiological 
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tests is that many techniques are directly applicable to animal studies, making 
possible direct cross-species comparisons.
Recent developments in quantitative neurophysiological methods provide promising 
research tools for the evaluation of neurotoxicity in humans. Popular techniques have 
included, peripheral nerve testing and SEPs, qEEG, the analysis of the P300 
waveform and ERPs. However, further research aimed at standardizing techniques, 
validating different methodologies and examining the effects of different exposures is 
necessary before such methods can be accepted as diagnostic instruments.17 
1.2.3.4. NEUROIMAGING TECHNIQUES 
Over the last 20 years, a number of image-producing technologies, such as 
computerized axial tomography (CAT), magnetic resonance imaging (MRI), positron 
emission tomography (PET) and single photon emission computerized tomography 
(SPECT) have been developed for use in the diagnosis of neurological disease. CAT 
and MRI produce images of the brain, and PET and SPECT supply functional or 
biochemical information that cannot be obtained with other methods in a non-invasive 
manner. Neuroimaging techniques provide an invaluable measure of local brain 
function and dysfunction, which can be integrated with neurobehavioural measures 
for studying brain-behaviour relationships at the human level. Neuroimaging 
techniques provide a unique research tool with which to investigate structural and 
biochemical changes in neurotoxic disease and, in the future, may constitute an 
important source of information regarding structural and functional changes in the 
human brain as a function of neurotoxic exposures.17 
In conclusion, there has been significant progress in the last decade in developing 
validated methods for detecting neurotoxicity in humans as well as an increased 
understanding of the factors that impact on the validity and reliability of human 
neurotoxicity studies. Standardised neuropsychological tests, validated computer-
assisted test batteries, neurophysiological and biochemical tests, and refined imaging 
techniques have been improved for use in both clinical and research applications. 
These techniques are being utilized in different epidemiological study designs to 
examine the relationship between exposure to neurotoxic compounds and health 
effects.17 
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Since the determination of exposure-response/effect relationships is a prerequisite 
for inferring a causal relationship between a chemical and a health effect, reliable 
and valid methods to determine the degree of exposure are of critical importance in 
these studies. Environmental monitoring can be used to measure current levels of 
external exposure, and biochemical techniques can be used to measure levels of 
internal exposure. Modelling techniques, such as PBPK modelling, may also prove 
useful in helping to interpret biomonitoring data. These objective measures, coupled 
with subject-specific information, can be used to provide estimates of dose. Recent 
studies, however, demonstrate the difficulties in obtaining reliable estimates of 
exposure and dose in human studies and highlight the need for improved methods in 
this area. In addition, the development of methods for measuring early biochemical 
effects (i.e., biomarkers of effect), which could be used to monitor early, readily 
reversible effects, should also be encouraged.17 
In addition, there are important individual differences in susceptibility to neurotoxic 
agents. The developing nervous system appears to be particularly vulnerable to 
some kinds of damage, and there is concern that neurotoxic exposure may be a 
contributory factor in neurodegenerative processes related to aging as well. Genetic 
differences in the metabolism of xenobiotics may also be of etiological importance in 
the expression of neurotoxic disease. Although progress has been made in the 
development of assessment techniques in children, more research is needed to 
establish normative data for use in different populations. Similarly, the study of the 
role of aging and genetic factors in the etiology of neurotoxic disease is also 
necessary.17 
1.2.4. ANIMAL STUDIES – FACTORS TO BE CONSIDERED IN THE DESIGN OF 
NEUROTOXICITY 
Determining the risk posed to human health from chemicals requires information 
about the potential toxicological hazards and the expected levels of exposure. Some 
toxicological data can be derived directly from humans. Sources of such information 
include accidental exposures to industrial chemicals, cases of food-related poisoning, 
epidemiological studies and clinical investigations. Although there are human data 
from clinical trials for drugs providing the most direct means of determining effects of 
potentially toxic substances, it is usually not applicable to other categories of 
substances. Quite often, the nature and extent of available human toxicological data 
are too incomplete to serve as the basis for an adequate assessment of potential 
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health hazards. Furthermore, for a majority of chemical substances, human 
toxicological data are simply not available.17 
Consequently, for most toxicological assessments, it is necessary to rely on 
information derived from animal models, usually rats or mice. One of the primary 
functions of animal studies is to predict human toxicity prior to human exposure. In 
some cases, species phylogenetically more similar to humans, such as monkeys or 
baboons, are used in neurotoxicological studies.17 
Biologically, animals resemble humans in many ways and can often serve as 
adequate models for toxicity studies (Russell, 1991).25 This is particularly true with 
regard to the assessment of adverse effects on the nervous system, whereby animal 
models provide a variety of useful information that helps minimize exposure of 
humans to the risk of neurotoxicity. There are many approaches to testing for 
neurotoxicity, including whole-animal (in vivo) testing and tissue/cell culture (in vitro) 
testing.17
In using animal models to predict neurotoxic risk in humans, it is important to 
understand that the biochemical and physiological mechanisms that underlie human 
neurological and psychological functions are often incompletely understood and, 
therefore, are difficult, if not impossible, to model exactly in animals. While this 
caveat does not preclude extrapolating the results of animal studies to humans, it 
does highlight the importance of using valid animal models in well-designed 
experimental studies.17  
1.2.4.1. GENERAL CONSIDERATIONS
Many factors must be taken into consideration with regard to any animal toxicology 
study. These include the choice and number of animals, dosage, route and duration 
of administration, metabolism and pharmacokinetics, and testing procedures.
1.2.4.2. OBJECTIVES
The nervous system is protected from undesirable external influences by both 
physical and chemical barriers. This protection, however, is not complete. The blood-
brain barrier has an important function in preserving the chemical constitution of the 
nervous system, but some noxious substances, particularly those that are lipid 
soluble, may still cross it. Another mode of entry is by uptake into the peripheral 
terminals of nerves, which may then transfer the substances into their cell bodies in 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
25
the central nervous system through retrograde axonal flow. Such a mechanism 
operates for substances as remote as tetanus toxin and some viruses.12 
The peripheral nervous system is, of course, more likely to be exposed to 
neurotoxicity. The neurons of the autonomic nervous system and the sensory ganglia 
are outside the blood-brain barrier, as are small regions of the CNS (Central Nervous 
System), circumventricular organs (e.g., area postrema) and, to a limited extent, the 
retina. As might be expected, the nervous system may be particularly vulnerable 
either during development or in senescence. Physical changes or the presence of 
toxins may also disrupt the blood-brain barrier and, thus, allow substances normally 
excluded from the brain to reach and affect it adversely.12 
The objectives of neurotoxicity testing are to: 
(a) identify whether the nervous system is altered by the toxicant (detection);
(b) characterise the nervous system alterations associated with exposure; 
(c) ascertain whether the nervous system is the primary target for the chemical; and 
(d) determine dose– and time– effect relationships aimed at establishing a no-
observed-adverse-effect level. 
In a sense, these objectives translate into a series of questions about the toxicity of a 
chemical, and achieving them requires behavioural, neurophysiological, biochemical, 
and neuropathological information.12  
When faced with a chemical for which no toxicological data are available, the first 
question is whether the nervous system is or is not affected by the chemical. This 
represents the most fundamental level of investigation and entails procedures that 
"screen" for neurotoxicity. Once a chemical is known to produce neurotoxic effects, 
further studies must be performed in order to characterize the nature and mechanism 
of the alterations. These studies explore the consequences of toxicant exposure and 
give an indication of whether or not the nervous system is the primary target organ. 
Many functions are mediated by unique neural substrates, and chemicals may 
produce selective effects. Thus, it is important to use a variety of tests that measure 
different functions, in order to maximize the probability of detecting a toxic effect.12
Although certain chemicals produce selective damage in the nervous system, a more 
common finding is one of widespread damage and disruption of a variety of 
functions. Ideally, characterization of such generalized neurotoxicity by a variety of 
methods will establish a profile of the disrupted functions.
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Once a chemical has been identified as neurotoxic, the next objective is to determine 
dose-effect and time-effect relationships. One aim of these studies is to establish no-
observed-adverse-effect levels, but to prove that a certain dose produces no effect 
may require a very large number of experimental animals (Dews P.B., 1982).39 To be 
useful in risk assessment, threshold determinations must be obtained by the most 
sensitive tests available.12  
The question of how to define toxicity is of critical importance for the ultimate goal of 
risk assessment and the establishment of hygienic standards. Considerable 
controversy exists concerning what constitutes an adverse effect in toxicology. 
According to one view, any evidence of a behavioural or biological change is 
considered to be an adverse effect. According to others, evidence is required of both 
an irreversible decrement in the ability of the organism to maintain homeostasis 
and/or an enhanced susceptibility to the deleterious effects of other environmental 
influences. In this latter view, differentiation between "non-adversive" and "adverse" 
effects requires considerable knowledge of the importance of reversible changes and 
subtle departures from "normal" behaviour, physiology, biochemistry, and 
morphology in terms of the organism's overall economy of life, ability to adapt to 
other stresses, and their possible effects on life span (WHO, 1978).13 Real or 
potential risks to the nervous system are difficult to assess because of its complexity. 
Some of the problems in assessment are associated with the wide variations that can 
occur but are still considered to be within the "normal" range. Some are associated 
with the plasticity of the nervous system. Other problems in assessment are related 
to incomplete understanding of what is being measured by certain tests. It is clear, 
therefore, that no single test will suffice to examine the functional capacity of the 
nervous system. The above comments suggest tiered testing approaches.12 
1.2.4.3. CHOICE OF ANIMALS
For obvious reasons of safety and ethics, it is necessary to use animals in toxicity 
assessments. However, the extrapolation of animal toxicological data to human 
beings is always tenuous and should be carried out with caution. In preliminary mass 
screening of known or suspected environmental toxicants, there are economic 
factors that must be taken into account. It is also important that there be adequate 
anatomical, physiological, pharmacological, and toxicological data bases on the 
species chosen for study, so that meaningful interpretations of effects can be made 
and appropriate hypotheses about mechanisms and loci of action can be framed.12 
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For these reasons, the mouse or rat is usually preferred in a preliminary screen, 
though the rodent differs from man in many significant ways. For more detailed 
studies, other species may provide a more appropriate model. For example, the adult 
chicken is the animal of choice to test organophosphate induced delayed 
neurotoxicity (Abou-Donia M.B., 1981).14  
Other variables, besides species, that must also be considered such as, the strain of 
animal used, its age and of course, its sex (male, female).
1.2.4.4. DOSING REGIMEN
In environmental toxicology, the detection of cumulative toxicity following continued 
(or intermittent) exposure is a major goal. Thus, a multiple-dosing regimen is most 
frequently used. It is important to assess the toxicity at various intervals, since both 
quantitative and qualitative changes in the response to environmental factors can 
occur on repeated exposure, or even with time following a single exposure (Evans 
H.L. & Weiss B., 1978).15 Assessments should be made for some time following 
cessation of the dosing regimen, since it is of interest to determine the reversibility of 
any effects noted during the dosing phase and to note any post-dosing effects.12 
1.2.4.5. FUNCTIONAL RESERVE AND ADAPTATION 
Functional reserve is the excess capacity possessed by the nervous system. Thus, a 
portion of the nervous system can be damaged, and this damage can go undetected 
by the usual functional tests. The situation in which a change in function was 
observed at one time, but can no longer be detected by the usual functional tests, is 
referred to as adaptation and presumably reflects compensatory processes. 
If a part of a redundant system is damaged, it is reasonable to assume that the 
reserve potential has been reduced. If compensatory changes have occurred, the 
ability of a system to make further compensatory changes may also have been 
reduced. One way to assess such changes is to incorporate in the test procedures 
one or more conditions in which the system(s) or organism(s) are placed under 
stress. The combination of the test substance plus stress may result in a greater 
deficit in performance than can be seen in animals receiving either the stress or the 
toxicant only.12 
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1.2.4.6. OTHER FACTORS
Several additional factors should be carefully considered in designing 
neurotoxicological tests. One condition that may affect toxicity is the nutritional state 
of the animal. Changes attributed to exposure to toxicants might be due to relatively 
nonspecific effects related to inhibition of growth or decreases in food or water 
consumption. This is particularly true in studies involving developing organisms. 
Another variable is the housing conditions of the experimental animal. In some 
cases, animals are housed individually in home cages during pharmacological or 
toxicological studies. This arrangement can alter the responsiveness of the subjects 
to drugs.
Moreover, it has been observed how biological rhythms influence the 
pharmacological and toxicological response to chemicals (Reiter L.W. & MacPhail 
R.C., 1982).16 These biological rhythms cannot be ignored and must be either 
controlled for in the study or studied explicitly.12 
1.3. NEUROTOXICITY RISK ASSESSMENT
1.3.1. RISK ASSESSMENT PRINCIPLES
Risk analysis is a process that incorporates three components: risk assessment, risk 
management and risk communication. The first component, risk assessment, 
consists of scientific analyses, the results of which are quantitative or qualitative 
expressions of the likelihood of harm associated with exposure to a chemical.20 
The assessment of human health risk requires identification, compilation and 
integration of information on the health hazards of a chemical, human exposure to 
the chemical and relationships among exposure, dose and adverse effects. 
Acquisition of information appropriate to a scenario of interest is a fundamental 
challenge in risk assessment. Numerous sources of such information can be readily 
found through literature searches facilitated by electronic tools. Compilations of 
relevant data prepared by international and other organisations also provide rapid 
access to information on chemical hazards, exposures and risks.20
Risk assessment is a process intended to identify and then to calculate or estimate 
the risk for a given target system to be affected by a particular substance, taking into 
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account the inherent characteristics of the substance of concern as well as the 
characteristics of the specific target system.17  
Risk management is a decision-making process involving considerations of political, 
social, economic and technical factors with relevant risk assessment information 
relating to a hazard so as to develop, analyse and compare regulatory and non-
regulatory options and to select and implement the optimal response for safety from 
that hazard. Hazard refers to the inherent property of a substance capable of having 
adverse effects (OECD/IPCS, 2001).40    
Throughout the document, frequent reference is made to some terms developed 
entirely from toxicological and epidemiological information, such as the acceptable 
daily intake (ADI) and acute reference dose (ARfD). Their definition is as follows:  
“acute reference dose (ARfD)” means the estimate of the amount of substance in 
food, expressed on a body weight basis, that can be ingested over a short period of 
time, usually during one day (24h or less), without appreciable risk to the consumer 
on the basis of the data produced by appropriate studies and taking into account 
sensitive groups within the population (e.g. children and the unborn).7 
“acceptable daily intake (ADI)” means the estimate of the amount of substances in 
food expressed on a body weight basis, that can be ingested daily over a lifetime, 
without appreciable risk to any consumer on the basis of all known facts at the time 
of evaluation, taking into account sensitive groups within the population (e.g. children 
and the unborn).7 
1.3.2. RISK ASSESSMENT PROCESS 
Human health risk assessment is a process intended to estimate the risk to a given 
target organism, system or (sub)population, including the identification of attendant 
uncertainties, following exposure to a particular agent, taking into account the 
inherent characteristics of the agent of concern as well as the characteristics of the 
specific target system (IPCS, 2004).41 Human health risk assessment of chemicals 
refers to methods and techniques that apply to the evaluation of hazards, exposure 
and harm posed by chemicals, which in some cases may differ from approaches 
used to assess risks associated with biological and physical agents.20  
The risk assessment process begins with problem formulation and includes four 
additional steps: 1) hazard identification, 2) hazard characterization, 3) exposure 
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assessment and 4) risk characterization (IPCS, 2004).41 The risk assessment 
paradigm, incorporating problem formulation, is summarized in Table 1.20 
Table 1: Paradigm for risk assessment, including problem formulation
Step Description Content 
Problem formulation Establishes the scope and 
objective of the assessment 
Defining the question 
Prior knowledge 
Desired outcomes 
Hazard identification Identifies the type and nature 




In vitro toxicology studies
Structure–activity studies 
Hazard characterization Qualitative or quantitative 
description of inherent 
properties of an agent having 
the potential to cause 
adverse health effects 
Selection of critical data set 
Modes/mechanisms of action 
Kinetic variability 
Dynamic variability 
Dose–response for critical 
effect 
Exposure assessment Evaluation of concentration 
or amount of a particular 











Source: Adapted from IPCS (2009)42 
Human health risk assessments of chemicals can be performed to evaluate past, 
current and even future exposures to any chemical found in air, soil, water, food, 
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consumer products or other materials. They can be quantitative or qualitative in 
nature. Risk assessments are often limited by a lack of complete information. To be 
protective of public health, risk assessments are typically performed in a manner that 
is unlikely to underestimate the actual risk. Regardless, chemical risk assessments 
rely on scientific understanding of pollutant behaviour, exposure, dose and toxicity. In 
general terms, risk depends on the following factors: 
• the amount of a chemical present in an environmental medium (e.g. soil, water, 
air), food and/or a product 
• the amount of contact (exposure) a person has with the pollutant in the medium 
• the toxicity of the chemical 
Obtaining knowledge to describe these three factors is the cornerstone or foundation 
of most chemical risk assessments. As these data are not always available, many 
risk assessments require that estimates or judgements be made regarding some 
data inputs or characterisations. Consequently, risk assessment results have 
associated uncertainties, which should be characterised as much as possible.20 
1.3.3. EFSA – RISK ASSESSMENT OF ACTIVE SUBSTANCES OF PESTICIDES 
In the territory of EU the risk management of the active substances of pesticides is 
addressed by the European Food Safety Authority (EFSA). EFSA’s role is to provide 
independent scientific advice to risk managers based on risk assessments. The 
European Commission and Member States take risk management decisions on 
regulatory issues, including approval of active substances and setting of legal limits 
for pesticide residues in food and feed (maximum residue levels, or MRLs) based on 
relative proposals made by the EFSA’s Pesticide Unit. 
Active substances undergo an intensive evaluation process before a decision can be 
made on approval. EFSA’s Pesticides Unit is responsible for the EU peer review of 
risk assessments of active substances used in plant protection products, in close 
cooperation with EU Member States. The risk assessment of active substances 
evaluates whether, when used correctly, these substances are likely to have any 
direct or indirect harmful effects on human or animal health – for example, through 
drinking water, food or feed – or on groundwater quality. In addition, the 
environmental risk assessment aims to evaluate the potential impact on non-target 
organisms.2
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Moreover, the Pesticides Unit is responsible for preparing the Annual Report on 
Pesticide Residues in the EU when also assists the Panel on Plant Protection 
Products and their Residues (PPR) with administrative and scientific support. 
EFSA’s Panel on Plant Protection Products and their Residues (PPR) gives scientific 
advice on issues that cannot be resolved within the peer review of active substances, 
MRL applications/MRL reviews or when guidance is needed on more generic issues, 
commonly in the fields of toxicology, ecotoxicology, fate and behaviour and the 
development of risk assessment practice.2 
1.3.4. GENERAL PRINCIPLES OF NEUROTOXICITY RISK ASSESSMENT
Neurotoxicity is one of several non-cancer end-points that share common default 
assumptions and principles. The interpretation of data as indicative of a potential 
neurotoxic effect involves the evaluation of the validity of the database. There are 
four principal questions that should be addressed: 
(1) whether the effects result from exposure 
(2) whether the effects are neurotoxicologically significant 
(3) whether there is internal consistency between behavioural, physiological, 
neurochemical and morphological end-points 
(4) whether the effects are predictive of what will happen under various conditions. 
Addressing these issues can provide a useful framework for evaluating either human 
or animal studies or the weight of evidence for a chemical (Sette W.F. & MacPhail 
R.C., 1992; Health Canada, 1994; Hertel R.F., 1996; IPCS, 1999).17, 51, 52, 53, 54  
1.3.4.1. DEVELOPMENTAL NEUROTOXICITY (DNT) – CHEMICAL 
HAZARDS IN CHILDREN
In its broadest sense, the environment encompasses all factors that are external to 
the human host, and children may be exposed to numerous environmental hazards 
from multiple sources and in a variety of settings. The production and use of toxic 
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chemicals pose potentially significant environmental threats to the health of children 
and are the major focus of this document. Global industrialisation, urbanisation, and 
intensified agriculture, along with increasing patterns of unsustainable consumption 
and environmental degradation, have released large amounts of toxic substances 
into the air, water, food and soil. 
Although estimates of the burden of disease in children due to environmental 
chemicals are generally not available, there is clear scientific evidence that exposure 
to environmental chemicals during different developmental stages can result in a 
number of adverse outcomes in children and have resulted in an increased incidence 
of certain childhood diseases.  A wide range of chemicals can affect children’s 
health, but a few chemical classes are of particular concern, among them are 
pesticides. Neonates and infants are also exposed to toxic chemicals (e.g. 
organochlorine pesticides, heavy metals) through breast milk. The younger child and 
toddler are susceptible to exposure from chemicals in solid food (e.g. pesticides) and 
air (e.g. particulate matter) and through dermal exposure (e.g. heavy metals in soil). 
Exposure to organophosphate pesticides typically occurs in older children and 
adolescents in rural areas through agricultural work or as bystanders during 
agricultural pest control.45 
Exposure to environmental chemicals such as methylmercury, lead, or certain 
pesticides at levels below those that cause structural defects may produce cellular or 
molecular changes that are expressed as neurobehavioural (functional) deficits or as 
increased susceptibility to neurodegenerative diseases much later in life. It has been 
hypothesised neurotoxic insults during development that result in no observable 
phenotype at birth or during childhood could manifest later in life as earlier onset of 
neurodegenerative diseases, such as Parkinson disease. Only a small number of 
neurotoxins have been adequately studied to address their specific neurobehavioural 
consequences after prenatal or perinatal exposure.45 
While adult neurotoxicology evaluates the effects of chemical exposure on relatively 
stable nervous system structure and function, developmental neurotoxicology 
addresses the special vulnerabilities of the young. Exposure of pregnant women to 
alcohol, recreational drugs, therapeutic drugs, nicotine and environmental chemicals 
may result in the immediate or delayed appearance of neurobehavioural impairment 
in children. Postnatal exposure of children to chemical agents in the environment, 
such as lead, also may impair IQ and other indices of neurobehavioural function. 
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Neurotoxic effects may impair speech and language, attention, general intelligence, 
"state" regulation and responsiveness to external stimulation, learning and memory, 
sensory and motor skills, visuospatial processing, affect and temperament, and 
responsiveness to nonverbal social stimuli. Chemical neurotoxicity may be 
manifested as decreases in functional capabilities or delays in normative 
developmental progression.17 
In humans, the ability of environmental agents to impact various target sites or 
pathways (e.g. autonomic, peripheral, or central nervous system) as presented 
above, may arise a diverse range of outcomes that should be considered. To this 
end, clinical assessment coupled with a battery of standardized assessment tools are 
likely to be needed. Specifically, gender-specific tools related to behavior should be 
considered accompanied with standardised clinical assessments available for 
newborns and paediatric populations; the last should take into account the 
characteristics or physical/biological properties of the exposure under investigation.45 
When evaluating toxicological studies in animal models for their relevance to 
humans, it is also important to keep in mind differences in the timing of critical events 
in nervous system development between humans and common laboratory animal 
species. For example, in rodents, considerable brain development occurs during the 
neonatal period, whereas most of this development occurs during the fetal period in 
humans.17 
Regarding animal studies, a draft OECD Test Guideline 426, Developmental 
Neurotoxicity (DNT) Study, has been developed based on the United States 
guideline (OECD, 2003).47 Developmental neurotoxicity studies are designed to 
develop data on the potential functional and morphological hazards for the nervous 
system arising in the offspring from exposure of the mother during pregnancy and 
lactation. The OECD draft test guideline is designed as a separate study, but the 
observations and measurements can also be incorporated into a two generation 
study. The neurological evaluation consists of assessment of reflex ontogeny, motor 
activity, motor and sensory function, and learning and memory; and evaluation of 
brain weights and neuropathology during postnatal development and adulthood. The 
behavioural testing includes assessment of the individual animal for a number of 
relevant behavioural functions, but none of the tests assesses two or more animals 
together. This means that some behavioural end-points of potential relevance (e.g. 
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sexual behaviour, play behaviour, social interaction among animals, and aggression) 
are not assessed using the current test guidelines.45
The recent days, the need for alternative testing methods has increased due to the 
time and cost consuming traditional animal-based testing strategy although the last 
provides developmental neurotoxicity testing information. Only vary few compounds 
– including pesticides – have been identified as developmental neurotoxicants 
(DNToxicants) due to the complexity of the central nervous system and the critical 
lack of knowledge of neurotoxic mechanisms.46 
 New directives and initiatives for developmental toxicity testing in the United States 
and Europe will rely increasingly on an integrated and intelligent new testing strategy 
(Hartung et al., 2013a)48 utilizing cell-based in vitro approaches (Krewski et al., 
2010).49 Metabolomics studies represent another major technology for phenotyping 
biological responses to DNToxicants. Bioinformatics plays a key role in mining the 
information-rich new technologies and making sense of the output by modelling. With 
interdisciplinary collaboration, toxicology can take advantage of such expert 
knowledge. The challenge and the opportunity lie in the transition from MoA models 
to pathway modelling. The next challenge will be integrating multi-omics 
technologies for DNT studies on a systems biology level. This kind of integrated 
approach would lead to a global assessment of adverse effects, indicating the 
potential of systems biology in terms of pharmacological and toxicological research. 
Quantitative measurement with multi-omics technologies will bridge the gap between 
molecular initiating events and relevant adverse outcomes. In addition, this kind of 
integrated approach will be a significant step towards the better understanding of the 
mechanisms underlying DNT, which could have profound impact on DNT chemical 
screening.46 
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2. MATERIALS AND METHODS
2.1. REVIEW OF DATA
Risk assessment is an empirically based process used to estimate the risk that 
exposure of an individual or population to a chemical, physical or biological agent will 
be associated with an adverse effect. Risk may be defined as the probability of 
adverse effects caused under specified conditions by a chemical, physical or 
biological agent in an organism, a population or an ecological system (OECD/IPCS, 
2001).40 The risk assessment process usually involves four steps: hazard 
identification, dose-response assessment, exposure assessment and risk 
characterization (IPCS, 1999).54  
2.1.1. FOUR STEPS OF RISK ASSESSMENT PROCESS
2.1.1.1. HAZARD IDENTIFICATION
Hazard identification is generally the first step in a risk assessment and is the 
process used to identify the specific chemical hazard and to determine whether 
exposure to this chemical has the potential to harm human health. Usually, hazard 
identification involves establishing the identity of the chemical of interest and 
determining whether the chemical has been considered hazardous by international 
organizations and, if so, to what degree.20 
2.1.1.2. HAZARD CHARACTERISATION
Hazard characterisation typically consists of a qualitative or quantitative description 
of the inherent properties of the agent having the potential to cause adverse health 
effects as a result of exposure. There are, however, chemicals that are essential to 
the human body. Adverse health effects can be observed if exposure to these is 
below a required level as well as above an upper tolerable level.20 
Quantitative descriptions often consist of a dose–response assessment, including 
identification of, for example, a no-observed-adverse-effect level (NOAEL), no-
observed-effect level (NOEL) or cancer potency factor, and the application of 
uncertainty factors to account for interspecies and intra-species variability, data 
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quality and other uncertainties. This information is used to develop guidance values, 
such as the TDI and ADI. In turn, human exposure factors, such as intake rates, are 
then considered to develop guideline values for chemicals in media such as air, 
water and food.20
The guidance values such as the ADI and TDI, which provide an estimate of the 
amount of chemical that can be taken in orally (mainly by food and drinking-water) by 
a person without appreciable health risk, are entirely developed from toxicological 
and epidemiological information. The development of health-based guidance values 
requires the assessment of the toxicological effect of a chemical in relation to 
exposure. The relationship between exposure and effect is frequently derived from 
standardised tests of laboratory animals conducted under controlled conditions. But 
in some cases, as in arsenic and benzene, these values are based on 
epidemiological studies (IARC, 1999, 2004).20, 43, 44 
For effects other than cancer, where a cancer effect in laboratory animals is 
considered not relevant to humans or where a non-genotoxic mechanism is 
suggested, health-based guidance values are characterized as thresholds of 
exposure below which adverse effects are considered unlikely to occur. Benchmarks 
of risk for non-cancer effects are most frequently expressed as rates of exposure with 
the units of milligrams per kilogram of body weight per day. Common terms for these 
values are ADI (e.g. ADIs have been developed for pesticides by the Joint 
FAO/WHO Meeting on Pesticide Residues (JMPR) and for food additives by 
JECFA), TDI, PTWI, PTMI (developed for food contaminants by JECFA) and 
acute reference dose (ARfD) (e.g. developed for pesticides by JMPR). These 
benchmark values are estimates of the amount of a substance in air, food, soil or 
drinking-water that can be taken in daily, weekly or monthly over a lifetime or other 
specified period without appreciable health risk.20
The ADI and TDI are estimates of exposure rate (sometimes called administered 
dose) and, as described above, are derived from toxicological and epidemiological 
information. For this reason, they consider the total (or aggregate) intake of a 
chemical from all routes and pathways. In contrast, the media-specific guideline 
values for environmental media take into account conditions specific to the medium 
of interest and also vary in the extent to which aggregate exposure is considered. For 
instance, the MRLs are not direct public health limits, but instead reflect agricultural 
practices and climate scenarios, and they are normally set at levels well below 
amounts that might lead to an adverse health effect. In contrast, the WHO drinking-
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water guidelines are primarily health-based and do attempt to account for exposure 
through other media.20 
2.1.1.3. EXPOSURE ASSESSMENT 
Exposure assessment is used to determine whether people are in contact with a 
potentially hazardous chemical and, if so, to how much, by what route, through what 
media and for how long. Because hazard characterization and risk characterization 
are dependent upon the route (oral, inhalation, dermal) and duration (short-term, 
medium-term, long-term) of exposure, knowledge of how and when people may be 
exposed is relevant to the determination of an appropriate guidance or guideline 
value. When combined with information on hazard characterization or a guidance or 
guideline value, exposure information is used to characterize health risks.20 
The exposure concentration is the concentration of a chemical in a medium with 
which a person is in contact. These media include air, water, soil, food and consumer 
products with which people come in contact. Ideally, exposure concentrations will be 
obtained for media, locations and durations that are representative of potential 
human contact with a chemical of concern.20 
The determination of the exposure assessment portion of the risk evaluation is 
addressed by the following parameters20: 
• the relevant routes and pathways of exposure 
• the environmental media expected to contain the chemical
• the appropriate duration of exposure
2.1.1.4. RISK CHARACTERISATION 
The last step of a chemical risk assessment – the risk characterisation – is typically a 
quantitative statement about the estimated exposure relative to the most appropriate 
health-based guidance value (i.e. ADI, TDI), media-specific quality guideline value or 
another hazard characterisation value, such as the cancer slope factor. In general, 
the risk statement is derived by either comparing the estimated exposure with a 
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guidance or guideline value or calculating the excess lifetime cancer risk associated 
with the estimated exposure.20
Further analysis of this step will follow further below. 
2.1.2. EXPOSURE ASSESSMENT
2.1.2.1. ROUTES AND PATHWAYS OF EXPOSURE
One of the major aspects of exposure assessment is determination of routes and 
pathways of exposure.  The medium of exposure refers to air, water, soil, food or 
products (consumer, commercial or industrial) that are thought to contain the 
chemical of interest. These exposures may occur in occupational or community (i.e. 
non-occupational) settings or while using products.20 
Ingestion exposure is associated with chemicals in food, water and soil, both indoors 
and outdoors. Inhalation exposure requires that chemicals be present in air, 
although it is important to recognise that chemicals with moderate to high vapour 
pressures and low solubilities can volatilise from water or soil and then be inhaled. 
Inhalation can also be an important route of exposure to less volatile chemicals, such 
as polychlorinated biphenyls, when present at elevated concentrations in soil and 
other solid substrates. Finally, dermal absorption requires contact between a 
chemical and skin, which can occur in water, during contact with soil, in the presence 
of high concentrations in air and during occupational or consumer use.20
The scope of an exposure assessment can be narrowed with information about the 
chemical and its properties, from which the important exposure media and routes can 
be inferred. For example, health-relevant exposures to some chemicals, such as 
ozone, occur through only one medium (in this case air), while for others that can be 
found in several media, such as lead and pesticides, information about the chemical 
properties and behaviour can point to environmental media or locations where the 
highest levels of the chemicals are likely. 
In addition, this information can suggest relevant pathways and routes of exposure. 
Pathway of exposure refers to the physical course taken by a chemical as it moves 
from a source to a point of contact with a person (e.g. through the environment to 
humans via food). Route of exposure refers to intake through ingestion, inhalation 
or dermal absorption. The exposure routes may have important implications in the 
hazard characterization step, as the danger posed by a chemical may differ by route.
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2.1.2.2. ESTIMATING EXPOSURES: MODELLING OR MEASURING 
APPROACHES
Generally, risk assessments, especially screening-level risk assessments, are based 
upon chemical concentrations in environmental media that are relatively easy to 
access, such as outdoor air, indoor air, lake water, river water and outdoor soil. 
These concentrations can be determined from a measurement campaign or a 
modelling effort.20  
Exposures can be measured directly, estimated using models or generalised from 
existing data. Each requires that exposures be determined for time periods relevant 
to possible adverse health outcomes. For example, if the relevant health hazard is 
chronic in nature, exposure should be long term as well. Measurements, on the other 
hand, generally provide the most accurate and relevant data, but are the most time 
and resource intensive, obviating their use for many risk assessments.20
2.1.2.2.1. EXPOSURE MODELS
Exposure models generally require information about the concentration of a chemical 
in a medium and the period of time over which individuals are in contact with the 
chemical. Chemical concentrations can be measured or can be estimated from 
chemical usage or previous data.20 
Given the complexity of many of these models, it is probable that specialised training 
on running the models will be necessary. In order to select the appropriate model, 
information about the geographic and temporal extent of the chemical exposures of 
interest and the exposed populations of interest should be obtained or otherwise 
determined.20
In case of chemical concentration estimates by models, the information about 
chemical contact is necessary. This can be obtained using a variety of techniques, 
including questionnaires or inquiries with affected individuals, demographic data, 
survey statistics, behaviour observation, activity diaries, activity models or, in the 
absence of more substantive information, assumptions about behaviour. Using this 
information, exposures for air, water, food or soil can be estimated using 
mathematical equations.20 
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2.1.2.2.2. EXPOSURE MEASUREMENTS
Exposure concentrations can also be obtained from measurements, whether they be 
historical, current or planned for the future. For these concentrations to be truly 
representative of exposures, they must measure the concentration of the chemical 
of interest in environmental media, such as air, water and soil, that are contacted or 
food that is ingested by a person. Exposure measurements are intended to match 
the actual media, location and duration that represent the human exposure to the 
chemical of concern, although this is often not possible to achieve.20 
Further, some consideration should be given to the heterogeneity of exposures 
within the relevant population. For example, if the exposures are similar for all 
individuals, then measurements made for a relatively small subset of individuals can 
be generalised to a larger population. Correspondingly, if exposures vary within a 
population by age, sex or residential location, it is possible that exposure 
measurements should be made for subsets within each of these groups and 
generalised to the larger group.20
2.1.2.3. DURATION OF EXPOSURE
The duration of exposure is a critical element in assessment and estimation of health 
risks, as the relevant period of exposure is defined by knowledge or theory of the 
mechanisms of injury or disease. Consequently, the duration of exposure is an 
explicit component of the design of exposure assessments as well as toxicological 
studies conducted for purposes of hazard identification and hazard 
characterisation.20
Single and short-term exposures over minutes, hours or a day are relevant for 
chemicals that have an immediate or rapid adverse effect on the body at certain 
concentrations.20
Medium-term or intermediate exposure is important for chemicals that are thought 
to exert adverse effects over a period of contact that ranges from weeks to months in 
duration.20
For chemicals that pose a hazard as a result of cumulative or long-term low-dose 
exposure, long-term average exposures are most relevant for characterization of 
adverse effects. Assessments of cancer risk are a special case of long-term 
exposure for which lifetime average exposure is generally of interest.20
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2.1.2.4. CONCENTRATION AND RATE OF EXPOSURE
In practice, exposures are generally expressed as either a concentration of the 
chemical in the exposure medium or a rate of contact with a chemical over a specific 
duration.20
For example, concentrations in contact media are usually expressed in units of 
micrograms per cubic metre (μg/m3) for air, micrograms per litre (μg/l) for water and 
milligrams per kilogram (mg/kg) for solids such as soil, dust and food. Rate of 
exposure for a chemical is typically referred to as average daily dose, with units of 
milligrams of chemical per kilogram of body weight per day (mg/kg body weight per 
day).20 
In general, exposure rate is calculated as the concentration of a chemical in an 
exposure medium multiplied by the rate at which a person inhales or ingests that 
medium, divided by a representative body weight.20
As shown in Equation 1, the period of exposure and averaging time of exposure are 
considered explicitly, as well20: 
concentration × contact rate × exposure duration 
Exposure rate =  ………………………………………………………………….. [1]
body weight × averaging time 
where: 
 concentration is the amount of chemical per mass or volume of the medium 
 contact rate is the mass or volume of the medium in contact with the body 
 exposure duration is the period of time over which the person is in contact 
with the chemical 
 body weight is the body weight over the averaging time 
 averaging time is the period of time over which the exposure is relevant for 
health risk characterisation
The averaging time used in calculation of average daily dose is typically different for 
estimation of non-cancer and cancer risks. For chemicals that pose a non-cancer 
hazard, the average exposure during the period of contact with a chemical is 
generally the relevant duration of exposure for risk assessment. For cancer risk 
assessment, however, the averaging time is fixed at a lifetime, which is commonly 
assumed to be 70 years in risk assessments.20
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2.1.2.5. BIOMARKERS OF EXPOSURE
Besides the above-described traditional exposure assessment, the use of biological 
markers is another method with which to evaluate human exposure to a chemical. 
Biological markers of exposure are considered measures of internal dose, 
whereas exposure describes the contact with a chemical at the boundary between an 
individual (e.g. skin, mouth or nostrils) and the environment, food or consumer 
product. 
Numerous biological media are available for use in exposure assessment. Selection 
of sampling media depends on the contaminant of interest, the pattern of exposure, 
the timing of exposure, the population studied, ease of collection and storage and 
participant burden.
2.1.3. RISK CHARACTERISATION
Generally, the risk characterization, as a statement, is derived by either comparing 
the estimated exposure with a guidance or guideline value (i.e. ADI, TDI, ARfD) or 
calculating the excess lifetime cancer risk associated with the estimated exposure.20 
 COMPARISON WITH A GUIDANCE OR GUIDELINE VALUE
Health-based guidance values or guideline values have been established for a 
number of chemicals by international organisations. In some cases, the guidance or 
guideline value is based on an exposure concentration or rate below which adverse 
effects are considered to be unlikely (threshold chemical). As described in previous 
section, this approach applies to toxicological effects that occur when a threshold of 
exposure or dose is exceeded.20 
Guidance or guideline values are also sometimes established for chemical exposures 
that are thought to have a continuous hazard characterisation relationship, and there 
is a theoretical risk of an effect at any level of exposure (non-threshold chemical). 
Carcinogens and some air pollutants, such as fine particulate matter, are examples 
of stressors that are considered to pose risk of an adverse health outcome at all 
levels of exposure. For these substances, guidance or guideline values are exposure 
concentrations or rates that correspond to levels of risk that have been determined to 
be tolerable. For instance, long-term average exposure to inorganic arsenic in 
drinking-water at a certain guideline value (i.e. concentration) may be equivalent to a 
lifetime cancer risk of 1 in 100 000 (WHO, 2008).20, 50  
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The ADI and TDI are estimates of exposure rate (sometimes called administered 
dose) and, as described further up, are derived from toxicological and 
epidemiological information. For this reason, they consider the total (or aggregate) 
intake of a chemical from all routes and pathways.20
For chemicals that have the potential to result in non-cancer effects, risk is frequently 
characterized as the ratio of the appropriate exposure rate (e.g. the average daily, 
weekly, monthly intake) to the health-based guidance value: ADI, TDI, PTWI, PTMI 
or ARfD (often used for pesticide residues and contaminants in food). For exposure 
to non-cancer chemical hazards in media such as air and drinking-water, the ratio of 
the chemical concentration in that medium to a reference concentration (e.g. the 
WHO air quality guideline or the WHO drinking-water quality guideline value) may 
also be used to assess risk. This ratio is sometimes referred to as the hazard or risk 
quotient. A hazard or risk quotient less than 1 indicates that the chemical 
exposure is less than the benchmark and that the exposure is unlikely to result in 
an adverse effect. For example, an evaluation of chemical concentrations in 
exposure media and rates of contact with those media may conclude that the 
exposure to a chemical is 15 times less than the ADI established by an authoritative 
organisation as a benchmark for risk of an adverse effect. Conversely, a hazard or 
risk quotient greater than 1 indicates that the exposure is greater than the 
benchmark and that the sources, pathways and routes of chemical exposure 
should be evaluated further.20 
 ESTIMATION OF CANCER RISK
For chemicals that may exert a carcinogenic effect, the risk characterisation is 
typically expressed as the excess lifetime cancer risk. Characterisation of cancer risk 
over a lifetime has become a convention primarily because cancer is thought to be a 
function of long-term rather than short-term exposure. Excess lifetime cancer risk is 
an estimate of the likelihood of cancer associated with a given level of exposure 
averaged over a lifetime.20
2.1.3.1. CUMULATIVE EXPOSURE RISK ASSESSMENT
Current risk assessment guidelines focus on assessing single chemicals following 
exposure via single pathways. In order to address aggregrate exposure or cumulative 
toxicity issues, research is needed to: 
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(1) test the hypothesis of additivity for chemicals having a similar mode of action; 
(2) assess possible non-additive interactions of chemicals with different modes of 
action; and 
(3) study potential interactions of multiple chemicals at doses below those required to 
produce detectable effects following single exposures.20 
Humans may be exposed to chemicals at different occasions and in a number of 
different ways. Exposure to chemicals may occur via the environment (through 
production and disposal of products), occupational use (during production or product 
use including consumer ones). Finally, a large number of chemicals are deliberately 
used for specific applications (pesticides, biocides, veterinary products, food 
additives), resulting in exposure through food and other routes. All of these may 
result in exposure of humans through the inhalatory, dermal and oral routes (Delmaar 
& Van Engelen, 2006).21, 23 
In the European Union’s Technical Guidance Documents (EC, 2003), the term 
“aggregate exposure” is used solely within the scope of consumer exposure 
assessment and is defined as exposure to the same chemical from multiple sources. 
“Combined exposure” is defined as exposure of the same person to the same 
substance in the same setting via different routes of entry into the body or from 
different products containing the same substance. In this abstract, “combined 
exposure” is considered to be synonymous with “aggregate exposure”.21, 24  
Aggregate risk is the risk associated with multiple pathways /routes of exposure to a 
single chemical. Cumulative risk is the combined risk from aggregate exposure to 
multiple chemicals (and may be restricted to chemicals that have a common 
mechanism of toxicity).21
Chemicals that act by the same mode of action and/or at the same target cell or 
tissue often act in a potency-corrected “Dose Additive” manner. Where chemicals 
act independently, by discrete modes of action or at different target cells or tissues, 
the effects may be additive (“Effects Additive” or “Response Additive”). 
Alternatively, chemicals may interact to produce an effect, such that their combined 
effect “Departs from Dose Additivity”. Such departures comprise “Synergy”, where 
the effect is greater than that predicted on the basis of additivity, and “Antagonism”, 
where the effect is less than that predicted on the basis of additivity.21 
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Relevant also to the development of a framework for risk assessment of combined 
exposures to multiple chemicals is a common understanding of “Mode of Action”, 
which has been defined by IPCS, as it figures prominently in approaches to grouping 
of chemicals for assessment of combined effects. A postulated mode of action is a 
biologically plausible sequence of key events leading to an observed effect supported 
by robust experimental observations and mechanistic data. It describes key 
cytological and biochemical events—that is, those that are both measurable and 
necessary to the observed effect. “Mechanism of Action”, which generally involves 
a sufficient understanding of the molecular basis for an effect so that causation can 
be established (Sonich Mullin et al., 2001).21, 22 
As humans are exposed constantly to a wide variety of chemicals, a major challenge 
in risk assessment is to determine the degree of exposure to multiple chemicals, the 
hazards associated with such combined exposure and the extent to which chemicals 
interact. Predicting risk from exposure to chemical mixtures is complex, as chemicals 
in mixtures can interact in terms of both toxicokinetics and toxicodynamics. Such 
interactions may result in effects that are either antagonistic or synergistic. The 
temporal nature of the exposures may play a lead role in determining these 
interactions.21 
2.1.3.2. AVAILABLE METHODS FOR COMBINED EXPOSURE RISK 
ASSESSMENT
There are currently a number of methods used to determine the risk of combined 
exposure to chemicals. They can be divided into those that simply add the risk from 
individual chemicals, those that sum effects based on relative potencies and those 
that rely only on indirect evidence. Most of these have been developed in response 
to a regulatory need (e.g. toxic equivalency factor [TEF] and dioxins), and each has 
advantages and disadvantages.21 
The Hazard Index (HI) is the sum of hazard quotients for substances that affect the 
same target organ or organ system. The hazard quotient is the ratio of the potential 
exposure to the substance to the level at which no adverse effects are expected (e.g. 
point of departure, ADI, divided by uncertainty factors). The HI can be used to identify 
the most risky substances in a mixture, i.e. the chemicals that have the highest 
health risks based on toxic potential and estimated or measured exposure.60 A 
second method, the Point of Departure Index (PODI), is a simple addition method 
that adds the no-observed-effect levels (or benchmark doses) of individual 
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chemicals. Neither of these methods includes possible interactions of chemicals that 
would result in antagonism or synergism.21  
The Toxic Equivalent (TEQ) method was developed for use with compounds that 
activate the aryl hydrocarbon receptor (Haws et al., 2006; Van den Berg et al., 
2006).55, 56 This is a relative potency method that assumes the additivity of doses of 
individual components of the mixture after normalisation of the response to a 
reference chemical. The Relative Potency Factor (RPF) method (USEPA, 2000)57 is 
a generalised form of the TEQ method and has been used for classes of pesticides 
and other chemicals. This method also uses dose addition as the default assumption 
for the effects of mixtures.21 
Two additional methods have been used when data limitations prevent the use of the 
above mentioned methods. The Whole Mixture Approach (Mumtaz et al., 1993)58 
uses effects data from exposure to the mixture of concern or a sufficiently similar 
mixture. These data are treated in a risk context similarly to single chemical data. 
Lastly, the Threshold of Toxicological Concern (TTC) has been proposed for use 
with complex mixtures where no effects data are available (Kroes et al., 2005).59 This 
method uses structure–activity relationships to assign exposure thresholds for 
comparison with the potential exposure level and requires exposure estimates.21 
Additionally, the Margin of Exposure (MOE) of a substance is the NOAEL divided 
by exposure so that the combined margin of exposure of a mixture (MOEmix) can be 
calculated accordingly. The margin of exposure index of a mixture is compared to an 
agreed acceptable threshold. According to EFSA, there are no established criteria for 
the magnitude of an acceptable MOEmix for mixtures of chemicals but it is widely 
accepted that at a MOEmix higher than the uncertainty factor of 100 the conclusion 
can be drawn that the risk of toxicity is unlikely.60, 61 
Moreover, there are methods for risk assessment of mixtures taking into account 
interactions. Toxicant interactions may take place during any of the processes that 
affect the toxic potency of a single compound: adsorption, distribution, metabolism, 
excretion and activity at the receptor site(s). They may interact chemically, and they 
may interact by causing different effects at different receptor sites.62 Interactions can 
be assumed to occur frequently and often are dose-dependent but, according to 
EFSA, there is no standard design to evaluate the potential interaction of 
compounds.63 
The physiologically based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling 
has been applied to the toxicological interactions of chemical mixtures many years 
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ago; since then it plays an active role in cumulative risk assessment. Specifically, 
PBPK/PD modeling can be used to describe the pharmacokinetics, and possibly 
pharmacodynamics, of a chemical mixture, including possible interaction effects.60   
For pesticides the suitable substance specific limit value, i.e. the reference level (refi) 
of no concern, usually is the accepted daily intake rate (ADI) relevant to human 
health but not to certain health endpoints. Calculating the endpoint specific health 
risk index for a mixture of pesticides by summing up the exposure to limit value ratios 
requires health endpoint specific limit values assumed to be protective for the 
selected endpoint. This kind of reference value, e.g. cancer health risk limit values for 
humans, is usually not available for pesticides. There are two possibilities to deal with 
this problem: The first is to identify compounds of the mixture affecting the same 
health endpoint on the basis of available evaluations, to relate exposure to generic 
ADIs instead of endpoint specific limit values, and then sum up the ratios to derive 
the index value. The second possibility is to identify compounds of the mixture 
showing effects when tested with a certain indicator system (e.g. genotoxicity tests), 
to relate exposure to the substance specific NOAEL derived with this test and sum up 
these ratios for all components of the mixture.60 
Grouping of unknown mixtures of unknown substances
Grouping pesticides by effects on indicator systems is of high importance because to 
date combination toxicology is facing a generic problem: for many potentially toxic 
substances produced or just present at relevant amounts the mechanism of action is 
unknown and their toxicity has not been evaluated. With respect to mixtures the 
approach is based on the identification of relationships between the structure of a 
substance and its toxicity. In the context of mixtures of chemicals with unknown 
mode of action the methods might be suitable to sort the compounds of a mixture by 
predicted modes of action in order to define groups of chemicals for which additive 
combination toxicology approaches, such as concentration or dose addition, or 
hazard index related methods, can be applied.60 
2.2. PRESENT STUDY – METHODS & PARAMETERS  
In present study, for the risk assessment of pesticides in food commodities the 
following methods and data have been used. 
The info about the diet (mean consumption) was taken by EFSA based on National 
Diet Survey in Greece related to sub-populations “lactating women in Greece” and 
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“children in Regional Prefecture of Crete”. The survey comprises 20 food 
categories as follows:  
 Grains and grain-based products
 Vegetables and vegetable products (including fungi
 Starchy roots and tubers
 Legumes, nuts and oilseeds
 Fruit and fruit products
 Meat and meat products (including edible offal)
 Fish and other seafood (including amphibians, rept
 Milk and dairy products
 Eggs and egg products
 Sugar and confectionary
 Animal and vegetable fats and oils
 Fruit and vegetable juices
 Non-alcoholic beverages (excepting milk based beverages)
 Alcoholic beverages
 Drinking water (water without any additives except
 Herbs, spices and condiments
 Food for infants and small children
 Products for special nutritional use
 Composite food (including frozen products)
 Snacks, desserts, and other foods
The next step was the determination of the dose which was based on various 
studies. These studies concerned the presence of pesticide residues in all the above 
food categories mainly in EU and abroad (for international foodstuffs i.e. baby food 
and those produced abroad i.e. nuts, spices) have been used; totally, 28 studies.70-97        
There were identified 197 different chemical substances that belong to 42 various 
chemical classes as follows:
Organophosphate, Carbamate, Neonicotinoid, Herbicide, Pyrethroid, 
Organochlorine, Halogenated, Dispeptide, Oxadiazine, Keto-enol, Azole, 
Triazine, Strobin, Xylylalanine, Dicarboximide, Organobromide, Pyrimidine, 
Pyridine, Anilide, Amide, Substituted Benzene, Alkyl Phthalate, OC/Aromatic 
Ketone, Organophosphate /Carbamate, Morpholine, Amine, Piperidine, 
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Anthranilic Diamide, Phenylpyrrole, Acylpicolide, Phosphonoglycine, 
Dithiolane, Urea, Semicarbazone, Diacylhydrazine, Dinitroaniline, Phenol, 
Phenoxy, Inorganic, Bridged Diphenyl, Quaternary Ammonium Compound, 
Spinosyn /Macrocyclic Lactone, although some were also Unclassified. 
The above identification of the each chemical substance classification was taken by 
the Pesticide Action Network (PAN) Pesticides Database – Chemicals, the 
Toxicology Network of the U.S. National library of Medicine (TOXNET) and the 
Inventory of evaluations of pesticides performed by the Joint FAO/WHO Meeting on 
Pesticide Residues (JMPR).66, 67, 68 The TOXNET was also the source for the 
determination of CAS Registry Number for each chemical substance.67   
The Dose (μg) was expressed as the result of multiplication of the mean 
consumption (grams per day) taken by the EFSA table as pre-mentioned with the 
chemical substance residues (μg) identified in each food category. The Total dose 
was the total sum of all the dose values for each chemical substance in all food 
categories. 
The Daily Intake (μg/g_bw/d) was calculated as the quotient of the total dose divided 
by the weight of 70kg man (used as standard value for body weight).    
The ADI (Acceptable Daily Intake) info was taken both from EFSA and JMPR-
Reports. It was given priority to info from EFSA meaning, the established values on 
EFSA data were used instead those from JMPR for the same chemical. For the rest 
chemicals that there was no ADI established by EFSA then it was taken by the JMPR 
data (if set). The EFSA’s data is determined as Chemical Hazards data – 
OpenFoodTox [https://dwh.efsa.europa.eu/bi/asp/Main.aspx?rwtrep=400] and 
released on the EFSA website on 20/01/2017.69 Regarding JMPR, the ADI info was 
taken from the WHO website under the name Inventory of evaluations performed 
by the Joint Meeting on Pesticide Residues (JMPR) 
[http://www.codexalimentarius.org/standards/pesticide-mrls/].68 Moreover, the same 
sources (EFSA, JMPR) were used for the toxicological evaluation of all available 
chemicals under this study. 
The RCR equation is used for the determination of the safety of pesticides.
The ADI (Acceptable Daily Intake) was calculated as part of the determination of the 
Risk Characterisation Ratio (RCR) for chronic toxicity risk. Specifically, this ratio 
is defined as follows:     
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Risk characterization ratio (RCR) = Exposure Estimate (Daily Intake) / 
Acceptable Daily Intake (ADI)
The Risk Characterisation Ratio (RCR) for the evaluation of acute toxicity risk of 
a chemical substance is defined as follows:   
Risk characterisation ratio (RCR) = Exposure Estimate (Daily Intake) / Oral 
Reference Dose   
The Oral Reference Dose values are taken by the CLARC Master Table (Annex 1) 
and its definition is referred at the CLARC website as follows: 
Reference dose (RfD) or reference concentration for non-cancer toxicity is an 
estimate with uncertainty spanning perhaps an order of magnitude of daily exposure 
to the human population (including sensitive subgroups) that is anticipated to be 
without appreciable deleterious effects during a lifetime, expressed in units of 
milligrams per kilogram body weight per day. It is arrived at by dividing empirical data 
(NOAEL or LOAEL) on effects by uncertainty factors that consider inter- and 
intraspecies variability, extent of data on all important chronic exposure endpoints, 
and availability of chronic as opposed to subchronic data. The RfDs are not 
applicable to non-threshold effects such as cancer. (Methodology for Deriving 
Ambient Water Quality Criteria for the Protection of Human Health (2000) Technical 
Support Document Volume 1: Risk Assessment; WAC 173-340-200).98 
Since the availability of dose-response data in humans is limited, extrapolation of 
data from animals to humans usually involves the application of uncertainty factors to 
the NOAEL/LOAEL or BMD. The NOAEL or BMD/uncertainty factor approach results 
in a reference dose (RfD) or reference concentration (RfC), which is an estimate 
(with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the 
human population (including sensitive subgroups) that is likely to be without an 
appreciable risk of deleterious effects during a lifetime. The oral RfD and inhalation 
RfC are applicable to chronic exposure situations and are based on an evaluation of 
all the noncancer health effects, including neurotoxicity data.99 
The Oral Carcinogenic potency factor (CPFo) is the upper 95th percentile 
confidence limit of the slope of the dose-response curve and is expressed in unit of 
measure of (mg/kg-day)-1. (WAC 173-340-200) The cancer potency factor is referred 
to by EPA as a slope factor.98  
The Margin of Safety (MoS) is the opposite of Risk Characterisation Ratio (RCR). 
It is used to describe the safety of a chemical substance; it is expressed as    
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Margin of Safety (MoS) = Oral Reference Dose / Exposure Estimate (Daily 
Intake)   
Another parameter to be taken into account is the Cancer Risk which is calculated 
as follows:
Cancer Risk = Daily Intake x Oral Cancer Potency Factor (CPFo )    
whereas, “Oral Cancer Potency Factor” is expressed in kg-day/mg. 
Moreover, the JMPR monographs have been used as a source for the toxicological 
evaluation of the chemical substances upon any kind of neurotoxicity end-point. The 
JMPR is an international expert scientific group that is administered jointly by FAO 
and WHO in 2010. JMPR, which consists of the FAO Panel of Experts on Pesticide 
Residues in Food and the Environment and the WHO Core Assessment Group on 
Pesticide Residues, has been meeting regularly since 1963. During the meetings, the 
WHO Core Assessment Group is responsible for reviewing toxicological and related 
data and for estimating, where possible, the ADIs as well as the ARfDs of the 
pesticides under consideration  
Finally, the cumulative risk factor has been calculated in order to determine the 
potential outcome to human health resulting from chronic exposure to various 
pesticides through daily food consumption. Moreover, the cumulative cancer risk 
from exposure to pesticides through diet has been evaluated.     
The cumulative risk for chronic exposure is the outcome of the following equation: 
Cumulative Risk = 1-(1-A)*(1-B)*(1-C)*…*(1-Z)
whereas, A, B, C…Z refers to the RCR for chronic risk defined for each chemical 
substance.   
Likewise, the cumulative cancer risk is the outcome of the following equation: 
Cumulative Risk = 1-(1-A)*(1-B)*(1-C)*…*(1-Z)
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3. RESULTS – DISCUSSION 
  
This dissertation aims in evaluating the safety level of the presence of pesticide 
residues in food through daily food consumption in Greece. As mentioned before, the 
exposure information is used to characterise health risks. Since there are many 
toxicological effects correlated with pesticides, this study is focused mainly on 
neurotoxicity end-point. Moreover, an approach of the potential cumulative risk is 
also accomplished.        
Therefore, the following parameters were calculated before proceeding with the main 
results. 
The determination of dose (μg) is based on the multiplication of the mean 
consumption value (g/day) of a food category by the residue value (μg/g) of the 
active substance detected in the same food category. By adding all the values under 
each chemical substance the total dose (μg) for the specific chemical is calculated. 
The total dose is used in order to define the “daily intake (μg/g_bw/d)” which refers 
to the exposure concentration. 
The daily intake is the quotient of the total dose divided by the weight of 70kg 
(7000g) man (used as standard value for body weight). 
According to the current dissertation, one hundred ninety seven (197) different 
pesticides identified and quantified in various twenty (20) food categories totally. 
3.1. LACTATING WOMEN
The results for the sub-population “lactating women in Greece” are as follows: 
The sixty six (66) out of 197 chemicals can present acute risk according to the 
results.               
The Risk Characterisation Ratio (RCR) for the evaluation of acute risk of a 
chemical substance is defined as follows:   
Risk characterisation ratio (RCR) = Exposure Estimate (Daily Intake) / Oral 
Reference Dose   
When the quotient is <1 the risk to the human health due to the chemical is 
considered small; specifically, the smaller than the one, the less minimum the risk.      
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Referring to the data, the results revealed that the majority of the active substances 
are much less than the one. Sixty six (66) out of 197 substances, or the 33.5% of 
them, are bearing greater health risk at different level. Among the 33.5%, the 7.6% or 
five (5) chemical substances were presenting the higher acute risk as higher than 
one, while about the 13.6% and 28.8%, or 9 and 19 substances accordingly, were 
following with a risk less closer to one (10-1 and 10-2 respectively). 
The most risky chemicals – higher than one – were dimethoate (OPP), 
methamidophos (OPP), parathion-methyl (OPP), propoxur (CARB), triadimefon 
(AZO). The four of them belong to the chemical class of organophosphates (OPP), 
whilst the other two to carbamates (CARB) and azoles chemical group (AZO). 
Those following most risky chemicals (10-1) were aldrin (OC), carbofuran (CARB), 
chlorpyrifos (OPP), dichlorvos (OPP/CARB), ethion (OPP), lindane (OC), heptachlor 
epoxide (OC), imazalil (AZO) and trifluralin (DINITROANILINE). Otherwise, in 
percentage, the 33.3% belongs to OC, 22.22% to OPP, 11.11% to CARB, 11.11% to 
OPP/CARB, 11.11% to AZO and 11.11% to DINITROANILINE.
The Risk Characterisation Ratio (RCR) for the evaluation of chronic risk of a 
chemical substance is defined as follows:   
Risk characterization ratio (RCR) = Exposure Estimate (Daily Intake) / 
Acceptable Daily Intake (ADI)
The ADI is expressed in mg/kg-bw/day as the daily intake that equals to μg/g-bw/day; 
the necessary conversions have been performed.  
According to the results, there were some chemicals equal to zero but all less than 
one. From 154 chemical substances, there were six (6) chemical substances equal 
zero (0) and eleven (11) much closer (10-1) to the one but not above it which can be 
regarded as the most risky ones to human health among the rest ones. Those with 
zero value were demeton-S-methyl sulfoxide (OPP), ethoprofos (OPP), maneb 
group (CARB), methamidophos (OPP), propoxur (CARB) and triadimephon 
(AZO), although those with 10-1 value were pirimiphos – methyl (OPP), oxamyl 
(CARB), omethoate (OPP), imazalil (AZO), etofenprox (PYR), dimethoate (OPP), 
diazinon (OPP), chlorpyrifos (OPP), chlorfenvinphos (OPP), carbofuran (CARB) and 
carbaryl (CARB). All of them comprise the 11% which summarise the 3.9% for zero 
value with the 7.1% for 10-1 value, as those followed with 10-2 comprise the 31.2%. 
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Specifically, the 48 less risky chemical substances accompanied with 10-2 belong to 
the chemical classes of dinitroaniline (1), organophosphates (11), organochlorines 
(5), azoles (7), phenoxy (1), carbamates (7), dicarboximide (3), pyrethrines (4), 
organophosphate/carbamate (1), anilides (1), amides (1), pyrimidines /pyridines (2), 
strobines (1), urea (1), spinosyn macrocyclic lactone (1) and morpholine (1).            
The cumulative risk for chronic exposure equals with 1.0E+00 which in other terms 
means that is marginal safe and potential concerns towards health safety cannot be 
avoided and/or ignored. 
 
The opposite of Risk Characterisation Ratio (RCR) is the Margin of Safety (MoS) 
that is used to describe the safety of a chemical substance; it is expressed as    
Margin of Safety (MoS) = Oral Reference Dose / Exposure Estimate (Daily 
Intake)   
The larger than the one the quotient the safer the chemical is. The results show that 
the less safe ones and those much closer to the one were those with 100, 101 and 
102 values which if expressed in percentage comprise 14.5%, 30.6% and 30.6% 
accordingly. Moreover, there was one value expressed as 10-1 that stands for 
parathion-methyl (OPP) which can be regarded as the most risky of all particular 
substances. Those attached with 100 are Aldrin (OC), carbofuran (CARB), 
chlorpyrifos (OPP), dichlorvos (OPP/CARB), ethion (OPP), lindane (OC), heptachlor 
epoxide (OC), imazalil (AZO) and trifluralin (DINITROANILINE). 
Referring to the chemical classes, in the particular case, the majority of the less safe 
chemicals belong to the chemical groups of organophosphates and organochlorines, 
followed by carbamates, azoles and dinitroaniline.  
The Cancer Risk is calculated as follows:
Cancer Risk = Daily Intake x Oral Cancer Potency Factor (CPFo )    
whereas, Oral Cancer Potency Factor is expressed in kg-day/mg. 
The smaller the product of multiplication the safer the chemical is regarding the 
cancer risk. 
The calculation of the cumulative risk for cancer reveals that there is such risk and 
equals with 3.1E-04. 
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The calculations for the cancer risk show that aldrin (OC), BHC – benzene 
hexachloride (OC), dichlorvos (OPP/CARB), lindane (OC), heptachlor (OC), 
heptachlor epoxide (OC) and trifluralin (DINITROANILINE), which belong to chemical 
classes of organochlorines, dinitroanilines and organophosphates/carbamates, are 
considered having the higher risk among those identified. It seems that the chemical 
class of organochlorines is having the highest cancer risk comparing with the other 
chemical classes. 
3.2. CHILDREN IN REGIONAL PREFECTURE OF CRETE 
The results for the sub-population “children in Regional Prefecture of Crete” are as 
follows: 
The fifty six (56) out of 197 chemicals can present acute neurotoxicity effects 
according to the toxicity tests performed.               
The Risk Characterisation Ratio (RCR) for the evaluation of acute risk of a 
chemical substance is defined as follows:   
Risk characterisation ratio (RCR) = Exposure Estimate (Daily Intake) / Oral 
Reference Dose   
When the quotient is <1 the risk to the human health due to the chemical is 
considered small; specifically, the smaller than the one, the less minimum the risk.      
Referring to the data, the results revealed that the majority of the active substances 
are much less than the one. Sixty (60) out of 197 substances, or the 30% of them, 
are bearing greater health risk at different level. Among the 30%, the 10% or six (6) 
chemical substances were presenting the higher acute risk as closer to one (10-1), 
while about the 23% and 38%, or 14 and 23 substances accordingly, were following 
with a risk less closer to one (10-2 and 10-3 respectively). 
The most risky chemicals (10-1) were chlorpyrifos, dimethoate, ethion, parathion-
methyl, heptachlor epoxide and imazalil. The first three belong to the chemical 
class of organophosphates (OPP), the fourth to the organochlorines (OC) and the 
last to the azoles chemical group (AZO).
Those following most risky chemicals (10-2) were aldrin (OC), carbofuran (CARB), 
chlorpyrifos-methyl (OPP), cypermethrin (PYR), 4,4’-DDT (OC), diazinon (OPP), 
dichlorvos (OPP/CARB), lindane or γ-HCH (ORGANOCHLORINE), iprodione 
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(DICARBOXIMIDE), linuron (UREA), malathion (OPP), phosmet (OPP), pirimiphos-
methyl (OPP) and trifluthrin (DINITROANILINE). 
Those with chemical risk accompanied with 10-3 were acephate, bifenthrin, carbaryl, 
chlorpropham, chlorothalonil, cyromazine, DDT, dieldrin, endosulfan, endrin, 
fluvalinate, glyphosate, heptachlor, metalaxyl, methomyl, myclobutanil, oxamyl, 
prochloraz, propargite, propiconazole, quinalphos, thiophanate-methyl, vinclozolin. 
The Risk Characterisation Ratio (RCR) for the evaluation of chronic risk of a 
chemical substance is defined as follows:   
Risk characterization ratio (RCR) = Exposure Estimate (Daily Intake) / 
Acceptable Daily Intake (ADI)
The ADI is expressed in mg/kg-bw/day as the daily intake that equals to μg/g-bw/day.  
According to the results, there were no chemicals above the one. From 138 chemical 
substances, only seven (7) chemical substances were much closer (10-1) to the one 
but not above it, these can be regarded as the most risky ones to human health 
among the rest ones. These were omethoate (OPP), imazalil (AZO), heptachlor 
epoxide (OC), dimethoate (OPP), chlorpyrifos (OPP), chlorfenvinphos (OPP), 
carbofuran (CARB). All of them comprise the 5.07% as those followed with 10-2 
comprise the 23.19% and those with 10-3 comprise the 28.98%. 
Specifically, the 32 less riskier chemical substances accompanied with 10-2 belong to 
the chemical classes of dinitroaniline (1), organophosphates (9), organochlorides (2), 
azoles (6), phenoxy (1), carbamates (6), dicarboximide (1), pyrethrines (4), 
organophosphate/carbamate (1) and morpholine (1).            
The cumulative risk for chronic exposure equals with 9.1E-01 which although is less 
than the one it still is very close to it arising potential concerns towards health safety.
 
The opposite of Risk Characterisation Ratio (RCR) is the Margin of Safety (MoS) 
that is used to describe the safety of a chemical substance; it is expressed as    
Margin of Safety (MoS) = Oral Reference Dose / Exposure Estimate (Daily 
Intake)   
The larger than the one the quotient the safer the chemical is. The results show that 
the less safest ones and those much closer to the one where those with 100, 101 and 
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102 values which if expressed in percentage comprise 10%, 21.67% and 40% 
accordingly. Those attached with 100 are chlorpyrifos (OPP), dimethoate (OPP), 
ethion (OPP), heptachlor epoxide (OC), imazalil (AZO), parathion-methyl (OPP). As 
before, under this parameter, the majority of the less safe chemicals belong to the 
chemical group of organophosphates and the other two to azoles and 
organochlorines. 
The Cancer Risk is calculated as follows:
Cancer Risk = Daily Intake x Oral Cancer Potency Factor (CPFo )    
whereas, Oral Cancer Potency Factor is expressed in kg-day/mg. 
The smaller the product of multiplication the safer the chemical is regarding the 
cancer risk. 
The calculation of the cumulative risk for cancer reveals that there is such risk and 
equals with 2.1E-04. 
The calculations for the cancer risk show that Aldrin (OC), dichlorvos (OPP/CARB), 
lindane (OC) and heptachlor epoxide (OC), which belong to chemical class of 
organochlorines (OC) and organophosphates /carbamates (OPP/CARB), are 
considered having the higher risk among those identified. It seems that the chemical 
class of organochlorines is having the highest cancer risk comparing with other 
chemical classes. 
3.3. NEUROTOXICITY EVALUATION
Referring to the toxicological evaluation of the chemical substances, this was 
performed either by EFSA and /or JMPR as pre-mentioned. The results of the 
evaluation on each identified pesticide revealed six (6) kind of neurotoxicity as end-
points such as, acute, short term, sub-chronic, chronic, developmental (DNT) 
and delayed neuropathy, and are being presented on the following graph – Table 2:    
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4. CONCLUSION
The role of Pesticides or Plant Protection Products (PPRs) is preventing crops from 
being damaged or destroyed by disease and pests and thus, maintaining crop yields. 
As the majority of pesticides are chemicals, by their nature, are potentially toxic to 
other organisms, including humans. Therefore, since their presence in food and feed 
is considered unavoidable nowadays, they need to be used safely and disposed of 
properly. 
The presence of pesticide residues in foodstuffs has been associated with human 
health effects many times through research and clinical observations. One of the 
major points was their toxicological effects of which neurotoxicity has being 
investigated in this study. Additionally, cancer risk is the other principal point that is 
taken into account through this study. Moreover, an approach of the potential 
cumulative risk due to chronic exposure and cancer risk is also accomplished.   
The result of the Risk Characterisation Ratio (RCR) for the evaluation of acute or 
chronic risk of a chemical substance is assessed as follows:   
When the quotient is <1 the risk to the human health due to the chemical is 
considered small; specifically, the smaller than the one, the less minimum the risk.      
Regarding the sub – population “lactating women”, the acute risk assessment 
revealed that the majority of active substances are much less than the one. Among 
197 substances, the 7.6% or five (5) chemical substances were presenting acute risk 
with values as higher than one. These were dimethoate (OPP), methamidophos 
(OPP), parathion-methyl (OPP), propoxur (CARB), triadimefon (AZO). The four of 
them belong to the chemical class of organophosphates (OPP), whilst the other two 
to carbamates (CARB) and azoles chemical group (AZO). 
The acute risk for the above pesticides can be regarded as high for the sub – 
population “lactating women in Greece”. 
Regarding the sub – population “children in regional prefecture of Crete”, the 
acute risk assessment revealed that the majority of the active substances are much 
less than the one. Among 197 substances, the 10% or six (6) chemical substances 
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were presenting the higher acute risk as closer to one. These were chlorpyrifos, 
dimethoate, ethion, parathion-methyl, heptachlor epoxide and imazalil. The first 
four belong to the chemical class of organophosphates (OPP), whilst the fifth to the 
organochlorines (OC) and the last to the azoles chemical group (AZO).
The acute risk for the above pesticides can be considered as low for the sub – 
population “children in regional prefecture of Crete”. 
Comparing the results for acute risk of the two sub – populations, it seems that the 
difference can be regarded to the diversity of daily intakes due to variant mean 
consumption of each food category between lactating women and children. 
Moreover, they share two chemical substances that belong to the chemical class of 
organophosphates (OPP). This chemical class can be assumed as having the 
highest acute risk for both sub – populations examined.     
        
According to the chronic risk assessment results for the sub – population “lactating 
women”, there were some chemicals equal to zero but all less than one. From 154 
chemical substances, the 3.9% of them or six (6) chemical substances equal zero (0) 
which were demeton-S-methyl sulfoxide (OPP), ethoprofos (OPP), maneb group 
(CARB), methamidophos (OPP), propoxur (CARB) and triadimephon (AZO).  
With regard to the chronic risk assessment results for the sub – population 
“children in regional prefecture of Crete”, there were no chemicals above the one. 
Among 138 chemical substances, only the 5.07% or seven (7) chemical substances 
were much closer to the one but none above it, which were omethoate (OPP), 
imazalil (AZO), heptachlor epoxide (OC), dimethoate (OPP), chlorpyrifos (OPP), 
chlorfenvinphos (OPP), carbofuran (CARB).  
Comparing the results for chronic risk of the two sub – populations, it seems that they 
are in line with no one value exceeding the one. Concerning of the individual impact 
of the identified chemical substances, it seems that they do not pose any significant 
chronic risk to human health through food consumption. 
In other terms, the chronic risk for the detected pesticides can be regarded as low for 
both sub–populations “lactating women in Greece” and “children in regional 
prefecture of Crete”. 
As in the acute risk assessment, the majority of the chemical substances for both sub 
– populations having the higher impact in the chronic risk assessment belong to the 
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chemical class of organophosphates (OPP), followed by carbamates and azoles 
chemical classes.      
Concerning of the cumulative risk for chronic exposure for “lactating women”, it 
equals with 1.0E+00 which in other terms means that is marginal safe and potential 
concerns towards health safety cannot be avoided and/or ignored. In the case of 
“children in regional prefecture of Crete”, the cumulative risk for chronic 
exposure equals with 9.1E-01 which although is less than the one it is still very close 
thus, arising potential concerns towards human health safety.
Regarding the cumulative risk assessment for cancer for “lactating women”, it 
reveals that there is such risk and equals with 3.1E-04. 
According to the results, the pesticides considering having the highest impact risk on  
cumulative cancer are aldrin (OC), BHC – benzene hexachloride (OC), dichlorvos 
(OPP/CARB), lindane (OC), heptachlor (OC), heptachlor epoxide (OC) and 
trifluralin (DINITROANILINE), which belong to the chemical classes of 
organochlorines, dinitroanilines and organophosphates/carbamates. Obviously, the 
chemical class of organochlorines is having the highest cumulative cancer risk 
comparing with the other chemical classes.
Likewise, the cumulative risk assessment for cancer for “children in the 
prefecture of Crete” reveals that there is such risk and equals with 2.1E-04. 
Moreover, the pesticides identified bearing the highest impact on cumulative cancer 
risk are: aldrin (OC), dichlorvos (OPP/CARB), lindane (OC) and heptachlor 
epoxide (OC), which belong to chemical class of organochlorines (OC) and 
organophosphates /carbamates (OPP/CARB). It seems that the chemical class of 
organochlorines is having the highest cumulative cancer risk comparing with other 
chemical classes. 
Comparing the results for cumulative cancer risk, it is revealed that there is such risk 
in both sub – populations examined. Additionally, both populations almost share the 
same pesticides identified with the highest impact of cumulative cancer risk on 
human health through diet, bringing also the chemical class of organochlorines at the 
top of such impact risk in this study. 
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Referring to the toxicological evaluation of the chemical substances upon 
neurotoxicity that was performed either by EFSA and /or JMPR, the results are as 
follows: 
A/A KIND OF NEUROTOXICITY NUMBER OF CHEMICALS
1 ACUTE 57
2 SHORT TERM 16
3 SUB-CHRONIC 26
4 CHRONIC 23
5 DNT (DEVELOPMENTAL NEUROTOXICITY) 7
6 DELAYED NEUROPATHY 2
7 NO EVIDENCE 
(OF NEUROTOXICITY)
65
8 NO DATA 
(OF NEUROTOXICITY AND /OR ANY TOXICITY)
64
 
The majority of the pesticides identified (197) in this study may induce acute 
neurotoxicity (57), followed by sub-chronic (26) and chronic neurotoxicity (23). 
Sixteen out of 197 pesticides can induce short term neurotoxicity, whilst seven and 
two may develop developmental neurotoxicity (DNT) and delayed neuropathy 
respectively. 
Additionally, the toxicological evaluation of sixty five (65) pesticides revealed that 
they do not induce any kind of neurotoxicity while sixty four (64) out of 197 were 
missing toxicological data.          
In conclusion, the exposure of sensitive population, such as lactating women and 
children, to pesticide residues in foodstuffs may provoke acute and chronic toxicity 
effects and cancer risk to their health.    
According to the latest scientific development internationally that gave rise to 
cumulative risk assessment, cumulative effects will only occur when chemicals with 
similar toxicological properties present on food are consumed together. Thus, the 
development of pesticides with better qualitative and quantitative attributes with 
regard to elimination of severe toxicity effects to human health should be progressed 
and also combined with effective pest management training to all stakeholders.                    
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LIST OF ACRONYMS AND ABBREVIATIONS
AChE acetylcholinesterase
ADI acceptable daily intake
ARfD acute reference dose
ATSDR Agency for Toxic Substances and Disease Registry (USA)
BMD benchmark dose
CAC Codex Alimentarius – International Food Standards 
CAS Chemical Abstracts Service
CNS central nervous system
CPFo oral cancer (or carcinogenic) potency factor 
DNT Developmental Neurotoxicity
EC European Commission
EEC European Economic Community 
EFSA European Food Safety Agency 
EHC Environmental Health Criteria
EPA Environmental Protection Agency
ERPs event – related potentials
EU European Union
FAO Food and Agriculture Organization of the United Nations
GAP good agricultural practice
HI hazard index
IARC International Agency for Research on Cancer
IQ Intelligence Quotient 
IPCS International Programme on Chemical Safety
IPM Integrated pest management
JECFA Joint FAO/WHO Expert Committee on Food Additives
JMPR Joint FAO/WHO Meeting on Pesticide Residues
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MoA mode of action
MOE margin of exposure
MOEmix margin of exposure of a mixture
MoS margin of safety
MRI magnetic resonance imaging
MRL maximum residue limit
NINDS National Institute of Neurological Disorders
NOAEL no-observed-adverse-effect level
NOEL no-observed-effect level
OECD Organisation for Economic Co-operation and Development
P300 component of the auditory event-related brain potential
PAN Pesticide Action Network
PBPK/PD physiologically based pharmacokinetic/pharmacodynamics  
PET positron emission tomography
PNS peripheral nervous system
PODI point of departure index
PPR Panel on Plant Protection Products and their Residues (EFSA)
PPPs plant protection products
PRIMo Pesticide Residue Intake Model
PTMI provisional tolerable monthly intake
PTWI provisional tolerable weekly intake
qEEG quantitative electroencephalography
RIVM National Institute for Public Health and the Environment (Netherlands) 
RMS Rapporteur Member State 
RCR risk characterisation ratio
RfC reference concentration
RfD reference dose
RPF Relative Potency Factor 
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RIVM National Institute for Public Health and the Environment (Netherlands)
SARs Structure-activity relationships
SEPs somatosensory evoked potentials
SF slope factor 
SPECT single photon emission computerized tomography
TDI tolerable daily intake 
TEF toxic equivalency factor 
TEQ toxic equivalent
TOCP tri-o-cresylphosphate
TOXNET toxicology data network
TTC threshold of toxicological concern
UN United Nations
UNEP United Nations Environment Programme
USA/US United States of America
USEPA United States Environmental Protection Agency
WAC Washington Administrative Code
WHO World Health Organization
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ANNEX 1






















acifluorfen, sodium 62476-59-9 1,30E-02
acrolein 107-02-8 5,00E-04
acrylamide 79-06-1 2,00E-03 5,00E-01
acrylic acid 79-10-7 5,00E-01
acrylonitrile 107-13-1 4,00E-02 5,40E-01
alachlor 15972-60-8 1,00E-02 5,60E-02
alar 1596-84-5 1,50E-01 1,80E-02
aldicarb 116-06-3 1,00E-03
aldicarb sulfone 1646-88-4 1,00E-03
aldrin 309-00-2 3,00E-05 1,70E+01
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ally 74223-64-6 2,50E-01
allyl alcohol 107-18-6 5,00E-03
allyl chloride 107-05-1 2,10E-02
aluminum 7429-90-5 1,00E+00







ammonium perchlorate 7790-98-9 7,00E-04
ammonium sulfamate 7773-06-0 2,00E-01
aniline 62-53-3 7,00E-03 5,70E-03
anthracene 120-12-7 3,00E-01
antimony 7440-36-0 4,00E-04
antimony pentoxide 1314-60-9 5,00E-04
antimony potassium tartrate 28300-74-5 9,00E-04
antimony tetroxide 1332-81-6 4,00E-04
antimony trioxide 1309-64-4
apollo 74115-24-5 1,30E-02
aramite 140-57-8 5,00E-02 2,50E-02
aroclor 1016 12674-11-2 7,00E-05 7,00E-02
aroclor 1254 11097-69-1 2,00E-05 2,00E+00
aroclor 1260 11096-82-5 2,00E+00
arsenic, inorganic 7440-38-2 3,00E-04 1,50E+00
arsine 7784-42-1 3,50E-06
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atrazine 1912-24-9 3,50E-02 2,30E-01
avermectin B1 65195-55-3 4,00E-04
azobenzene 103-33-3 1,10E-01









benzene 71-43-2 4,00E-03 5,50E-02
benzenethiol 108-98-5 1,00E-03






benzoic acid 65-85-0 4,00E+00
benzotrichloride 98-07-7 1,30E+01
benzyl alcohol 100-51-6 1,00E-01
benzyl chloride 100-44-7 2,00E-03 1,70E-01
beryllium 7440-41-7 2,00E-03
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biphenyl;1,1- 92-52-4 5,00E-01 8,00E-03
bis(2-chloro-1-methyl-ethyl)ether 108-60-1 4,00E-02 7,00E-02
bis(2-chloroethyl)ether 111-44-4 1,10E+00
bis(2-chloroisopropyl) ether 39638-32-9
bis(2-ethylhexyl) phthalate 117-81-7 2,00E-02 1,40E-02
bis(chloromethyl)ether 542-88-1 2,20E+02
bisphenol a 80-05-7 5,00E-02
boron 7440-42-8 2,00E-01
bromate 15541-45-4 4,00E-03 7,00E-01
bromodichloromethane 75-27-4 2,00E-02 6,20E-02
bromoethene 593-60-2




bromoxynil octanoate 1689-99-2 2,00E-02
butadiene;1,3- 106-99-0 3,40E+00
butanol;n- 71-36-3 1,00E-01
butyl benzyl phthalate 85-68-7 2,00E-01 1,90E-03
butylate 2008-41-5 5,00E-02
butylphthalyl butylglycolate 85-70-1 1,00E+00
butyric acid;4-(2-methyl-4-chlorophenoxy)- 94-81-5 1,00E-02
cacodylic acid 75-60-5 2,00E-02
cadmium (soil and nonpotable surface water) 7440-43-9a 1,00E-03
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cadmium (potable groundwater and surface 
water)
7440-43-9 5,00E-04
calcium cyanide 592-01-8 1,00E-03
caprolactam 105-60-2 5,00E-01
captafol 2425-06-1 2,00E-03 1,50E-01




carbon disulfide 75-15-0 1,00E-01





chloral hydrate 302-17-0 1,00E-01
chloramben 133-90-4 1,50E-02
chloranil 118-75-2 4,00E-01




chlorine cyanide 506-77-4 5,00E-02
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chloro-2-methylaniline hydrochloride;4- 3165-93-3 4,60E-01
chloro-2-methylaniline;4- 95-69-2 3,00E-03 1,00E-01
chloroacetic acid 79-11-8 2,00E-03
chloroacetophenone;2- 532-27-4
chloroaniline;p- 106-47-8 4,00E-03 2,00E-01
chlorobenzene 108-90-7 2,00E-02
chlorobenzilate 510-15-6 2,00E-02 1,10E-01




chloroform 67-66-3 1,00E-02 3,10E-02
chloromethane 74-87-3
chloromethyl methyl ether 107-30-2 2,40E+00
chloronitrobenzene;o- 88-73-3 3,00E-03 3,00E-01
chloronitrobenzene;p- 100-00-5 1,00E-03 6,30E-03
chlorophenol;2- 95-57-8 5,00E-03
chlorophenyl methyl sulfide;p- 123-09-1
chlorophenyl methyl sulfone;p- 98-57-7
chlorophenyl methyl sulfoxide;p- 934-73-6
chloropropane;2- 75-29-6






Institutional Repository - Library & Information Centre - University of Thessaly







coke oven emissions 8007-45-2
coal tar creosote 8001-58-9
copper 7440-50-8 4,00E-02




crotonaldehyde 123-73-9 1,00E-03 1,90E+00
cumene 98-82-8 1,00E-01
cyanazine 21725-46-2 2,00E-03 8,40E-01
cyanide 57-12-5 6,00E-04
cyanogen 460-19-5 1,00E-03









dalapon, sodium salt 75-99-0 3,00E-02
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ddt 50-29-3 5,00E-04 3,40E-01
decabromodiphenyl ether 1163-19-5 7,00E-03 7,00E-04
demeton 8065-48-3 4,00E-05





dibromo-3-chloropropane;1,2- 96-12-8 2,00E-04 8,00E-01
dibromobenzene;1,4- 106-37-6 1,00E-02
dibromochloromethane 124-48-1 2,00E-02 8,40E-02





dichlorobenzene;1,4- 106-46-7 7,00E-02 5,40E-03
dichlorobenzidine;3,3'- 91-94-1 4,50E-01
dichlorodifluoromethane 75-71-8 2,00E-01
dichloroethane;1,1- 75-34-3 2,00E-01 5,70E-03
dichloroethane;1,2- 107-06-2 6,00E-03 9,10E-02
dichloroethylene,1,2- (mixed isomers) 540-59-0 9,00E-03
dichloroethylene;1,1- 75-35-4 5,00E-02
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dichlorophenoxyacetic acid;2,4- 94-75-7 1,00E-02
dichloropropane;1,2- 78-87-5 9,00E-02 3,60E-02
dichloropropanol;2,3- 616-23-9 3,00E-03
dichloropropene;1,3- 542-75-6 3,00E-02 1,00E-01
dichlorvos 62-73-7 5,00E-04 2,90E-01
dicofol 115-32-2
dicyclopentadiene 77-73-6 8,00E-03
dieldrin 60-57-1 5,00E-05 1,60E+01
diethyl phthalate 84-66-2 8,00E-01
diethylene glycol 111-46-6
diethylene glycol dinitrate 693-21-0
diethylene glycol monobutyl ether 112-34-5 3,00E-02
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dimethyl terephthalate 120-61-6 1,00E-01
dimethylamine 124-40-3
dimethylaniline hydrochloride;2,4- 21436-96-4 5,80E-01












dinitro-o-cyclohexyl phenol;4,6- 131-89-5 2,00E-03
dinitrophenol;2,4- 51-28-5 2,00E-03
dinitrotoluene mixture; 2,4-/2,6- 25321-14-6 9,00E-04 4,50E-01
dinitrotoluene;2,4- 121-14-2 2,00E-03 3,10E-01
dinitrotoluene;2,6- 606-20-2 3,00E-04 1,50E+00
di-n-octyl phthalate 117-84-0 1,00E-02
dinoseb 88-85-7 1,00E-03
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direct black 38 1937-37-7 7,40E+00
direct blue 6 2602-46-2 7,40E+00
direct brown 95 16071-86-6 6,70E+00












ethoxyethanol acetate;2- 111-15-9 1,00E-01
ethoxyethanol;2- 110-80-5 9,00E-02
ethyl acetate 141-78-6 9,00E-01
ethyl acrylate 140-88-5 4,80E-02
ethyl chloride 75-00-3
ethyl dipropylthiocarbamate;S- 759-94-4 2,50E-02
ethyl ether 60-29-7 2,00E-01
ethyl methacrylate 97-63-2 9,00E-02
ethyl p-nitrophenyl phenylphosphorothioate 2104-64-5 1,00E-05
ethylbenzene 100-41-4 1,00E-01
ethylene cyanohydrin 109-78-4 7,00E-02
ethylene diamine 107-15-3 9,00E-02
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ethylene dibromide (EDB) 106-93-4 9,00E-03 2,00E+00
ethylene glycol 107-21-1 2,00E+00
ethylene glycol monobutyl ether (EGBE) 111-76-2 1,00E-01
ethylene oxide 75-21-8 3,10E-01
ethylene thiourea 96-45-7 8,00E-05 4,50E-02
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gross alpha particle activity unavailable20
gross beta particle activity unavailable21
haloxyfop-methyl 69806-40-2 5,00E-05
harmony 79277-27-3 1,30E-02
heptachlor 76-44-8 5,00E-04 4,50E+00
heptachlor epoxide 1024-57-3 1,30E-05 9,10E+00
heptane;n- 142-82-5
hexabromobenzene 87-82-1 2,00E-03
hexabromodiphenyl ether; 2,2',4,4',5,5'- 68631-49-2 2,00E-04
hexachlorobenzene 118-74-1 8,00E-04 1,60E+00
hexachlorobutadiene 87-68-3 1,00E-03 7,80E-02





hexachlorodibenzo-p-dioxin, mixture 19408-74-3 6,20E+03
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hydrazine 302-01-2 3,00E+00
hydrazine sulfate 10034-93-2 3,00E+00
hydrogen chloride 7647-01-0
hydrogen cyanide 74-90-8 6,00E-04
hydrogen sulfide 7783-06-4






isobutyl alcohol 78-83-1 3,00E-01
isophorone 78-59-1 2,00E-01 9,50E-04
isopropalin 33820-53-0 1,50E-02
isopropyl methyl phosphonic acid 1832-54-8 1,00E-01




lindane 58-89-9 3,00E-04 1,10E+00
linuron 330-55-2 2,00E-03
lithium perchlorate 7791-03-9 7,00E-04
londax 83055-99-6 2,00E-01
malathion 121-75-5 2,00E-02
maleic anhydride 108-31-6 1,00E-01
maleic hydrazide 123-33-1 5,00E-01
malononitrile 109-77-3 1,00E-04
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mepiquat chloride 24307-26-4 3,00E-02











methoxyethanol acetate;2- 110-49-6 8,00E-03
methoxyethanol;2- 109-86-4 5,00E-03
methyl acetate 79-20-9 1,00E+00
methyl acrylate 96-33-3 3,00E-02
methyl ethyl ketone 78-93-3 6,00E-01
methyl isobutyl ketone 108-10-1 8,00E-02
methyl mercury 22967-92-6 1,00E-04
methyl methacrylate 80-62-6 1,40E+00
methyl naphthalene;1- 90-12-0 7,00E-02 2,90E-02
methyl naphthalene;2- 91-57-6 4,00E-03
methyl parathion 298-00-0 2,50E-04
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methyl styrene 25013-15-4 6,00E-03
methyl styrene, alpha 98-83-9 7,00E-02
methyl tert-butyl ether 1634-04-4 1,80E-03
methyl-4-chlorophenoxy-acetic acid;2- 94-74-6 5,00E-04
methyl-5-nitroaniline;2- 99-55-8 2,00E-02 9,00E-03
methylaniline hydrochloride;2- 636-21-5 1,30E-01
methylaniline;2- 95-53-4
methylcyclohexane 108-87-2
methylene bis(2-chloroaniline);4,4'- 101-14-4 2,00E-03 1,00E-01
methylene bis(n,n'-dimethyl)aniline;4,4'- 101-61-1 4,60E-02
methylene bromide 74-95-3 1,00E-02
methylene chloride 75-09-2 6,00E-03 2,00E-03
methylene diphenyl diisocyanate (MDI) 101-68-8
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n-butylbenzene 104-51-8 5,00E-02
niagara blue 4B 2429-74-5
nickel refinery dust unavailable04 1,10E-02
nickel soluble salts 7440-02-0 2,00E-02






















nitrotoluene, m- 99-08-1 1,00E-04
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nitrotoluene, o- 88-72-2 9,00E-04 2,20E-01




















pentabromodiphenyl ether; 2,2',4,4',5- 60348-60-9 1,00E-04
pentabromodiphenyl ethers 32534-81-9 2,00E-03
pentachlorobenzene 608-93-5 8,00E-04
pentachloronitrobenzene 82-68-8 3,00E-03 2,60E-01
pentachlorophenol 87-86-5 5,00E-03 4,00E-01
perchlorate and perchlorate salts 7601-90-3 7,00E-04
permethrin 52645-53-1 5,00E-02
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phenylenediamine, p- 106-50-3 1,90E-01
phenylenediamine;m- 108-45-2 6,00E-03
phenylenediamine;o- 95-54-5 4,70E-02





phosphoric acid 7664-38-2 4,90E+01
phosphorus 7723-14-0 2,00E-05
phthalic acid;p- 100-21-0 1,00E+00
phthalic anhydride 85-44-9 2,00E+00
picloram 1918-02-1 7,00E-02
pirimiphos-methyl 29232-93-7 1,00E-02
polybrominated biphenyls 67774-32-7 7,00E-06 3,00E+01
polychlorinated biphenyls (PCBs) 1336-36-3 2,00E+00
potassium cyanide 151-50-8 2,00E-03
potassium perchlorate 7778-74-7 7,00E-04
potassium silver cyanide 506-61-6 5,00E-03
prochloraz (not in HSDB) 67747-09-5 9,00E-03 1,50E-01
profluralin 26399-36-0 6,00E-03
prometon 1610-18-0 1,50E-02
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propionic acid;(2-methyl-4-chlorophenoxy)2- 93-65-2 1,00E-03
propylbenzene;n- 103-65-1 1,00E-01
propylene glycol 57-55-6 2,00E+01
propylene glycol dinitrate;1,2- 6423-43-4
propylene glycol monoethyl ether 52125-53-8 7,00E-01
propylene glycol monomethyl ether 107-98-2 7,00E-01








radium 226 and 228 unavailable23
rdx 121-82-4 3,00E-03 1,10E-01
refractory ceramic fibers unavailable07
resmethrin 10453-86-8 3,00E-02
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selenious acid 7783-00-8 5,00E-03




silver cyanide 506-64-9 1,00E-01
simazine 122-34-9 5,00E-03 1,20E-01
sodium azide 26628-22-8 4,00E-03
sodium cyanide 143-33-9 1,00E-03
sodium diethyldithiocarbamate 148-18-5 3,00E-02 2,70E-01
sodium fluoroacetate 62-74-8 2,00E-05
sodium metavanadate 13718-26-8 1,00E-03






tcdd;2,3,7,8- (Low organic) (dioxin) 1746-01-6 7,00E-10 1,30E+05
tebuthiuron 34014-18-1 7,00E-02
temephos 3383-96-8 2,00E-02
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tetrabromodiphenyl ether 2,2',4,4' 5436-43-1 1,00E-04
tetrachlorobenzene;1,2,4,5- 95-94-3 3,00E-04
tetrachloroethane;1,1,1,2- 630-20-6 3,00E-02 2,60E-02
tetrachloroethane;1,1,2,2- 79-34-5 2,00E-02 2,00E-01
tetrachloroethylene (PCE) 127-18-4 6,00E-03 2,10E-03
tetrachlorophenol;2,3,4,6- 58-90-2 3,00E-02
tetrachlorotoluene;p,a,a,a,- 5216-25-1 2,00E+01
tetrachlorvinphos 961-11-5 3,00E-02 2,40E-02
tetraethyl dithiopyrophosphate 3689-24-5 5,00E-04
tetraethyl lead 78-00-2 1,00E-07
tetrafluoroethane;1,1,1,2- 811-97-2
thallic oxide 1314-32-5
thallium acetate 563-68-8 6,00E-06
thallium carbonate 6533-73-9 2,00E-05
thallium chloride 7791-12-0 6,00E-06
thallium nitrate 10102-45-1 7,00E-06
thallium selenite 12039-52-0
thallium(I) sulfate 7446-18-6 2,00E-05
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tnt 118-96-7 5,00E-04 3,00E-02
toluene 108-88-3 8,00E-02
toluene diisocyanate mixture;2,4-/2,6- 26471-62-5
toluenediamine;2,4- 95-80-7
toluenediamine;2,5- 95-70-5 2,00E-04 1,80E-01
toluenediamine;2,6- 823-40-5
toluidine;p- 106-49-0 4,00E-03 3,00E-02
total dissolved solids unavailable18
toxaphene 8001-35-2 1,10E+00
tp;2,4,5- 93-72-1 8,00E-03
tph, diesel range organics unavailable09
tph, heavy oils unavailable10
tph, mineral oil unavailable11
tph: gasoline range organics, benzene 
present*
unavailable25







tributyltin oxide 56-35-9 3,00E-04
trichloro-1,2,2-trifluoroethane;1,1,2- 76-13-1 3,00E+01
trichloroaniline hydrochloride;2,4,6- 33663-50-2 2,90E-02
trichloroaniline;2,4,6- 634-93-5 3,00E-05 7,00E-03
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trichlorobenzene;1,2,4- 120-82-1 1,00E-02 2,90E-02
trichloroethane;1,1,1- 71-55-6 2,00E+00
trichloroethane;1,1,2- 79-00-5 4,00E-03 5,70E-02
trichloroethylene (TCE) 79-01-6 5,00E-04 Guidance
trichlorofluoromethane 75-69-4 3,00E-01
trichlorophenol;2,4,5- 95-95-4 1,00E-01
trichlorophenol;2,4,6- 88-06-2 1,00E-03 1,10E-02
trichlorophenoxyacetic acid;2,4,5- 93-76-5 1,00E-02
trichloropropane;1,1,2- 598-77-6 5,00E-03




trifluralin 1582-09-8 7,50E-03 7,70E-03
trihalomethanes, total (TTHMs) unavailable13





uranium, soluble salts unavailable12 3,00E-03
vanadium 7440-62-2 5,00E-03




vinyl acetate 108-05-4 1,00E+00
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vinyl chloride 75-01-4 3,00E-03 Guidance
warfarin 81-81-2 3,00E-04






zinc cyanide 557-21-1 5,00E-02
zinc phosphide 1314-84-7 3,00E-04
zineb 12122-67-7 5,00E-02
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ANNEX 2
TOXICOLOGICAL MONOGRAPHS – JMPR 
PESTICIDE RISK ASSESSMENT OF ACTIVE SUBSTANCE – EFSA 
These monographs, published by the World Health Organization, contain detailed 
descriptions of the biological and toxicological data used in JMPR's evaluations, as 
well as conclusions such as intake assessments for the pesticides under 
consideration. In addition, they provide full references to the relevant literature. The 
information and endpoints contained in the evaluations are also summarized in the 
reports published as FAO Plant Production and Protection Papers.
1. ACEPHATE  
Source: ACEPHATE 3–16 JMPR 2005 
Kind of Neurotoxicity: acute/short-term neurotoxicity
The Meeting established an ADI of 0–0.03 mg/kg bw based on the NOAEL of 0.25 
mg/kg bw per day from the study of repeated doses in humans and an overall safety 
factor of 10. The Meeting established an ARfD of 0.1 mg/kg bw on the basis of the 
NOAEL of 1.2 mg/kg bw from the study of single doses in humans and an overall 
safety factor of 10.
The overall safety factor of 10 was derived by dividing the default value of 10 by 2 
(because inhibition of acetylcholinesterase activity depends on the Cmax) and by 
multiplying by 2 (because some uncertainty remains with respect to the in-vivo 
sensitivity to inhibition of human brain acetylcholinesterase activity relative to that of 
erythrocyte acetylcholinesterase activity, since brain acetylcholinesterase may be 
more sensitive than erythrocyte acetylcholinesterase).
Neurotoxicity/delayed neurotoxicity
NOAEL for acute neurotoxicity 1.2 mg/kg bw (humans)
NOAEL in short-term study of neurotoxicity 0.25 mg/kg bw per day (humans)
No signs of delayed polyneuropathy (hens)
Summary Value Study Safety factor
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ADI 0–0.03 mg/kg bw Human, 28-day study 10
ARfD 0.1 mg/kg bw Human, single-dose study 10 
2. ACETAMIPRID  
Source: ACETAMIPRID 3–92 JMPR 2011
Kind of Neurotoxicity: Acute /Developmental neurotoxicity 
Acetamiprid did not cause delayed neuropathy in hens.
Neurotoxicity/delayed neurotoxicity
Acute neurotoxicity target/critical effect Motor activity and increased 
frequency of urination 
Lowest relevant acute neurotoxic NOAEL 10 mg/kg bw 
Subchronic neurotoxicity target/critical effect Not neurotoxic (rats) 
Developmental neurotoxicity target/critical effect Deficits in auditory startle 
response 
Lowest relevant developmental neurotoxic NOAEL 10 mg/kg bw per day (rat)
Summary
Value Study Safety factor
ARfD 0.1 mg/kg bw Acute neurotoxicity, rat (supported 100
by maternal toxicity in the 
developmental neurotoxicity rat study)
3. ACETOCHLOR  
Source: ACETOCHLOR 79–185 JMPR 2015
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
In an acute neurotoxicity study in rats administered a single oral gavage acetochlor 
dose of 0, 150, 500 or 1500 mg/kg bw, decreased body weights and body weight 
gain and reduced feed consumption were observed at 1500 mg/kg bw. No 
neurotoxicity was observed. 
In a 93-day study of neurotoxicity in rats given diets containing acetochlor at a 
concentration of 0, 200, 600 or 1750 ppm (equal to 0, 15.4, 47.6 and 139 mg/kg bw 
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per day for males and 0, 18.3, 55.9 and 166.5 mg/kg bw per day for females, 
respectively), marginal decreases in mean body weight and body weight gain in 
males and females were observed at 1750 ppm (equal to 139 mg/kg bw per day). 
There was no evidence for neurotoxicity or neuropathological effects up to 1750 ppm 
(equal to 139 mg/kg bw per day), the highest dose tested. 
The Meeting concluded that acetochlor is not neurotoxic.
4. ACRINATHRIN 
Source: EFSA Journal 2013;11(12):3469 8
Kind of Neurotoxicity: ACUTE NEUROTOXICITY EVIDENCE
Neurotoxicity  was  investigated  in  rats,  showing  an  acute NOAEL of 1 mg/kg bw 
and  a LOAEL of 2.4  mg/kg bw per day in a 90-day study.
Neurotoxicity  was  investigated  in  rats,  showing  an  acute NOAEL of 1 mg/kg bw 
and  a LOAEL of 2.4  mg/kg bw per day in a 90-day study.
Neurotoxicity was investigated in rats, showing an acute NOAEL of 1 mg/kg bw and a 
LOAEL of 2.4 mg/kg bw per day in a 90-day study. 
For the derivation of the reference values, the experts agreed to use the results of 
the acute neurotoxicity study with rats. Applying a safety factor of 100, this resulted in 
an Acceptable Daily Intake (ADI) of 0.01 mg/kg bw per day, an Acute Reference 
Dose (ARfD) of 0.01 mg/kg bw and, considering an additional correction for an oral 
absorption of 71 %, an Acceptable Operator Exposure Level (AOEL) of 0.007 mg/kg 
bw per day. 
5. ALDRIN / DIELDRIN / CHLORDANE / DDT / ENDRIN / HEPTACHLOR
Source: JMPR REPORT 1994
Kind of Neurotoxicity: NO DATA 
TOXICOLOGICAL END-POINTS FOR PESTICIDES PRESENT IN THE 
ENVIRONMENT AS UNAVOIDABLE CONTAMINANTS
Several pesticides that have been allocated ADIs by the JMPR are no longer used in 
agricultural practice but may be present in food commodities as contaminants 
because of their persistence in the environment. Extraneous Residue Limits (ERLs) 
have been assigned to commodities containing these pesticides by the Codex 
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Committee on Pesticide Residues on the basis of food monitoring data, not Good 
Agricultural Practice.
 ADIs were established in the past for these pesticides, most of which bioaccumulate 
in human tissues, on the basis of toxicological data, but studies with adequate power 
to detect toxic effects have not been performed on most of them. It is unlikely that 
further studies will be carried out, because these pesticides are no longer used in 
agricultural practice and do not have industrial sponsors. For these reasons, the Joint 
Meeting did not consider it appropriate to maintain traditional ADIs for them. At the 
same time, it is useful to maintain a numerical toxicological end-point to serve as a 
guideline with which potential dietary intakes can be compared.
For these reasons and to parallel the action that has been taken on residues, the 
Meeting converted the ADI for each of these pesticides to a provisional tolerable daily 
intake (PTDI). 
The term "tolerable" rather than "acceptable" was used to signify permissibility rather 
than acceptability of the intake of environmental contaminants unavoidably 
associated with the consumption of otherwise wholesome food. Use of the term 
"provisional" expresses the fact that reliable data on the consequences of human 
exposure to these pesticides are lacking and that the submission from any source of 
relevant safety data is encouraged.
 In line with the foregoing, PTDIs were established as follows:






 The Meeting recommended that these PTDIs be reviewed whenever possible
modifications of ERLs are considered.
6. ATRAZINE–DESETHYL (DEA) 
Source: ATRAZINE 37–138 JMPR 2007
Kind of Neurotoxicity: NO EVIDENCE OF NEUROTOXICITY  
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No evidence of neurotoxicity in standard tests for toxicity; however, neuroendocrine 
mode of action has been established for atrazine and its chloro-s-triazine metabolites
Other toxicological studies:
Studies on metabolites DEA, DIA, DACT have the same neuroendocrine mode of 
action and similar potency to atrazine. Mode of neuroendocrine action Atrazine and 
its chlorometabolites modify hypothalamic catecholamine function and regulation, 
leading to alterations in pituitary LH and prolactin secretion.
Summary Atrazine 
(aGroup ADI or ARfD for atrazine, deethyl-atrazine (DEA), deisopropyl-atrazine (DIA) 
and diaminochlorotriazine (DACT))
Value Study Safety factor
Group ADIa 0–0.02 mg/kg bw Sprague-Dawley rats; 6-month 100
study of LH surge/estrous cycle 
disruption 
Group ARfDa 0.1 mg/kg bw Rat; special 4-day study of 100
prolactin release, supported by 
studies of developmental toxicity
in rats and rabbits 
7. AZINPHOS-ETHYL   
Source: JMPR
Kind of Neurotoxicity: NO DATA  
1973 NO ADI 
8. AZINPHOS-METHYL 
Source: AZINPHOS-METHYL 139–172 JMPR 2007
Kind of Neurotoxicity: ACUTE NEUROTOXICITY  
Azinphos-methyl was highly acutely toxic (LD50 range, 4.4–26 mg/kg bw) when 
administered orally in an aqueous or non-aqueous vehicle to rats, and its profile of 
clinical signs was similar to those of other cholinesterase-inhibiting 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
107
organophosphorus pesticides. Clinical signs observed in experimental animals after 
acute exposure were salivation, lacrimation, vomiting, diarrhea, anorexia, reduced 
locomotor activity, piloerection, staggering gait and muscular tremors. These signs 
were generally evident within 5–20 min after dosing. 
The main toxicological findings in repeat-dose studies in rodents and dogs 
were inhibition of cholinesterase activity and, at higher doses, reduced body-
weight gain and signs of neurotoxicity. In long-term studies of toxicity, 
inhibition of cholinesterase activity was again the main toxicological finding in 
mice and rats.
The Meeting established an ADI of 0–0.03 mg/kg bw per day based on a NOAEL of 
0.29 mg/kg bw per day for the absence of inhibition of erythrocyte 
acetylcholinesterase activity in a 30-day study of toxicity in male volunteers and a 
safety factor of 10. The Meeting also considered the ADI to be protective for other, 
non-neurotoxic effects of azinphos-methyl observed in short- and long-term studies 
with repeated doses, and in studies of reproductive and developmental toxicity, 
where the use of a safety factor of 10 would be appropriate.
The Meeting established an ARfD of 0.1 mg/kg bw based on the NOAEL of 1 
mg/kg bw and using a safety factor of 10. In a study of acute neurotoxicity in 
rats, the NOAEL was 2 mg/kg bw on the basis of inhibition of cholinesterase 
activity in the brain. At a dose of 2 mg/kg bw, significant inhibition of 
acetylcholinesterase activity in erythrocytes of male rats was observed, but not 
at 1 mg/kg bw in female rats.
Estimate of acceptable daily intake for humans  0–0.03 mg/kg bw 
Estimate of acute reference dose 0.1 mg/kg bw
9. AZOXYSTROBIN  
Source: AZOXYSTROBIN 3–34 JMPR 2008
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
In a study of acute neurotoxicity in rats, no treatment-related effects on motor activity 
parameters, brain measurements (weight, length and width) or neurohistopathology 
were observed at doses of up to and including 2000 mg/kg bw.
In a short-term study of neurotoxicity in rats, no treatment-related changes in 
mortality, clinical signs, FOB, motor activity, brain measurements (weight, length, and 
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width), gross necropsy, or neurohistopathology were observed at doses of up to 2000 
ppm, equal to 161 mg/kg bw per day, the highest dose tested.
Azoxystrobin was not considered to be neurotoxic on the basis of the available data.
The Meeting established an ADI of 0–0.2 mg/kg bw based on a NOAEL of 300 ppm 
(equal to 18.2 mg/kg bw per day) in a 2-year study of carcinogenicity in rats, 
identified on the basis of reduced body weights, food consumption and food 
efficiency, and bile-duct lesions seen at 750 ppm (equal to 34 mg/kg bw per day) and 
above, and using a safety factor of 100.
The Meeting concluded that it was unnecessary to establish an ARfD for 
azoxystrobin because no toxicity could be attributable to a single exposure in the 
available database, including a study of developmental toxicity in rats and rabbits and 
a study of acute neurotoxicity in rats.
Acute neurotoxicity  No sign of specific neurotoxicity
10. BHC (HCH or Benzene hexachloride) 
Source: JMPR
Kind of Neurotoxicity: NO DATA
NO ADI TECHNICAL GRADES; MIXTURES OF ISOMERS
11. BENALAXYL  
Source: BENALAXYL 39–8 JMPR 2005
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Except for some nonspecific symptoms observed in the studies of acute toxicity at 
doses at or above the median lethal dose (LD50), the studies of acute toxicity and 
short- and long-term studies reported previously revealed neither clinical signs nor 
any biochemical or histopathological changes that might point to a neurotoxic 
potential of benalaxyl. Special studies in the field of neurotoxicity were therefore not 
necessary.
No specific studies of neurotoxicity with benalaxyl were available; however, no 
evidence of neurotoxicity was apparent from the available studies of toxicity.
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The Meeting established an ADI of 0–0.07 mg/kg bw based on a NOAEL of 6.5 
mg/kg bw per day for atrophy of the seminiferous tubules occurring at 25 mg/kg bw 
per day in a 1-year study in dogs and using a safety factor of 100. 
The Meeting established a conservative ARfD of 0.1 mg/kg bw for benalaxyl for 
women of childbearing age on the basis of a NOAEL of 12.5 mg/kg bw per day in a 
study of developmental toxicity in rats, and a safety factor of 100. There is no 
concern regarding the acute toxicity of this compound for the rest of the population, 
including children.
Neurotoxicity/delayed neurotoxicity  No specific study; no findings in other studies
12. BENOMYL 
FAO Plant Production and Protection Paper, 133, 1996 - Pesticide residues in food - 
1995. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and WHO Toxicological and Environmental Core 
Assessment
Source: JMPR REPORT 1995
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
An ADI of 0-0.1 mg/kg bw was established on the basis of the NOAEL of 13 mg/kg 
bw per day in the two-year study in dogs and applying a safety factor of 100. This 
ADI should be used when assessing exposure to benomyl itself. Since the use of 
benomyl on crops gives rise to residues of carbendazim and since the ADI for 
carbendazim is lower than that which would be derived from the data on benomyl, 
the Meeting concluded that the intake of residues in food should be compared with 
the ADI of 0-0.03 mg/kg bw for carbendazim. A toxicological monograph was 
prepared, summarizing the data received since the previous evaluation and including 
summaries from the previous monograph and monograph addenda.
13. BIFENTHRIN   
Source: BIFENTHRIN 3–52 JMPR 2009
Kind of Neurotoxicity: NEUROTOXICITY (SHORT-TERM/ACUTE)
In a study of acute neurotoxicity in rats given undiluted bifenthrin, the NOAEL was 35 
mg/kg bw on the basis of mortality (females only), clinical signs and FOB findings 
and differences in motor activity observed at the LOAEL of 75 mg/kg bw. In a 
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published study by Wolansky, Gennings & Crofton (2006), male rats were given 
bifenthrin via gavage as nine doses (8–18 rats per dose) ranging from 0.03 to 28 
mg/kg bw in corn oil (1 ml/kg bw), and motor activity was assessed for 1 h during the 
period of peak effects (4 h after dosing). The data were modelled, and a threshold 
dose was determined to be 1.28 mg/kg bw. The threshold dose is defined as an 
estimate of the highest no-effect level at which treated rats did not display any 
significant decreases in motor activity. In a 90-day study of neurotoxicity in rats, the 
NOAEL was 50 ppm, equal to 2.9 mg/kg bw per day, on the basis of neuromuscular 
findings (tremors, changes in grip strength and landing foot splay) observed at the 
LOAEL of 100 ppm, equal to 6.0 mg/kg bw per day. In a study of developmental 
neurotoxicity in rats given diets containing bifenthrin, the NOAEL for maternal toxicity 
was 50 ppm, equal to 3.6 mg/ kg bw per day, on the basis of tremors, clonic 
convulsions and increased grooming counts seen at the LOAEL of 100 ppm, equal to 
7.2 mg/kg per day. The NOAEL for offspring toxicity was 50 ppm, equal to 3.6 mg/kg 
bw per day, on the basis of increased grooming counts seen at the LOAEL of 100 
ppm, equal to 7.2 mg/kg bw per day. In studies of delayed neurotoxicity in adult hens 
and rats, no evidence of delayed neurotoxicity was observed. 
On the basis of the available data, the Meeting considered that bifenthrin was 
neurotoxic.
The Meeting established an ADI of 0–0.01 mg/kg bw on the basis of a NOAEL of 1.0 
mg/kg bw per day in a study of developmental toxicity in rats (gavage) based on the 
increased incidence of tremors in dams during days 10–19 of gestation and 
increased fetal and litter incidences of hydroureter without hydronephrosis seen at 
the LOAEL of 2.0 mg/kg bw per day, and using a safety factor of 100.
The Meeting established an acute reference dose (ARfD) of 0.01 mg/kg bw based on 
a threshold dose of 1.3 mg/kg bw for motor activity in a study of acute toxicity in rats 
treated by gavage and using a safety factor of 100.
Neurotoxicity/delayed neurotoxicity
Acute neurotoxicity Decrease in motor activity, (threshold dose) 1.28 mg/kg bw 
(rats)
Short-term study of neurotoxicity NOAEL: 2.9 mg/kg bw per day 
(rats)
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Developmental neurotoxicity No neurodevelopmental toxicity 
observed, NOAEL: 125 ppm, equal to 9.0 mg/kg bw per day (rats), the highest dose 
tested
14. BOSCALID 
Source: BOSCALID X-X JMPR 2006
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity  No signs of neurotoxicity
In a single-dose study of neurotoxicity, no signs of neurotoxicity were observed.
In a multiple-dose study of neurotoxicity, there were no signs of neurotoxicity at any 
dose.
As there were no neurotoxic effects observed in any of the experiments with 
boscalid, studies on delayed neurotoxicity in hens were not performed.
In this study of developmental neurotoxicity, boscalid had no adverse effects on the 
embryonic, fetal and postnatal development of the nervous system in Wistar rats at 
doses of up to 10 000 ppm, equal to 1442 mg/kg bw per day, the highest dose tested 
(Kaufmann et al., 2001). The Meeting concluded that boscalid is not neurotoxic in 
adult or developing rats.
The Meeting concluded that boscalid is unlikely to cause neurotoxicity in 
human beings.
An ADI of 0–0.04 mg/kg bw was established for boscalid based on the NOAEL of 4.4 
mg/kg bw per day, identified on the basis of increased gamma-glutamyltransferase 
activity and increased incidences of hepatic eosinophilic foci in male rats in a 24-
month long-term dietary study of toxicity and carcinogenicity and a safety factor of 
100. 
The Meeting concluded that it was not necessary to establish an ARfD for boscalid in 
view of the well-demonstrated lack of toxicity in studies of acute toxicity, the absence 
of relevant developmental toxicity that could have occurred as a consequence of a 
single exposure, the absence of any indication of neurotoxicity and the absence of 
any other adverse effects that would be likely to be induced after a single or a small 
number of exposures in repeat-dose studies.
15. BROMOPROPYLATE  
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FAO Plant Production and Protection Paper, 122, 1993 - Pesticide residues in food - 
1993. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues
Source: JMPR REPORT 1993
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
An ADI was established, based on the NOAEL of 2.7 mg/kg bw/day in the one-year 
study in dogs, using a 100-fold safety factor.
Estimate of acceptable daily intake for humans 0-0.03 mg/kg bw
16. BUPIRIMATE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
17. BUTRALIN 
Reasoned opinion on the review of the existing maximum residue levels (MRLs) for 
butralin according to Article 12 of Regulation (EC) No 396/2005. EFSA Journal, 
Volume 10, Issue 4, April 2012, 2651 (EFSA Journal 2012;10(4):2651)
Source: EFSA
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
The toxicological profile of butralin was evaluated by France in the framework of 
Directive 91/414/EEC. Based on the available information, France proposed an ADI 
of 0.003 mg/kg bw/d (multigeneration study in the rat and teratogenicity study in the 
rabbit) and an ARfD of 0.003 mg/kg bw (multi-generation reproduction study in the 
rat). EFSA emphasizes that these toxicological reference values have never been 
peer reviewed, neither by Member States, nor by EFSA. 
Considering that the use of butralin is no longer authorised within the EU, that no 
CXLs are available for this active substance and that no uses authorised in third 
countries were notified to the RMS, residues of butralin are not expected to occur in 
any plant commodity or livestock. 
The nature of butralin residues in commodities of animal origin was also investigated 
in the lactating goats. Despite a high dosing rate, negligible residues were present in 
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the edible tissues and milk and it can be concluded that butralin would be by default 
the only marker for enforcement of a potential illegal use.
18. CADUSAFOS   
Source: CADUSAFOS 53–102 JMPR 2009
Kind of Neurotoxicity: ACUTE NEUROTOXICITY EVIDENCE 
Neurotoxicity/delayed neurotoxicity Organothiophosphorus compound, neurotoxic. 
No evidence of delayed neuropathy
Acute neurotoxicity Toxicity 0.02 mg/kg bw
In a 13-week feeding study of neurotoxicity in rats, the NOAEL was 0.5 ppm, equal to 
0.031 mg/kg bw per day, on the basis of clinical signs, reduced body weights and 
reduced erythrocyte and brain cholinesterase activities at 300 ppm. The Meeting 
considered that cadusafos is neurotoxic.
In a study of delayed neurotoxicity in hens, the Meeting concluded that cadusafos is 
unlikely to cause delayed neuropathy at lethal doses.
The Meeting established an ADI of 0–0.0005 mg/kg bw based on a NOAEL of 1 ppm, 
equal to 0.045 mg/kg bw per day, identified on the basis of inhibition of erythrocyte 
cholinesterase activity at 5 ppm, equal to 0.222 mg/kg bw per day, in the long-term 
study in rats. A safety factor of 100 was applied. 
The Meeting established an acute reference dose (ARfD) of 0.001 mg/kg bw based 
on a NOAEL of 0.1 mg/kg bw per day identified on the basis of clinical effects in 
dams at 0.3 mg/kg bw per day in the study of developmental toxicity in rabbits. A 
safety factor of 100 was applied. The large dose spacing between the LOAEL and 
the NOAEL in the study of acute neurotoxicity made this study unsuitable for the 
derivation of an ARfD. The Meeting also noted that the ARfD established might be 
conservative because it was derived using clinical signs that occurred only after 
administration of several doses.
19. CAPTAN      
Source: CAPTAN 13–22 JMPR 2004
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
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Other than developmental effects, captan produced no toxicological effects that might 
be considered to be a consequence of acute exposure. The Meeting concluded that it 
was not necessary to establish an ARfD for the general population, including children 
aged 1–6 years, for whom separate data on dietary intake are available. The Meeting 
concluded that it might be necessary to establish an ARfD to protect the embryo or 
fetus from possible effects in utero. Such an ARfD would apply to women of 
childbearing age. 
The maternal toxicity and associated increases in skeletal variations and fetal 
bodyweight reductions observed in studies of developmental toxicity in rabbits are 
likely to be caused by high local concentrations of captan and are not considered to 
be relevant to dietary exposure. However, the observed intrauterine deaths and fetal 
malformations could not, with confidence, be attributed to maternal toxicity. 
The Meeting concluded that the database was insufficient (in particular, with regard 
to the absence of studies on the developmental effects of THPI to establish the mode 
of action by which the increased incidences of intrauterine deaths and of fetuses with 
malformations, observed at 100mg/kgbw per day (NOAEL, 30mg/kgbw per day) in 
rabbits, were induced. As a consequence, their relevance for deriving an ARfD could 
not be dismissed. Therefore the Meeting established an ARfD of 0.3mg/kgbw, based 
on a NOAEL of 30mg/kgbw per day for increased incidences of intrauterine deaths 
and malformations at 100mg/kgbw per day in the study in rabbits and a safety factor 
of 100. The use of a safety factor of 100 was considered to be conservative; although 
the mode of action by which the developmental effects were induced is uncertain, 
they are possibly secondary to maternal toxicity. The ARfD also covers the effects 
observed in the case report in humans. The Meeting noted that it might be possible 
to refine the ARfD using the results of an appropriately designed study. 
Estimate of acute reference dose 0.3mg/kgbw for women of childbearing age 
Unnecessary for the general population.
20. CARBARYL 
FAO Plant Production and Protection Paper, 167, 2001 - Pesticide residues in food - 
2001. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 2001
Kind of Neurotoxicity: ACUTE – SUBCHRONIC NEUROTOXICITY
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Neurotoxicity / Delayed neurotoxicity
Acute; NOAEL < 10 mg/kg bw; inhibition of cholinesterase activity 
(rats, single dose) 3.8 mg/kg bw; inhibition of cholinesterase 
activity (5 weeks, dogs)
90-day; NOAEL 1 mg/kg bw per day; inhibition of cholinesterase 
activity (rats)
Delayed neuropathy Negative
21. CARBENDAZIM   
Source: CARBENDAZIM 87–106 JMPR 2005
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
The Meeting established an ARfD of 0.1 mg/kg bw based on an overall NOAEL of 10 
mg/kg bw per day for developmental toxicity from three studies in rats and one study 
in rabbits, and a safety factor of 100. The Meeting concluded that this ARfD applies 
only to women of childbearing age. 
For the general population, including children, the Meeting established an ARfD of 
0.5 mg/kg bw based on the NOAEL of 50 mg/kg bw in the study of toxicity to the 
male reproductive system in rats and supported by the studies on micronucleus or 
aneuploidy induction in vivo, using a safety factor of 100. 
An additional safety factor for the severity of the effects was considered to be 
unnecessary, since the underlying mechanism is clearly understood and there is a 
clear threshold for these effects. 
Estimate of acute reference dose 0.1 mg/kg bw for women of childbearing age 0.5 
mg/kg bw for the general population, including children.
22. CARBOFURAN 
Source: CARBOFURAN 81–104 JMPR 2008
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
Rat Acute study of toxicity (pups aged 11 days and adults) Inhibition of pup 
brain acetylcholinesterase activity 0.03 mg/kg bw
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23. CHLORANTRANILIPROLE    
Source: CHLORANTRANILIPROLE 105–134 JMPR 2008
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
In a study of acute neurotoxicity, no adverse compound-related effects on mortality, 
clinical signs of toxicity, body weight, bodyweight gain, food consumption, food 
efficiency, FOB parameters, motor activity, gross pathology, or neuropathology were 
observed at any dose in males or females. The NOAEL was 2000 mg/kg bw, the 
highest dose tested (Malley, 2004b).
In a 90-day study of neurotoxicity, there were no test substance-related effects on 
mortality, clinical observations, body weight, body-weight gain, food consumption, 
food efficiency, FOB parameters, motor activity, or on gross or microscopic pathology 
in males or females. The NOAEL was 20 000 ppm, equal to 1313 mg/kg bw per day, 
the highest dose tested (Malley, 2006b).
Therefore, regarding neurotoxicity studies, no neurotoxic effects were 
observed.
The Meeting established an acceptable daily intake (ADI) for chlorantraniliprole of 0–
2 mg/kg bw on the basis of eosinophilic foci accompanied by hepatocellular 
hypertrophy and increased liver weight in mice in an 18-month feeding study for 
which the NOAEL was 158 mg/kg bw per day, and using a safety factor of 100.
The Meeting concluded that it was not necessary to establish an acute reference 
dose (ARfD) for chlorantraniliprole in view of its low acute toxicity, the absence of 
developmental toxicity, and the absence of any other toxicological effects that would 
be likely to be elicited by a single dose.
24. CHLORDANE (OXYCHLORDANE – TRANS-CHLORDANE)  
Chlordane as undesirable substance in animal feed, EFSA Journal (2007) 582, 
1-53
Source: EFSA REPORT
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Chlordane has been banned for use in the European Union since 1981 and in most 
other countries world-wide. Chlordane was commercially introduced as a non-
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systemic contact insecticide in 1947. From the 1970s a more refined formulation 
containing more than 95 % cis- and trans-chlordane was also produced.
Oxychlordane (a major metabolite of cis- and trans-chlordane) and nonachlor are 
more toxic than cis- and trans-chlordane. In mammals, the main target organs are 
the nervous system and the liver. Chlordane causes liver tumours in mice, probably 
via nongenotoxic mechanisms. Chlordane is classified by IARC as possibly 
carcinogenic to humans (group 2B).
JMPR re-evaluated its earlier assessments on chlordane in 1986 (FAO/WHO, 1987) 
and established an ADI of 0.5 μg/kg b.w. by applying an uncertainty factor of 100 to a 
NOAEL of 50 μg/kg b.w. per day for liver toxicity in a long-term study in rats. In 1994, 
JMPR converted the ADI into a provisional tolerable daily intake (PTDI) with the 
same value (FAO/WHO, 1995). Chlordane is not mutagenic in vivo and not or only 
weakly mutagenic in a few tests in vitro. It is a promoter of liver tumours in vivo and 
exhibit biochemical properties shared by many promoters of liver tumours.  
The current human dietary exposure to chlordane is in the low ng/kg b.w. per day 
range, which is two to three orders of magnitude below the provisional tolerable daily 
intake of 500 ng/kg b.w. established by the WHO in 1995.
25. CHLORFENVINPHOS   
FAO Plant Production and Protection Paper, 127, 1995 - Pesticide residues in food - 
1994. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues.
Source: JMPR REPORT 1994 
Kind of Neurotoxicity: NEUROTOXICITY EVIDENCE (SHORT-TERM)
WHO has classified chlorfenvinphos as extremely hazardous.
A four-week study in which mice were fed 0, 1, 10, 100 or 1000 ppm chlorfenvinphos 
in the diet showed inhibition of plasma and erythrocyte cholinesterase at 100 and 
1000 ppm. Brain cholinesterase activity was inhibited at 10 and 1000 ppm in males 
and at all dose levels in females; hence no NOAEL could be established for female 
mice (NOAEL <0.18 mg/kg bw per day) and the NOAEL in males was 1 ppm, equal 
to 0.18 mg/kg bw per day.
In a one-year study in which dogs were fed 0, 3, 100 or 3000 ppm in the diet, 
inhibition of erythrocyte cholinesterase activity and increased relative adrenal weight 
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were seen in males and increased relative thyroid weight in females at the highest 
dose. The NOAEL was 100 ppm, equal to 2.8 mg/kg bw per day.
Delayed neurotoxicity in chickens has not been evaluated.
An ADI of 0-0.0005 mg/kg bw was established on the basis of the NOAEL of 0.05 
mg/kg bw per day in the two-generation reproductive toxicity study in rats and a 100-
fold safety factor.
26. CHLORMEQUAT   
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 1999 
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
The compound was reviewed again by the 1997 Meeting, when an ADI of 0-0.05 
mg/kg bw was allocated on the basis of the NOAEL of 4.7 mg/kg bw per day for 
diarrhoea, vomiting, and salivation in a one-year study of toxicity in dogs, and using a 
safety factor of 100. The compound was considered by the present Meeting solely to 
determine an acute reference dose.
An acute reference dose of 0.05 mg/kg bw was established on the basis of the 
NOAEL of 4.7 mg/kg bw per day in the one-year study in dogs, as the clinical signs 
that were found were considered to be acute. A 100-fold safety factor was used.
27. CHLOROTHALONIL  
Source: CHLOROTHALONIL 103–154 JMPR 2009 
Kind of Neurotoxicity: NO NEUROTOXICITY DATA / NO NEUROTOXIC 
POTENTIAL
Neurotoxicity No data. 
No indication of neurotoxic potential.
28. CHLORPROFAM 
Source: CHLORPROPHAM - JMPR 2005.pdf
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Kind of Neurotoxicity: NO NEUROTOXICITY DATA 
29. CHLORPYRIFOS 
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 1999
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
30. CHLORPYRIFOS-METHYL 
Source: CHLORPYRIFOS-METHYL 155–202 JMPR 2009
Kind of Neurotoxicity: DELAYED NEUROPATHY EVIDENCE
No acute or repeated-dose neurotoxicity studies or developmental neurotoxicity 
studies have been performed with chlorpyrifos-methyl.
The Meeting concluded that chlorpyrifos-methyl was unlikely to produce delayed 
neuropathy in the absence of very severe cholinergic toxicity.
Histopathological indications of neuropathy at 5000 mg/kg bw; no indications of 
delayed neuropathy at 500 mg/kg bw per day for 13 weeks; very weak inhibitor of 
NTE in vitro. 
31. CLOTHIANIDIN 
Source: CLOTHIANIDIN 19–116 JMPR 2010
Kind of Neurotoxicity: ACUTE/SHORT TERM NEUROTOXICITY
The Meeting concluded that clothianidin is not a developmental neurotoxicant. At 
relatively high doses, it can cause transient, acute neurobehavioural effects.
Neurotoxicity/delayed neurotoxicity:
Acute neurotoxicity target/critical effect Decreased locomotor activity
Lowest relevant acute neurotoxic NOAEL 60 mg/kg bw per day
Short-term neurotoxicity target/critical effect Decreased body weight and feed 
consumption
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Lowest relevant subchronic neurotoxic NOAEL 60 mg/kg bw per day
Developmental neurotoxicity target/critical effect No biologically significant effects
Lowest relevant developmental neurotoxic NOAEL 142 mg/kg bw per day (highest 
dose tested)
32. COUMAPHOS  
Source: JMPR 
Kind of Neurotoxicity: NO DATA 
NO ADI
33. CYFLUTHRIN 
Source: CYFLUTHRIN AND BETA-CYFLUTHRIN X-X JMPR 2006 
Kind of Neurotoxicity: ACUTE NEUROTOXICITY EVIDENCE
Acute neurotoxicity  Neurotoxicity 1 mg/kg bw  ARfD established
Neurotoxicity/delayed neurotoxicity:
Neurotoxicity Behavioural effects (increased motility, grooming and 
digging movements)
Lowest relevant oral NOAEL 1 mg/kg bw (single and repeated dose by gavage, 
beta-cyfl uthrin and cyfluthrin, rats)
34. CYHALOTHRIN / LAMBDA-CYHALOTHRIN 
Source: LAMBDA-CYHALOTHRIN 173–200 JMPR 2007
Kind of Neurotoxicity: ACUTE NEUROTOXICITY EVIDENCE
Neurotoxicity Type II pyrethroid toxicity (choreoathetosis/salivation 
syndrome)
No evidence for developmental neurotoxicity was observed.
The most sensitive systemic effect of lambda-cyhalothrin/cyhalothrin was 
neurotoxicity (decreased motor activity), which was observed in a study of acute 
toxicity in rats. On the basis of these effects, the Meeting established a group ADI for 
cyhalothrin and lambda cyhalothrin of 0–0.02 mg/kg bw, using a safety factor of 25. 
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The Meeting established a group ARfD for cyhalothrin and lambda-cyhalothrin of 
0.02 mg/kg bw on the basis of systemic neurotoxicity (decreased motor activity) 
observed in a study of acute toxicity in rats.
35. CYPERMETHRIN  
Source: CYPERMETHRINS X-X JMPR 2006
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
GROUP ADI FOR CYPERMETHRIN, ALPHA-CYPERMETHRIN AND ZETA-
CYPERMETHRIN
Neurotoxicity:
Target/critical effect Clinical signs, changes in FOB tests and 
degenerative changes to the sciatic nerve
Lowest relevant NOAEL 4 mg/kg bw per day (single-dose study in rats)
Delayed neurotoxicity: 
Target/critical effect No delayed effect
Lowest relevant NOAEL > 1000 mg/kg bw per day (hens)
Medical data Paraesthesia after dermal exposure
Group ARfD 0.04 mg/kg bw Rat, study of acute neurotoxicity with alpha-
cypermethrin (& cypermethrin) 100
36. CYPROCONAZOLE 
Source: CYPROCONAZOLE 117–202 JMPR 2010
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Subchronic neurotoxicity Not neurotoxic (90-day study in rats)
37. CYPRODINIL
Source: CYPRODINIL 33–84 JMPR 2003
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Lack of neurotoxicity after a single exposure
Neurotoxicity/delayed neurotoxicity
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Acute neurotoxicity No evidence of neuropathology at doses of up 
to 2000 mg/kgbw in rats; NOAEL was 200 
mg/kg bw, on the basis of clinical signs
90-day study of neurotoxicity No evidence of neurotoxicity or neuropathology; 
NOAEL was 54.5 mg/kg bw per day on the 
basis of liver, kidney and thyroid histopathology
38. CYROMAZINE 
Source: CYROMAZINE X-X JMPR 2006
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Neurotoxicity/delayed neurotoxicity No specific study; no findings in other studies
39. DDT /DDD/ DDE 
FAO Plant Production and Protection Paper, 163, 2001 - Pesticide residues in food 
2000 Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group. CONFIRMED 
ALSO BY 2002 JMPR.
Source: JMPR REPORTS 2000 & 2002
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
An ADI of 0–0.02 mg/kg bw was allocated in 1984 for any combination of DDT, DDD, 
and DDE on the basis of data for both humans and experimental animals. The 1994 
JMPR converted the ADI to a PTDI. An extensive range of studies on the 
biochemistry and toxicology of DDT and related compounds, including hormone-
modulating effects, in vivo and in vitro has been reported since the 1984 JMPR. The 
present Meeting considered numerous reviews of the toxicity of DDT that have been 
published recently, and summarized new data on the toxicologically relevant effects 
of DDT and its metabolites. Mixtures of the para,para' and ortho,para' isomers of 
DDT, DDE, and TDE are referred to as the ‘DDT complex’. 
The newer studies and reviews provided the basis for a change by the present 
Meeting of the PTDI established in 1984. The Meeting derived a PDTI of 0.01 
mg/kg bw on the basis of the NOAEL of 1 mg/kg bw per day for developmental 
toxicity in rats and a safety factor of 100. DDT is no longer used in agricultural 
practice but may be present in food commodities as a contaminant because of 
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its persistence in the environment. As peaks of acute dietary intake above the 
PTDI are not likely to occur, an acute RfD was not allocated. 
40. DELTAMETHRIN 
FAO Plant Production and Protection Paper, 163, 2001 - Pesticide residues in food - 
2000. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 2000
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
The results of acute and 90-day studies of neurotoxicity in rats and of acute delayed
Neurotoxicity in hens showed that deltamethrin does not induce 
neuropathological changes. The NOAEL for neurotoxicity in a study in rats given 
a single dose by gavage was 5 mg/kg bw on the basis of effects in a battery of 
tests for function and locomotor activity at 15 mg/kg bw per day. The NOAEL 
for systemic toxicity and neurotoxicity in a 90-day study in rats was 200 ppm, equal to 
14 mg/kg bw per day, on the basis of effects on function in a battery of tests at 800 
ppm, equal to 54 mg/kg bw per day, the highest dose tested.
The Meeting concluded that the existing database was adequate to characterize the 
potential hazard of deltamethrin to fetuses, infants, and children. Although 
deltamethrin is known to be neurotoxic to adults, the Meeting did not recommend 
that a study of developmental neurotoxicity be conducted since there was no 
evidence that offspring exposed pre- or postnatally are more sensitive than adults in 
the same experiment.
Neurotoxicity/Delayed neurotoxicity NOAEL, 5 mg/kg bw per day in a single-dose 
study in rats 
NOAEL, 14 mg/kg bw per day in a 90-day study 
in rats; no delayed effect 
NOAEL > 5000 mg/kg bw per day in hens
Acute RfD: 0.05 mg/kg bw Study of acute neurotoxicity in rats 100
41. OXYDEMETON-METHYL  
Source: OXYDEMETON-METHYL 283-298 JMPR 2002
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Kind of Neurotoxicity: ACUTE & SHORT-TERM NEUROTOXICITY
Acute and short-term neurotoxicity observed. 
42. DIAZINON 
Source: DIAZINON X-X JMPR 2006
Kind of Neurotoxicity: ACUTE-SUBCHRONIC-CHRONIC NEUROTOXICITY 
The most sensitive end-point observed in all species given single and repeated 
doses of diazinon was inhibition of cholinesterase activity. This apparent sex 
difference in sensitivity for cholinesterase inhibition was confirmed in a 28-day dietary 
exposure study in rats in which cholinesterase activity was monitored in the blood 
and in regional areas of the brain.
In a 1-year study in dogs, clinical signs and reduced body-weight gain were observed 
in females at slightly lower doses. 
The Meeting reaffirmed the ARfD of 0.03 mg/kg bw established by the 2001 JMPR. 
This ARfD was based on the NOAEL of 2.5 mg/kg bw identified in studies of acute 
toxicity and neurotoxicity in rats, and a safety factor of 100. This ARfD was supported 
by the NOAEL of 0.21 mg/kg bw identified in the study in humans given a single dose 
of diazinon, and a safety factor of 10.
43. DICHLORVOS  
Source: DICHLORVOS (addendum) 93–150 JMPR 2011
Kind of Neurotoxicity: ACUTE – SUBCHRONIC NEUROTOXICITY 
Neurotoxicity Neurotoxic due to cholinesterase inhibition. No 
evidence of delayed neuropathy up to 16.5 
mg/kg bw (hens) or 70 mg/kg bw (rats), the 
highest doses tested. Very weak inhibitor of 
NTE activity in vitro 
Lowest relevant oral NOAEL 0.1 mg/kg bw per day (13-week rat study) 
Developmental neurotoxicity No evidence of developmental neurotoxicity up 
to 7.5 mg/kg bw per day (rats), highest dose 
tested
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
125
In studies of neurotoxicity in rats, dichlorvos was administered as a single dose of up 
to 70 mg/kg bw or as repeated doses of up to 15 mg/kg bw per day. The NOAEL 
following a single gavage dose was 0.5 mg/kg bw, based on clinical signs of 
neurotoxicity at 35 mg/kg bw observed during the functional observational battery 15 
minutes after dosing; no signs of neurotoxicity were observed 7 or 14 days after 
dosing. Following repeated gavage doses of up to 15 mg/kg bw per day for 13 
weeks, clinical signs of neurotoxicity were observed within 15 minutes of dosing 
throughout the study, at and above 7.5 mg/kg bw per day. These signs coincided 
with the inhibition of ChE activity in erythrocytes and brain. 
44. DICOFOL 
Source: DICOFOL (addendum) 151–210 JMPR 2011
Kind of Neurotoxicity: ACUTE – SUBCHRONIC NEUROTOXICITY 
Acute neurotoxicity target/critical effect Ataxia, decreased motor activity 
at systemically toxic dose 
Lowest relevant acute neurotoxicity NOAEL 15 mg/kg bw 
Subchronic neurotoxicity target/critical effect Decreased motor activity at 
systemically toxic doses 
Lowest relevant subchronic neurotoxicity NOAEL 0.2 mg/kg bw per day (90-day 
neurotoxicity study)
45. DIETHOFENCARB  
Source: JMPR
Kind of Neurotoxicity: NO DATA 
46. DIFENOCONAZOLE   
Source: DIFENOCONAZOLE 201–272 JMPR 2007
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
The Meeting concluded that difenoconazole is unlikely to cause neurotoxicity 
in humans.
Neurotoxicity/delayed neurotoxicity: 
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Single-dose study of neurotoxicity No signs of neurotoxicity, NOAEL was 
25 mg/kg bw (rats) 
Ninety-day study of neurotoxicity No signs of neurotoxicity, NOAEL was 
2.3 mg/kg bw (rats)
These responses were considered to be non-specific effects of difenoconazole 
because of the absence of any changes in the multiple end-points of neurotoxicity 
that were measured and the absence of neuropathological findings.
An acute reference dose (ARfD) of 0.3 mg/kg bw was established for difenoconazole. 
This was based on the NOAEL of 25.0 mg/kg bw in rats, identified on the basis of 
clinical signs in a singledose study of neurotoxicity and using a safety factor of 100. 
This ARfD is supported by the NOAEL of 25 mg/kg bw per day for maternal toxicity in 
a study of developmental toxicity in rats and rabbits on the basis of excess salivation 
in rats at 100 mg/kg bw per day and body-weight loss in rabbits d uring the first few 
days of treatment at 75 mg/kg bw per day.
47. DIMETHOATE 
Source: DIMETHOATE 85–100 JMPR 2003
Kind of Neurotoxicity: ACUTE/SUBCHRONIC/CHRONIC/DNT 
After considering the previous evaluations of dimethoate and the new data submitted, 
the Meeting established an acute RfD of 0.02mg/kgbw on the basis of the overall 
NOAEL of 2mg/kgbw for cholinesterase inhibition in studies in rats, and a safety 
factor of 100. This acute RfD was supported by the NOAEL of about 0.2mg/kgbw per 
day in studies in volunteers receiving single or repeated doses, which were evaluated 
by the 1996 JMPR. 
The Meeting considered these effects to be of no relevance for setting the acute RfD, 
since they would not be expected to occur after a single exposure, and concluded 
that the new studies supported the current ADI of 0–0.002mg/kgbw.
48. DIMETHOMORPH  
Source: DIMETHOMORPH 273–315 JMPR 2007
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity No evidence in conventional studies
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49. DIPHENYLAMINE  
FAO Plant Production and Protection Paper, 148, 1999 - Pesticide residues in food - 
1998. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR 1998
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Neurotoxicity / Delayed neurotoxicity No data
50. ENDOSULFAN  
Source: JMPR 1998
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
FAO Plant Production and Protection Paper, 148, 1999 - Pesticide residues in food -
1998. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Acute reference dose 0.02 mg/kg bw based on a NOAEL of 2 
mg/kg bw per day in rats in a study of 
neurotoxicity and with a safety factor of 100
51. ENDOSULFAN I (ALPHA) & ENDOSULFAN II (BETA)  
Source: JMPR
Kind of Neurotoxicity: NO DATA
52. ENDOSULFAN SULFATE 
Source: JMPR REPORT 1998
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
The metabolites of endosulfan include endosulfan sulfate, diol, hydroxy-ether, ether, 
and lactone but most of its metabolites are polar substances which have not yet been 
identified. Endosulfan would not be expected to accumulate significantly in human 
tissues. (JMPR REPORT 1998)
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Kind of Neurotoxicity: NO DATA
54. ESFENVALERATE  
Source: ESFENVALERATE 41-76 JMPR 2002
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
Target /Critical effect Tremors
Lowest relevant NOAEL for acute neurotoxicity  1.8 mg/kg bw
Target /Critical effect for 90-day neurotoxicity Decreased motoractivity
Lowest relevant NOAEL for 90-day neurotoxicity  3.0 mg/kg bw
Acute RfD        0.02 mg/kg bw Rat, acute neurotoxicity 100 
55. ETHION 
Source: JMPR
Kind of Neurotoxicity: NO DATA
56. ETHOPROPHOS  
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 1999 
Kind of Neurotoxicity: ACUTE-CHRONIC NEUROTOXICITY
Neurotoxicity/ Delayed neurotoxicity 5 mg/kg bw per day (acute study in rats)
<4 ppm, equal to 0.26 mg/kg bw per day 
(13-week study in rats)
No evidence for delayed neurotoxicity 
in hens, but some equivocal findings.
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ADI 0-0.0004 mg/kg bw Two-year study, rat; two-generation study of 
reproductive toxicity, rats 100
Acute reference dose 0.05 mg/kg bw Acute neurotoxicity, 
rats 100
The present Meeting established an ADI of 0-0.0004 mg/kg bw on the basis of the 
NOAEL of 1 ppm, equal to 0.04 mg/kg bw per day, for inhibition of brain 
acetylcholinesterase activity in the two-year study of toxicity and 
carcinogenicity in rats and in the study of reproductive toxicity in rats, and a 100-fold 
safety factor.
An acute reference dose of 0.05 mg/kg bw was established on the basis of the 
NOAEL of 5 mg/kg bw in the study of acute neurotoxicity in rats, in which 
functional and/or behavioural effects and inhibition of erythrocyte 
acetylcholinesterase were observed at the next highest dose, and a 100-fold safety 
factor.
57. ETOFENPROX 
Source: ETOFENPROX 253–324 JMPR 2011  
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity Acute neurotoxicity Not neurotoxic (rats) 
Subacute neurotoxicity Not neurotoxic (13-week study in rats)
Neurodevelopmental toxicity Not neurodevelopmental toxicant (rats)
58. FAMOXADONE
Source: FAMOXADONE 101–149 JMPR 2003    
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity 
Target/critical effect None 
Lowest relevant NOAEL >1000mg/kgbw
59. FENARIMOL
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FAO Plant Production and Protection Paper, 133, 1996 - Pesticide residues in food - 
1995. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and WHO Toxicological and Environmental Core 
Assessment
Source: JMPR REPORT 1995
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
A toxicological monograph was prepared, summarizing the data that were reviewed 
by the present Meeting. 
TOXICOLOGICAL EVALUATION 
Levels that cause no toxic effect 
Mouse: 24 mg/kg bw per day (12-month study of chronic toxicity ) 20 mg/kg bw per 
day (three-generation study of reproductive toxicity) 
Rat: 1.2 mg/kg bw per day (three studies of carcinogenicity) 0.62 mg/kg bw per day 
(multigeneration study of reproductive toxicity)* 13 mg/kg bw per day (embryo- and 
fetotoxicity in study of developmental toxicity) 
Dog: 12 mg/kg bw per day (one-year study of toxicity) 
Rabbit: 50 mg/kg bw per day (maternal and embryo- or fetotoxicity in a study of 
developmental toxicity) 
*Data considered irrelevant for evaluation with respect to human health.
Estimate of acceptable daily intake for humans 0-0.01 mg/kg bw
60. FENHEXAMID  
Source: FENHEXAMID 255–301 JMPR 2005
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity 
Acute neurotoxicity No evidence of neurotoxicity at doses of up to 
2000 mg/kg bw (rats)
61. FENITROTHION 
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FAO Plant Production and Protection Paper, 163, 2001 - Pesticide residues in food - 
2000. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 2000
Kind of Neurotoxicity: REVERSIBLE NEUROTOXICITY EVIDENCE
Neurotoxicity/Delayed neurotoxicity Reversible neurotoxicity consistent with 
cholinesterase inhibition. No evidence of 
delayed neurotoxicity or of 
histopathological changes in nerves of 
hens (500 mg/kg bw) or rats (200 mg/kg 
bw or 17.6 mg/kg bw per day for 13 
weeks)
The Meeting affirmed the ADI of 0–0.005 mg/kg bw that was established by the 1988 
Joint Meeting, which was based on a NOAEL of 0.5 mg/kg bw per day for inhibition of 
brain and erythrocyte cholinesterase activity in a 2-year study of toxicity in rats and a 
safety factor of 100. This was supported by a NOAEL of 0.57 mg/kg bw per day for 
inhibition of brain and Erythrocyte cholinesterase activity in a 3-month study of 
ocular toxicity in rats and a NOAEL of 0.65 mg/kg bw per day for reduced food 
consumption and body-weight gain in a study of reproductive toxicity in rats. The 4-
day study in volunteers was not considered suitable for establishing an ADI because 
of its short duration and the associated absence of steady-state kinetics.
The Meeting allocated an acute RfD of 0.04 mg/kg bw to fenitrothion on the basis of 
a NOAEL of 0.36 mg/kg bw for inhibition of erythrocyte acetylcholinesterase activity 
in a study in volunteers and a safety factor of 10. 
62. FENOXYCARB 
Source: JMPR
Kind of Neurotoxicity: NO DATA
63. FENPROPIDINE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
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64. FENPROPIMORPH 
Source: FENPROPIMORPH 27–34 JMPR 2004
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
In a study of acute neurotoxicity in rats, the NOAEL was 100mg/kgbw per day on the 
basis of clinical and behavioural signs observed at doses of 500 and 1500mg/kgbw 
per day.
65. FENTHION
FAO Plant Production and Protection Paper, 145, 1998 - Pesticide residues in food - 
1997. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 1997
Kind of Neurotoxicity: ACUTE NEUROTOXICITY EVIDENCE
Fenthion was reviewed by the 1995 JMPR, which established an ADI of 0-0.007 
mg/kg bw on the basis of an NOAEL of 0.07 mg/kg bw per day (the highest dose 
tested) for the inhibition of erythrocyte acetylcholinesterase activity in a 25-day study 
in volunteers. The available data did not permit the Meeting to establish an acute 
reference dose (acute RfD) different from the ADI. A study of neurotoxicity in rats 
given a single dose was available to the present Meeting to assist in reviewing the 
acute RfD. 
In rats treated by gavage with single doses of 0, 1, 50 (males), 75 (females), 150 
(males), or 225 (females) mg/kg bw of technical-grade fenthion, the NOAEL for the 
inhibition of brain acetylcholinesterase activity and for neurobehavioural 
effects was 1 mg/kg bw. 
In a study that was reviewed by the 1995 JMPR, the administration of 0.07 mg/kg bw 
to volunteers daily for about 25 days did not inhibit erythrocyte acetylcholinesterase 
activity. 
The Meeting concluded that an acute reference dose of 0.01 mg/kg bw could be 
allocated by taking into account the NOAEL of 1 mg/kg bw in rats and applying a 
safety factor of 100. 
An addendum to the toxicological monograph was prepared.
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TOXICOLOGICAL EVALUATION RELEVANT FOR ESTABLISHING AN ACUTE 
RFD 
Levels that cause no toxic effect 
Rat: 1 mg/kg bw (single oral administration, inhibition of brain acetylcholinesterase 
activity) 
Human: 0.07 mg /kg bw per day (four-week study in volunteers, highest dose tested)
Estimated acute reference dose for humans 0.01 mg/kg bw
66. FENTHION OXON
Source: JMPR
Kind of Neurotoxicity: NO DATA
67. FENTHION SULFONE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
68. FENTHION SULFOXIDE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
69. FENVALERATE 
Source: FENVALERATE 307–361 JMPR 2012
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
Neurotoxicity Target/critical effect Clinical signs typical of type II 
pyrethroids 
Acute neurotoxicity NOAEL 20 mg/kg bw (rat) 
Subchronic neurotoxicity No data
A study of the neurotoxic potential of esfenvalerate and fenvalerate in corn oil 
was conducted in rats following a single oral gavage dose. The NOAELs were 5 and 
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20 mg/kg bw for esfenvalerate and fenvalerate, respectively, based on the toxic signs 
typical of type II pyrethroids. Signs were observed within 2 hours of dosing at 20 
and 90 mg/kg bw for esfenvalerate and fenvalerate, respectively.
No histopathological lesions in the sciatic nerve were observed in rats following a 
single-dose administration of fenvalerate at 200 mg/kg bw. In a separate study, rats 
were administered fenvalerate orally at dose levels ranging from 0 to 400 mg/kg bw 
per day for 7 consecutive days. A significant neurological deficit was demonstrated 
using an inclined plane test (expressed as the angle at which the animals cannot 
maintain their hold on an inclining plane). In addition to functional deficits, increases 
in the activity of the lysosomal enzymes β-glucuronidase and β-galactosidase in the 
posterior tibial nerve and trigeminal ganglia were observed.
70. FIPRONIL  
FAO Plant Production and Protection Paper, 145, 1998 - Pesticide residues in food - 
1997. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 1997
Kind of Neurotoxicity: SHORT TERM-DNT NEUROTOXICITY 
Acute reference dose for fipronil:
The Meeting allocated an acute reference dose of 0.003 mg/kg bw for both 
fipronil and fipronildesulfinyl on the basis of the NOAEL of 0.3 mg/kg bw per 
day in a study of neurotoxicity in rats given repeated doses of fipronil, and a 
safety factor of 100. The study of neurotoxicity in rats given single doses was not 
considered in allocating the acute reference dose because of concern about the 
prolonged toxicokinetics of fipronil. This acute reference dose will provide a safety 
factor of about 700 for the NOAEL in the study of neurotoxicity in rats given single 
doses of fipronil-desulfinyl.
Studies without which the determination of an ADI is impracticable, to be 
provided by 2000:
1. Short-term study of neurotoxicity in rats with fipronil-desulfinyl in the diet.
2. Developmental neurotoxicity study in rats with fipronil-desulfinyl in the diet.
3. The results of an ongoing long-term study with fipronil-desulfinyl in rats.
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Toxicological criteria for setting guidance values for dietary and non-dietary exposure 
to fipronil and its photodegradation product fipronil-desulfinyl:
SHORT-TERM (1-7days): 
Neurotoxicity, rat (single dose by gavage) NOAEL = 0.5 mg/kg bw per day: 
decreased hind-leg splay
Medium term (1-26 weeks)
Repeated oral, developmental
neurotoxicity, rat NOAEL = 0.9 mg/kg bw per day 
for maternal toxicity.
NOAEL = 0.05 mg/kg bw per day 
for developmental toxicity.
Levels that cause no toxic effect:
RAT:
0.5 mg/kg bw (single dose, study of neurotoxicity by gavage)
5 ppm, equal to 0.3 mg/kg bw per day (repeated doses in the diet, study of 
neurotoxicity)
10 ppm, equal to 0.9 mg/kg bw per day (maternal toxicity and developmental 
neurotoxicity in a study of developmental neurotoxicity)
0.5 ppm, equal to 0.05 mg/kg bw per day (developmental toxicity in a study of 
developmental neurotoxicity)
71. FLONICAMID 
Source: FLONICAMID X–X JMPR 2015
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity:
Acute neurotoxicity NOAEL 600 mg/kg bw (highest dose tested; rat)
Subchronic neurotoxicity NOAEL 625 mg/kg bw per day (highest dose tested; rat) 
Developmental neurotoxicity NOAEL No data
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The Meeting concluded that it was not necessary to establish an acute reference 
dose (ARfD) for flonicamid in view of its low acute toxicity and the absence of 
developmental toxicity and any other toxicological effects that would be likely to be 
elicited by a single dose.
The Meeting established an ADI of 0–0.07 mg/kg bw on the basis of a NOAEL of 
7.32 mg/kg bw per day in the 2-year rat study, based on decreased body weight, 
decreased rearing, effects on clinical chemistry and effects on kidney and muscle 
observed at 36.5 mg/kg bw per day. This ADI is supported by the overall NOAEL of 8 
mg/kg bw per day in dogs and the NOAELs of 7.5 mg/kg bw per day for maternal and 
embryo/fetal toxicity in the developmental toxicity study in rabbits. A safety factor of 
100 was applied.
72. FLUDIOXONIL 
Source: FLUDIOXONIL 47–84 JMPR 2004
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity No evidence of neurotoxicity or delayed neurotoxicity in any study 
conducted
73. FLUBENDIAMIDE 
Source: FLUBENDIAMIDE 345–382 JMPR 2010
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity 
Neurotoxicity No neurotoxic effects 
Developmental neurotoxicity No neurotoxic effects  
74. FLUOPICOLIDE 
Source: FLUOPICOLIDE 269–356 JMPR 2009
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity No signs of neurotoxicity No data
75. FLUSILAZOLE 
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Source: FLUSILAZOLE 317–347 JMPR 2007
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE 
No neurotoxic effects were seen during conventional repeat-dose studies with 
flusilazole.
Neurotoxicity/delayed neurotoxicity: 
No indications of neurotoxicity in studies of acute toxicity or repeated doses
ADI 0–0.007 mg/kg bw Dog, 1-year study 100 
ARfD 0.02 mg/kg bw Rat, study of developmental toxicity 100
76. FLUTRIAFOL 
Source: FLUTRIAFOL 325–372 JMPR 2011
Kind of Neurotoxicity: ACUTE NEUROTOXICITY 
Neurotoxicity/delayed neurotoxicity 
Acute study Altered FOB and motor activity; neurotoxicity 
NOAEL 250 mg/kg bw (rat)
Ninety-day study Not neurotoxic
In an acute neurotoxicity study in rats, there was no evidence of neuropathy at 750 
mg/kg bw, the highest dose tested. The NOAEL for acute neurotoxicity was 250 
mg/kg bw, based on altered FOB and motor activity findings on day 1 at 750 mg/kg 
bw. The NOAEL for general toxicity was less than 125 mg/kg bw, based on transient 
reductions in body weight gain in males at all doses. In a repeated-dose neurotoxicity 
study, there were no signs of neuropathy or neurotoxicity at 3000 ppm (equal to 172 
mg/kg bw per day), the highest dose tested.
77. FLUVALINATE  
Source: JMPR
Kind of Neurotoxicity: NO DATA
78. FOLPET  
Source: FOLPET 85–94 JMPR 2004
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Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Other than developmental effects, folpet produced no toxicological effects that might 
be considered to be a consequence of acute exposure. The Meeting concluded that it 
was not necessary to establish an ARfD for the general population, including children 
aged 1–6 years for whom separate data on dietary intake are available. The Meeting 
concluded that it might be necessary to establish an ARfD to protect the embryo or 
fetus from possible effects in utero. Such an ARfD would apply to women of 
childbearing age.
The maternal toxicity and the associated reductions in fetal body weight, delayed 
ossification and increased incidences in skeletal variations observed in studies of 
developmental toxicity in rabbits are likely to be caused by high local concentrations 
of folpet and are not considered to be relevant to dietary exposure. However, the 
increased incidence of hydrocephalus observed could not be attributed with 
confidence to maternal toxicity. 
The Meeting concluded that the database was insufficient (in particular, with regard 
to the absence of studies on the developmental effects of phthalimide) to establish 
the mode of action by which the increased incidence of hydrocephalus, observed in 
rabbits at 60mg/kg bw per day (NOAEL, 20mg/kg bw per day) was induced, and as a 
consequence, their relevance for deriving an ARfD could not be dismissed. Therefore 
the Meeting established an ARfD of 0.2mg/kg bw based on a NOAEL of 20mg/kg bw 
per day for the increased incidence of hydrocephalus at 60mg/kg bw per day in 
rabbits and a safety factor of 100. The use of a safety factor of 100 was considered 
to be conservative; although the mode of action by which the developmental effects 
are induced was uncertain, they are possibly secondary to maternal toxicity. The 
Meeting noted that it might be possible to refine this ARfD using the results of an 
appropriately designed study. 
Estimate of acute reference dose 
0.2mg/kg bw for women of childbearing age 
Unnecessary for the general population
79. FORMETANATE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
139
80. GLYPHOSATE 
Source: GLYPHOSATE 95–169 JMPR 2004
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity No evidence of neurotoxicty in any study 
conducted
81. HEPTACHLOR and its metabolites 
Source: JMPR REPORT 1991
Kind of Neurotoxicity: NO NEUROTOXICITY DATA 
82. HEXACHLOROBENZENE / HCB 
Source: JMPR
Kind of Neurotoxicity: NO DATA
ADI WITHDRAWN IN 1978
83. HCH 
Source: JMPR
Kind of Neurotoxicity: NO DATA
84. IMAZALIL 
Source: IMAZALIL 303–314 JMPR 2005 
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Special studies: developmental neurotoxicity
A study of reproductive toxicity with measurement of neurobehavioural end-points 
was reported in which groups of 10 male and 10 female Crj.
In view of the inconsistent results at the lowest dose, the many end-points measured, 
and lack of dose–response relationships in the adverse outcomes observed, the 
NOAEL was the lowest dose tested, about 20 mg/kg bw per day (Tanaka, 1995).
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85. IMIDACLOPRID 
FAO Plant Production and Protection Paper, 167, 2001 - Pesticide residues in food - 
2001. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 2001
Kind of Neurotoxicity: ACUTE – SHORT TERM NEUROTOXICITY
In a study of acute neurotoxicity in rats, clinical signs and effects on motor and 
locomotor activity and in the “functional observational battery” were observed at 
doses 150 mg/kg bw 1 day after application. Complete recovery was observed within 
7 days. The NOAEL was 42 mg/kg bw. In a 13-week study of neurotoxicity in rats, 
the NOAEL of 140 ppm, equal to 9.3 mg/kg bw per day, was based on reduced body-
weight gain and food consumption at doses 960 ppm, equal to 63 mg/kg bw per day. 
Behavioural effects were observed only in the “functional observational battery” in 
males at 3000 ppm, equal to 200 mg/kg bw per day.
Neurotoxicity
Clinical signs and neurobehavioural 
effects ascribed to acute cholinergic 
toxicity; short-term effects related to 
general toxicity
NOAEL (acute neurotoxicity) 42 mg/kg bw
NOAEL (short-term study of neurotoxicity) 140 ppm (9.3 mg/kg bw per day)
86. INDOXACARB 
Source: INDOXACARB 31 –3 JMPR 2005  
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
Neurotoxicity/delayed neurotoxicity 
Evidence of neurotoxicity at high doses (100 
mg/kg bw in females and 200 mg/kg bw in 
males)
Lowest relevant NOAEL 12.5 mg/kg bw (for reduced body-weight gain 
and food consumption )
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ARfD      0.1 mg/kg bw       Rat, acute neurotoxicity  100
In a study of acute neurotoxicity in rats, reduced body-weight gain and food 
consumption occurred at doses of 50 mg/kg bw and above in females and 200 
mg/kg bw in males. The NOAEL was 12.5 mg/kg bw. In females, evidence of 
neurotoxicity, such as slightly reduced motor activity, was observed at 100 mg/kg 
bw. In males, a reduced forelimb grip strength and decreased foot splay was 
observed at 200 mg/kg bw.
87. IPRODIONE    
FAO Plant Production and Protection Paper, 133, 1996 - Pesticide residues in food - 
1995. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and WHO Toxicological and Environmental Core 
Assessment
Source: JMPR REPORT 1995  
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Iprodione, a dicarboximide fungicide, was previously evaluated toxicologically by the 
JMPR in 1977 133 iprodione and 1992. An ADI of 0-0.2 mg/kg bw was allocated in 
1992. Since that time, long-term carcinogenicity studies in rats and mice that 
included higher doses and supplemental studies of the possible mechanism of 
tumorigenicity have become available and were evaluated by the present Meeting.
An ADI of 0-0.06 mg/kg bw was established on the basis of an NOAEL of 6 mg/kg bw 
per day in the most recent two-year study of carcinogenicity in rats and a safety 
factor of 100.
88. KRESOXIM-METHYL 
FAO Plant Production and Protection Paper, 148, 1999 - Pesticide residues in food - 
1998. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 1998  
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
142
Neurotoxicity / Delayed neurotoxicity No data
89. ISOPROTHIOLANE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
90. LUFENURON 
Source: LUFENURON 453–500 JMPR 2015   
Kind of Neurotoxicity: SUBCHRONIC NEUROTOXICITY
Neurotoxicity: 
Acute neurotoxicity NOAEL No evidence of acute neurotoxicity 
Subchronic neurotoxicity NOAEL 5.43 mg/kg bw per day (4 months; rat) 
Developmental neurotoxicity NOAEL No data
91. MANDIPROPAMID 
Source: MANDIPROPAMID 173–196 JMPR 2008    
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity: 
Acute neurotoxicity and studies of short-term neurotoxicity No indications of 
neurotoxicity in studies of 
acute toxicity or repeat-
dose studies
92. MANEB (dithiocarbamates)
FAO Plant Production and Protection Paper, 122, 1993 - Pesticide residues in food - 
1993. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues
Source: JMPR REPORT 1993    
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Maneb or the sum of any combination of maneb, mancozeb, and zineb, of which not 
more than 0.002 mg/kg bw may be present as ethylenethiourea (ETU).
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GROUP ADI WITH MANCOZEB, METIRAM & ZINEB  0.03 
93. METAFLUMIZONE 
Source: METAFLUMIZONE 357–418 JMPR 2009    
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity: 
Acute neurotoxicity No evidence of neurotoxicity; NOAEL: 2000 mg/kg bw 
(highest dose tested) 
Subchronic neurotoxicity No evidence of neurotoxicity; NOAEL: 300/150 mg/kg 
bw per day (highest dose tested; 90-day study in rats)
94. METALAXYL – METALAXYL-M 
Source: METALAXYL AND METALAXYL-M 165-221 JMPR 2002
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity No concerns arising from available information
95. METHAMIDOPHOS 
Source: METHAMIDOPHOS 223-253 JMPR 2002
Kind of Neurotoxicity: ACUTE – SHORT – DELAYED NEUROTOXICITY
Acute Neurotoxicity NOAEL: 0.3 mg/kg bw for inhibition of cholinesterase activity 
(rats) 
ARfD 0.01 mg/kg bw 
90-day NOAEL: 1ppm (equal to 0.067 mg/kg bw for 
inhibition of cholinesterase activity, rats)
Delayed Polyneuropathy Signs of delayed polyneuropathy observed at 
doses above the LD50    
96. METHIDATHION 
FAO Plant Production and Protection Paper, 145, 1998 - Pesticide residues in food - 
1997. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
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Source: JMPR REPORT 1997
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
In another study of acute neurotoxicity in rats, changes in clinical signs, the results of 
a battery of functional observational tests, and maze activity were observed at the 
time of peak effect (about 2 h after treatment) at 8 mg/kg bw and above in males and 
at 4 mg/kg bw and above in females. Inhibition of acetylcholinesterase activity in 
various regions of the brain was found at doses of 4 mg/kg bw and above. Reduced 
acetylcholinesterase activity in the cortex and hyppocampus of a male treated with 1 
mg/kg bw was not considered to be relevant. The overall NOAEL in this study was 1 
mg/kg bw.
97. METHIOCARB 
FAO Plant Production and Protection Paper, 148, 1999 - Pesticide residues in food - 
1998. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 1998
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/Delayed neurotoxicity Does not cause delayed polyneuropathy
In an early study of neurotoxicity in hens, methiocarb did not cause delayed 
polyneuropathy of the organophosphorus type. Atropine has consistently been shown 
to be an effective antidote for methiocarb, while the effects of pyridinium oximes were 
somewhat inconsistent.
98. METHOMYL 
FAO Plant Production and Protection Paper, 167, 2001 - Pesticide residues in food - 
2001. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 2001
Kind of Neurotoxicity: ACUTE – SHORT TERM NEUROTOXICITY 
Rat:
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Acute neurotoxicity after 
administration by gavage Inhibition of erythrocyte and brain cholinesterase 
NOAEL 0.25 mg/kg bw LOAEL 0.5 mg/kg bw
Acute neurotoxicity after
administration in the diet Reduced response to tail pinch 
NOAEL 1.0 mg/kg bw LOAEL 1.9 mg/kg bw
13-week study of
neurotoxicity after
administration in the diet Clinical signs and brain cholinesterase inhibition
NOAEL 150 ppm (equal to 9.4 mg/kg bw per day)
LOAEL 1500 ppm (equal to 95 mg/kg bw per day)
99. METHOXYCHLOR
Source: JMPR
Kind of Neurotoxicity: NO DATA
ONLY ADI
100. METHOXYFENOZIDE 
Source: METHOXYFENOZIDE 161–202 JMPR 2003
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity: 
Acute neurotoxicity NOAEL: >2000 mg/kg bw; no neuropathy (rat) 
90-day study of neurotoxicity NOAEL: 1318 mg/kgbw per day (highest dose 
tested); no neuropathy (rat)
101. MIREX 
Source: JMPR
Kind of Neurotoxicity: NO DATA
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102. MONOCROTOPHOS 
FAO Plant Production and Protection Paper, 122, 1993 - Pesticide residues in food - 
1993. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues.
Source: JMPR REPORT 1993
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
103. MYCLOBUTANIL 
Source: MYCLOBUTANIL 357–405 JMPR 2014
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Neurotoxicity 
Acute neurotoxicity NOAEL No data 
Subchronic neurotoxicity NOAEL No data 
Developmental neurotoxicity NOAEL No data
104. OXADIXYL
Source: JMPR
Kind of Neurotoxicity: NO DATA
105. OXAMYL 
Source: OXAMYL 255-282 JMPR 2002
Kind of Neurotoxicity: ACUTE-SHORT TERM NEUROTOXICITY 
Neurotoxicity Inhibition of cholinesterase activity in brain, plasma and
erythrocytes and clinical and behavioural effects 
associated with cholinesterase inhibition
Lowest relevant oral
NOAEL 0.1 mg/kg bw, rats
Delayed neurotoxicity No concern
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Acute neurotoxicity /Neurotoxicity effect NOAEL 0.1mg/kg bw 
LOAEL 0.75 mg/kg bw
90- day neurotoxicity /Neurotoxicity effect NOAEL 30 ppm, equal to 1.7 
mg/kg bw per day
LOAEL250 ppm, equal to 15 
mg/kg bw per day
106. PENCONAZOLE 
Source: PENCONAZOLE 501–558 JMPR 2015
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Neurotoxicity
Acute neurotoxicity NOAEL No data
Subchronic neurotoxicity NOAEL No data
Developmental neurotoxicity NOAEL No data
107. PENCYCURON 
Source: JMPR
Kind of Neurotoxicity: NO DATA
108. PENDIMETHALIN 
Source: JMPR
Kind of Neurotoxicity: NO DATA
ONLY ADI
109. PHOSALONE 
FAO Plant Production and Protection Paper, 167, 2001 - Pesticide residues in food - 
2001. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 2001
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
148
There is no evidence that phosalone has the potential to cause delayed neuropathy.
110. PHOSMET 
Source: PHOSMET 267–273 JMPR 2003
Kind of Neurotoxicity: ACUTE NEUROTOXICITY 
In study of acute neurotoxicity in rats given phosmet by gavage, erythrocyte 
acetylcholinesterase activity was inhibited by >70% at 22.5mg/kgbw and by about 
10% at 4.5mg/kgbw. Brain acetylcholinesterase activity was inhibited by >60% at 
22.5mg/kgbw (Cappon, 1998). These results suggest that rabbits given phosmet at a 
dose of 15mg/kgbw (as in the study of developmental toxicity by Moxon, 1991) would 
show significant inhibition of acetylcholinesterase activity.
The 1998 JMPR concluded that: “. . . there was no evidence that phosmet could 
produce clinical signs of delayed polyneuropathy or significantly inhibit neuropathy 
target esterase” (Annex 1, reference 85).
The Meeting established an acute RfD of 0.2mg/kgbw based on the NOAEL of 
2mg/kgbw (the highest dose tested) for inhibition of erythrocyte cholinesterase in 
men and women, and a safety factor of 10.
111. PARATHION-METHYL  
FAO Plant Production and Protection Paper, 133, 1996 - Pesticide residues in food - 
1995. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and WHO Toxicological and Environmental Core 
Assessment.
Source: JMPR REPORT 1995
Kind of Neurotoxicity: CHRONIC NEUROTOXICITY 
In a one-year study in rats to determine the ocular and neurotoxic effects of 
parathion-methyl, dietary levels of 0, 0.5, 2.5, 12 or 50 ppm were administered. 
Ocular toxicity was not observed. Degenerative changes of the sciatic nerve and 
its extensions consistent with demyelination were observed at the two highest 
doses.
In another two-year study in rats, parathion-methyl did not induce carcinogenic 
effects. The NOAEL was 5 ppm (equivalent to 0.25 mg/kg bw per day) on the basis 
of the observation of tremors, anogenital staining, reduced body weight, retinal 
Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 15:42:27 EEST - 137.108.70.13
149
degeneration, sciatic nerve degeneration, decreased packed cell volume and 
haemoglobin and erythrocyte counts, and decreased brain cholinesterase 
activity in males and females at 50 ppm (equivalent to 2.5 mg/kg bw per day).
An ADI of 0-0.003 mg/kg bw was established on the basis of the NOAEL of 5 ppm, 
equivalent to 0.25 mg/kg bw per day, in the two-year study in rats for retinal 
degeneration, sciatic nerve demyelination, reduced body weight, anaemia, and 
decreased brain acetylcholinesterase activities. A safety factor of 100 was used. 
Since the toxicological end-points seen in animals were other than 
acetylcholinesterase inhibition, a safety factor of 10 could not be applied to the 
NOAEL in humans.
An acute reference dose of 0.03 mg/kg bw was derived by applying the usual 10-
fold safety factor from an NOAEL of 19 mg/kg bw (highest oral dose), corresponding 
to about 0.3 mg/kg bw per day, in humans. This was based on the absence of 
inhibition of erythrocyte acetylcholinesterase.
112. PENTACHLOROBENZENE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
113. PERMETHRIN 
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group.
Source: JMPR REPORT 1999
Kind of Neurotoxicity: ACUTE – SHORT TERM NEUROTOXICITY
Neurotoxicity/Delayed neurotoxicity NOAEL, 150 mg/kg bw, single dose, 
rats;
NOAEL ,15.5 mg/kg bw per day in a 90-
day study, rats
No acute delayed effect in hens (9050 
mg/kg bw)
The results of acute and 90-day studies of neurotoxicity in rats and of an acute 
delayed neurotoxicity study in hens showed that technical-grade permethrin does not 
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induce neuropathological changes. The NOAEL for neurotoxicity in a study in rats 
given a single dose was 150 mg/kg bw, on the basis of clinical signs of 
neurotoxicity and significant changes in measurements in a functional observational 
battery of tests at 300 mg/kg bw. The NOAEL for neurotoxicity in a 13-week study 
in rats was 15 mg/kg bw per day, on the basis of clinical signs of neurotoxicity 
and significant changes in measurements in the functional observational battery of 
tests at 90 mg/kg bw per day.
114. PHENYLPHENOL
Source: JMPR
Kind of Neurotoxicity: NO DATA
115. 2-PHENYLPHENOL 
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 1999
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/Delayed neurotoxicity 
No evidence of developmental neurobehavioral toxicity in rats. No evidence of 
neurotoxicity or neuropathology in medium- and long-term studies, mice, rats, dogs, 
or in developmental toxicity studies, mice, rats and rabbits.
116. PROMETRYN 
Source: JMPR
Kind of Neurotoxicity: NO DATA 
117. PIPERONYL BUTOXIDE 
Source: JMPR REPORTS 1992 & 1995
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
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118. PIRIMICARB 
Source: PIRIMICARB 207–279 JMPR 2004 
Kind of Neurotoxicity: ACUTE – SHORT TERM NEUROTOXICITY 
Neurotoxicity/delayed neurotoxicity
Target/critical effect Nervous system/cholinergic signs
Lowest relevant NOAEL 10 mg/kg bw
90-day neurotoxicity
Target/critical effect Nervous system/cholinergic signs
Lowest relevant NOAEL 77mg/kg bw per day
ARfD 0.1mg/kg bw Rat; mortality and clinical signs of 
neurotoxicity in a study of acute neurotoxicity 100
119. PIRIMIPHOS-METHYL 
Source: PIRIMIPHOS-METHYL X-X JMPR 2006
Kind of Neurotoxicity: ACUTE NEUROTOXICITY 
Two single-dose studies of neurotoxicity in rats were available. In the first, after 
administration of a high dose (1000 mg/kg bw) of pirimiphos-methyl, maximum 
inhibition (61%) of brain acetylcholinesterase activity was found after 24 h. Partial 
recovery was apparent at 48–72 h. In the second single-dose study of neurotoxicity, 
rats treated with pirimiphos-methyl at 150 or 1500 mg/kg bw showed dose-dependent 
reductions in erythrocyte and brain acetylcholinesterase activity 24 h after 
administration. In the animals at the highest dose, brain acetylcholinesterase activity 
had only partially recovered by day 15 after treatment. On the basis of the inhibition 
in brain cholinesterase activity at 24 h, the NOAEL was 15 mg/kg bw.
In one 28-day and one 56-day study in humans, pirimiphos-methyl was administered 
orally at a dose of 0.25 mg/kg bw per day. In neither study was inhibition of 
erythrocyte acetylcholinesterase activity nor any other toxicologically relevant effect 
observed.
Rat    Acute neurotoxicity  Neurotoxicity NOAEL 15 mg/kg bw  
LOAEL 150 mg/kg bw
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In establishing an ARfD, the Meeting concluded that it is appropriate to use data on 
inhibition of acetylcholinesterase activity in rats from a single-dose study of 
neurotoxicity in which a NOAEL of 15 mg/kg bw was identifi ed. Based on this 
NOAEL, the Meeting established an ARfD of 0.2 mg/kg bw, using a safety factor of 
100.
120. PROCHLORAZ 
Source: JMPR REPORT 2001
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE 
Neurotoxicity/delayed neurotoxicity No concern from other studies
121. PROCYMIDONE 
Source: PROCYMIDONE 349–401 JMPR 2007
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity No evidence in conventional studies
122. PROFENOFOS 
Source: PROFENOFOS 403–443 JMPR 2007 
Kind of Neurotoxicity: ACUTE – DNT NEUROTOXICITY 
Neurotoxicity/delayed neurotoxicity 
Acute neurotoxicity Inhibition of brain acetylcholinesterase activity, 
NOAEL was 100 mg/kg bw per day (rats) 
Developmental neurotoxicity Inhibition of brain acetylcholinesterase activity, 
NOAEL was 5.1 mg/kg bw per day (rats) 
Delayed neuropathy No delayed neurotoxicity, NOAEL was 45.7 
mg/kg bw (chickens)
ARfD 1 mg/kg bw Rat, study of acute neurotoxicity 100
In studies of acute neurotoxicity in rats, identified on the basis of clinical signs of 
neurotoxicity seen at >=200 mg/kg bw and inhibition of brain acetylcholinesterase 
activity at 400 mg/kg bw and using a safety factor of 100. 
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The Meeting established an ADI of 0–0.03 mg/kg bw per day based on an overall 
NOAEL of 2.9 mg/kg bw per day identified on the basis of inhibition of brain 
acetylcholinesterase activity in three short-term studies in dogs and using a safety 
factor of 100. This ADI was supported by the NOAEL of 5.1 mg/kg bw per day 
identified on inhibition of maternal and pup brain acetylcholinesterase activity in a 
study of developmental neurotoxicity in rats and a NOAEL of 4.5 mg/kg bw per day 
identified on the basis of inhibition of brain acetylcholinesterase activity in a 2-year 
study in mice.
123. PROPAMOCARB 
Source: JMPR REPORT 2005 
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
ARfD 2 mg/kg bw Rat, acute neurotoxicity 100
Neurotoxicity/delayed neurotoxicity Neurotoxicity Decreased activity 1 h 
after a single dose administered by 
gavage (rats) Vacuolization of the 
choroid plexus in the brain after 
repeated dosing (rats) 
Lowest relevant oral NOAEL 200 mg/kg bw (single dose by gavage) 
52 mg/kg bw per day (repeated dietary 
dosing)
124. PROPARGITE 
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 1999 
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/Delayed neurotoxicity No evidence of neurotoxicity
125. PROPICONAZOLE 
Source: PROPICONAZOLE 281–323 JMPR 2004
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Kind of Neurotoxicity: NO NEUROTOXICITY DATA
Neurotoxicity/delayed neurotoxicity No specific studies; no findings in other studies
126. PROPOXUR 
Source: JMPR
Kind of Neurotoxicity: NO DATA
ONLY ADI
127. PYMETROZINE 
Source: PYMETROZINE X–X JMPR 2014
Kind of Neurotoxicity: ACUTE – SUBCHRONIC NEUROTOXICITY
Acute neurotoxicity NOAEL < 125 mg/kg bw per day, lowest 
dose tested (rat) 
Subchronic neurotoxicity NOAEL 68 mg/kg bw per day (rat) 
Developmental neurotoxicity NOAEL No data
The acute neurotoxicity of pymetrozine was investigated in rats at doses of 0, 125, 
500 and 2000 mg/kg bw. Three males died at 2000 mg/kg bw. Dose-related 
reductions in locomotor activity were seen in all dose groups at 4–5 hours post-
dosing, but not subsequently. There were no indications of neuropathy. No NOAEL 
was identified. 
In a subchronic (90-day) neurotoxicity study in rats, dietary concentrations were 0, 
500, 1000 and 3000 ppm (equal to 0, 35, 68 and 201 mg/kg bw per day for males 
and 0, 41, 81 and 204 mg/kg bw per day for females, respectively). The NOAEL for 
neurotoxicity and systemic toxicity was 1000 ppm (equal to 68 mg/kg bw per day), 
based on altered behaviours (continuous head movements and abnormal gait) and 
reduced body weights at 3000 ppm (equal to 201 mg/kg bw per day). There was no 
evidence of neuropathy.
128. PYRACLOSTROBIN 
Source: PYRACLOSTROBIN 275–319 JMPR 2003
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
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Pyraclostrobin was not found to be neurotoxic.
129. PYRAZOPHOS 
FAO Plant Production and Protection Paper, 116, 1993 - Pesticide residues in food - 
1992. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues
Source: JMPR REPORT 1992
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Pyrazophos did not cause delayed neuropathy in hens.
In a 92/96 (female/male) week study in mice at dietary concentrations of 0, 1, 5 or 25 
ppm, pyrazophos did not cause adverse effects up to the highest nominal 
concentration of 25 ppm, equal to 3.5 and 4.1 mg/kg bw/day in males and females, 
respectively. Inhibition of serum and erythrocyte cholinesterase activities but not of 
brain acetyl cholinesterase activity was observed at 5 ppm and above. The poor 
correspondence between actual and nominal concentrations of pyrazophos in diets 
hampered definitive evaluation of this study.
In a two-year study in rats at dietary levels of 0, 2, 80 or 320 ppm, the NOAEL was 2 
ppm, equal to 0.1 mg/kg bw/day, based on a higher incidence of hemangiomas in 
mesenteric lymph nodes detected in males at the higher doses. Marginal brain acetyl 
cholinesterase inhibition was noted at 320 ppm only.
In a two-year study in rats at dietary concentrations of 0, 5, 8, 10 or 50 ppm the 
NOAEL was 50 ppm, equivalent to 2.5 mg/kg bw/day, based on the absence of 
adverse effects including brain acetyl cholinesterase inhibition at this dose level. No 
compound-related abnormalities were detected in mesenteric lymph nodes.
130. PYRETHRINS (PYRETHRIN I)
FAO Plant Production and Protection Paper, 116, 1993 – Pesticide residues in food – 
1992. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues
Source: JMPR REPORT 1992
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
In a study of neurotoxicity in rats given single oral doses, acute neurological 
disorders (tremors, wetness of the urogenital area, salivation, perinasal encrustation, 
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exaggerated startle response, decreased grip strength, and hind-leg splay) and 
behavioural effects (increased motor activity and decreased rearing and ambulation) 
were noted, with a NOAEL of 20 mg/kg bw.
131. PYRIDABEN 
Source: JMPR
Kind of Neurotoxicity: NO DATA
132. PYRIMETHANIL 
Source: PYRIMETHANIL 445–486 JMPR 2007
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity 
Acute neurotoxicity No sign of specific neurotoxicity
133. PYRIPROXYFEN 
FAO Plant Production and Protection Paper, 153, 1999 - Pesticide residues in food - 
1999. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 1999
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/Delayed neurotoxicity No evidence of developmental 
neurobehavioural toxicity in rat. No 
evidence of neurotoxicty or 
neuropathology in medium- or long-term 
studies in mouse, rat, dog or during 
development in rat, rabbit.
134. QUINALPHOS 
Source: JMPR 
Kind of Neurotoxicity: NO DATA
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135. SPINOZAD 
FAO Plant Production and Protection Paper, 167, 2001 - Pesticide residues in food - 
2001. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and the WHO Core Assessment Group
Source: JMPR REPORT 2001
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity was investigated in rats by giving them a single dose of up to 2000 
mg/kg bw, doses up to 43 mg/kg bw per day for 3 months, or doses up to 49 mg/kg 
bw per day for 12 months. Comprehensive behavioural and histopathological 
investigations revealed no evidence of neurotoxicity.
Neurotoxicity/Delayed neurotoxicity 
No evidence of neurotoxicity in a 12-month study in rats at doses up to 49 mg/kg bw 
per day
136. SPIRODICLOFEN 
Source: SPIRODICLOFEN 419–496 JMPR 2009
Kind of Neurotoxicity: SUBCHRONIC NEUROTOXICITY
Neurotoxicity/delayed neurotoxicity 
Acute neurotoxicity No evidence of neurotoxicity; NOAEL: 1000 mg/kg bw 
per day 
Subchronic neurotoxicity Decreased motor and locomotor activity (females 
only); NOAEL: 87 mg/kg bw per day 
Developmental neurotoxicity No evidence of developmental neurotoxicity
Neurotoxicity was investigated in a study of acute neurotoxicity, a short-term study of 
toxicity and studies of developmental neurotoxicity in rats. There was no evidence of 
neurotoxicity in the study of acute neurotoxicity, and the only evidence of 
neurotoxicity in the short-term study was decreased motor and locomotor activity 
in females at 12 500 ppm, equal to 1310 mg/kg bw per day (the limit dose), during 1 
week of treatment.
Two studies of developmental neurotoxicity were conducted. Overall, the Meeting 
considered that these studies did not indicate any treatment-related fi ndings on 
neurotoxicity parameters in offspring.  
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Kind of Neurotoxicity: NO DATA
138. SPIROXAMINE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
139. SULFON 
Source: JMPR
Kind of Neurotoxicity: NO DATA
140. SULFUR 
Source: JMPR
Kind of Neurotoxicity: NO DATA
141. TEBUCONAZOLE 
Source: TEBUCONAZOLE 503–564 JMPR 2010
Kind of Neurotoxicity: ACUTE NEUROTOXICITY 
Neurotoxicity/delayed neurotoxicity 
Acute neurotoxicity Increased motor activity in rats 
Subchronic neurotoxicity No neurotoxicity in rats     
Developmental neurotoxicity No neurodevelopmental toxicity in rats
In a study of acute neurotoxicity in rats with tebuconazole, the NOAEL was 50 
mg/kg bw based on increased motor activity in male and female rats and 
decreased footsplay in female rats at 100 mg/kg bw. In a 90-day study of 
neurotoxicity in rats, no systemic or neurotoxic effects were seen at doses up to 1600 
ppm (equal to 107 mg/kg bw per day), the highest dose tested. In a developmental 
neurotoxicity study in rats with dietary administration, the maternal NOAEL was 300 
ppm (equal to 22 mg/kg bw per day), based on decreased body weights, body weight 
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gains and feed consumption, prolonged gestation with mortality and an increased 
number of dead fetuses at 1000 ppm (equal to 65 mg/kg bw per day). The offspring 
toxicity NOAEL was 300 ppm (equal to 22 mg/kg bw per day), based on decreased 
pup viability, decreases in body weights and absolute brain weights, brain 
measurements and evidence of developmental delays seen at 1000 ppm (equal to 65 
mg/kg bw per day), the highest dose tested. Tebuconazole did not produce 
neurobehavioural or neuropathological changes.
142. TEBUFENPYRAD 
Source: JMPR
Kind of Neurotoxicity: NO DATA
143. TETRACONAZOLE 
Source: JMPR
Kind of Neurotoxicity: NO DATA
144. TETRADIFON 
Source: JMPR
Kind of Neurotoxicity: NO DATA
145. THIABENDAZOLE 
Source: THIABENDAZOLE X-X JMPR 2006
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
In order to better understand the nature and duration of the reversible neuroactive 
effects observed in the main single-dose study of toxicity (Noakes, 2004b), and also 
to establish clear NOAELs for all observation periods, an additional study was 
conducted. 
These reversible neuroactive effects were similar in severity and duration to those 
observed at 100 mg/kg in the preceding study in rats treated by gavage (Noakes, 
2004b). There were no toxicologically significant effects on body weight. Slightly low 
food consumption was seen for females treated with thiabendazole at 100 mg/kg bw 
on day 1 only.
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Single-dose studies of toxicity: Three single-dose studies of toxicity in rats were 
provided for assessment by the present Meeting. As the neuroactive effects 
observed at 100 mg/kg bw were marginal, the NOAEL was 100 mg/kg bw. In the 
dietary study, no treatment-related effects on clinical signs, FOB assessment, motor 
activity or body weight were observed at up to 600 ppm (equal to 46 mg/kg bw), the 
highest dose tested.
146. THIACLOPRID 
Source: THIACLOPRID X-X JMPR 2006
Kind of Neurotoxicity: ACUTE NEUROTOXICITY
Neurotoxicity 
Acute neurotoxicity Clinical signs, effects in FOB observations, 
decreased motor and locomotor activity; NOAEL: 
3.1 mg/kg bw 
Subchronic neurotoxicity No evidence of neurotoxicity; NOAEL: 101 mg/kg bw 
per day at highest dose tested 
Developmental neurotoxicity No evidence of developmental neurotoxicity; decreased 
body weight and delayed sexual maturation at 
maternally toxic doses; NOAEL: 4.4 mg/kg bw per day
147. THIAMETHOXAM 
Source: THIAMETHOXAM 565–676 JMPR 2010
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity/delayed neurotoxicity No signs of neurotoxicity
148. THIAMETHOXAM (+CLOTHIANIDIN) 
Source: JMPR 
Kind of Neurotoxicity: NO DATA
149. THIOPHANATE-METHYL 
Source: THIOPHANATE-METHYL X-X JMPR 2006
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Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
In a study of acute neurotoxicity in rats, the NOAEL for general toxicity was 125 
mg/kg bw on the basis of transient reductions in body-weight gains (including body-
weight losses) and feed consumption at 500 mg/kg bw and above. The NOAEL for 
neurotoxicity was 2000 mg/kg bw, the highest dose tested. 
In a short-term study of neurotoxicity in rats, the NOAEL for general toxicity was 500 
ppm (equal to 30.3 and 34.9 mg/kg bw per day in males and females, respectively) 
on the basis of decreased body weights and feed consumption in females and 
increased liver and thyroid weights in both sexes at 2500 ppm. No neurohistological 
changes were seen at 2500 ppm. The NOAEL for neurotoxicity was 2500 ppm (equal 
to 149.6 and 166.3 mg/kg bw per day in males and females, respectively), the 
highest dose tested.
The Meeting concluded that it was not necessary to establish an ARfD for 
thiophanate-methyl in view of its low acute toxicity, the absence of relevant 
developmental toxicity that could be a consequence of acute exposure, the absence 
of relevant findings in a study of acute neurotoxicity, and the absence of any 
other toxicological effect that would be likely to be elicited by a single dose.
150. TOLCLOFOS-METHYL 
FAO Plant Production and Protection Paper, 127, 1995 - Pesticide residues in food - 
1994. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and a WHO Expert Group on Pesticide Residues.
Source: JMPR REPORT 1994
Kind of Neurotoxicity: SUBCHRONIC NEUROTOXICITY
Tolclofos-methyl did not cause delayed neuropathy in chickens. 
In a nine-month toxicity study in which mice were fed tolclofos-methyl in the diet at 0, 
10, 30, 100 or 3000 ppm the NOAEL was 100 ppm, equal to 12 mg/kg bw per day, 
on the basis of inhibition of brain cholinesterase and effects on body weight at 3000 
ppm.
In a 32-34-day toxicity study in which rats were fed diets containing 0, 200, 1000, 
5000 or 20,000 ppm the NOAEL was 1000 ppm, equal to 79 mg/kg bw per day, on 
the basis of inhibition of brain cholinesterase and increased relative kidney weight at 
5000 ppm. In a 13-week toxicity study in which rats were fed diets containing 0, 100, 
1000 or 10,000 ppm the NOAEL was again 1000 ppm, equal to 66 mg/kg bw per day, 
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on the basis of effects on body, liver and kidney weights at 10,000 ppm. In a 28-week 
toxicity study in which rats were fed dietary levels of 0, 300, 1000, 3000 or 10,000 
ppm the NOAEL was also 1000 ppm, equal to 65 mg/kg bw per day, on the basis of 
histopathological liver changes in females at 3000 ppm.
151. TRIADIMENOL AND TRIADIMEFON 
Source: TRIADIMENOL AND TRIADIMEFON 325–386 JMPR 2004
Kind of Neurotoxicity: ACUTE-SUBCHRONIC NEUROTOXICITY
TRIADIMENOL:
Neurotoxicity/delayed neurotoxicity 
Critical effects at LOAEL See triadimefon 
Lowest NOAEL See triadimefon
TRIADIMEFON:
Neurotoxicity/delayed neurotoxicity 
Critical effects Increased activity in study of acute neurotoxicity 
after gavage administration (rat) 
Lowest NOAEL 2 mg/kg bw 
Critical effects Increased activity in short-term feeding study 
(rat) 
Lowest NOAEL 3.4 mg/kg bw
152. TRIAZOPHOS 
Source: TRIADIMENOL AND TRIADIMEFON 325–386 JMPR 2004
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE
Neurotoxicity
Delayed neuropathy No concern for delayed polyneuropathy at 
doses relevant to human dietary intake
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Kind of Neurotoxicity: NO DATA
155. TRIFLOXYSTROBIN 
Source: TRIFLOXYSTROBIN 387–450 JMPR 2004
Kind of Neurotoxicity: NO NEUROTOXICITY EVIDENCE 
Neurotoxicity No evidence of acute neurotoxicity in rats
156. TRIFLURALIN 
Source: JMPR 
Kind of Neurotoxicity: NO DATA
157. VINCLOZOLIN 
FAO Plant Production and Protection Paper, 133, 1996 - Pesticide residues in food - 
1995. Report of the Joint Meeting of the FAO Panel of Experts on Pesticide Residues 
in Food and the Environment and WHO Toxicological and Environmental Core 
Assessment
Source: JMPR REPORT 1995
Kind of Neurotoxicity: NO NEUROTOXICITY DATA
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